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ABSTRACT 
Cold water immersion is commonly used to alleviate the stress and damage that ensues 
following strenuous exercise. Alongside its purported performance and analgesic benefits 
recent literature highlights the positive impact it may have towards endurance adaptive 
responses, particularly on key markers of mitochondrial biogenesis. Despite these recent 
advances showing PGC-1α, the ‘master regulator’ of mitochondrial biogenesis, being 
augmented in its post-exercise response by cold water immersion, the precise controlling 
mechanisms remain to be determined. However, it has been suggested that local cooling 
effects on AMPK and p38 MAPK related signalling and/or increased systemic β-adrenergic 
stimulation are involved.  
 
Study 1 (Chapter 4) examined whether post-exercise cold-water immersion induced 
augmentation of PGC-1α mRNA is mediated through local or systemic mechanisms. 
Participants completed acute cycling followed by seated-rest (CON) or single-leg cold-
water immersion (CWI; 10 min, 8°C) with muscle biopsies obtained pre-, post- and 3 h 
post-exercise from a single limb in the CON condition but from both limbs in CWI (thereby 
providing tissue from a CWI and non-immersed limb, NOT).  Muscle temperature 
decreased following CWI (-5°C), with lesser changes observed in CON and NOT (-3°C; 
P<0.05). A significant interaction effect was present for AMPK phosphorylation (P=0.031). 
Exercise (CON) increased gene expression of PGC-1α 3 h post-exercise (~5-fold; P<0.001). 
Post-exercise CWI augmented PGC-1α expression above CON in immersed (CWI; ~9-fold; 
P=0.003) and NOT limbs (~12-fold; P=0.001). Plasma Normetanephrine concentration was 
higher in CWI vs. CON post-immersion (860 vs. 665 pmol·L-1; P=0.034). Data herein 
reports for the first time that local cooling of the immersed limb evokes transcriptional 
control of PGC1-α in the non-immersed limb, suggesting increased systemic β-adrenergic 
activation of AMPK may mediate, in part, post-exercise cold-induction of PGC-1α mRNA. 
 
Study 2 (Chapter 5) assessed the impact of combining a post-exercise cooling stimulus with 
prior low glycogen as both stressors are shown to separately enhance the post-exercise 
PGC-1α response. A single-leg depletion protocol and bi-lateral muscle biopsies with and 
without post-exercise CWI were utilised to give the following conditions: High glycogen 
control (HI CON), Low glycogen control (LO CON), High glycogen CWI (HI CWI) and 
Low glycogen CWI (LO CWI). HI limbs began the experimental day ~190 mmol·kg-1dry 
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weight (dw) with low limbs at ~85 mmol·kg-1dw glycogen before undergoing the same 
relative exercise protocol as Chapter 4. PGC-1α mRNA was different between conditions 
(P = 0.039) with HI glycogen limbs showing greater expression than contralateral LO 
glycogen limbs (P < 0.05). PGC-1α mRNA increased to a greater extent in CWI HI vs. 
CON HI (ES 0.67 Large). Data herein supports previous research that shows post-exercise 
CWI is able to augment PGC-1α above the exercise response alone, however this response 
was not evident in heavily depleted limbs (~85 mmol·kg-1dw), suggesting a critical 
threshold may exist for the expected enhancement of PGC-1α to occur when exercise is 
commenced in a low glycogen state. 
 
Chapter 6 sought to examine the contribution of CWI (Chapter 4, Experiment 1) and/or low 
muscle glycogen (Chapter 5, Experiment 2) in the activation of PGC-1α via either the 
canonical (Exon 1a) or the alternative promoter (Exon 1b) regions. Data was obtained using 
muscle biopsy samples collected from the previous chapters (Chapter 4 and 5). Exercise 
increased the expression of promoter specific PGC-1α, with greater fold changes seen in 
Exon 1b. Experiment 1 (Chapter 4) showed PGC-1α Exon 1b expression closely matched 
the pattern of expression seen for total-PGC-1α, with large, systemic cold-induced increases 
in the non-immersed (NOT, 2344 fold change from Pre, P = 0.010) and immersed (CWI, 
1860 fold change from Pre, P = 0.07), compared with the control limb (CON, 579 fold 
change from Pre). Results from experiment 2 (Chapter 5) saw PGC-1α Exon 1a and 1b gene 
expression increase post-exercise, with the Exon 1b response showing lower fold-changes 
at 3h post-exercise compared to those from Experiment 1 (chapter 4), despite the same 
exercise protocol being utilised (~200 fold increases in experiment 2 vs. ~2000 fold 
increases in experiment 1). The data suggests that depletion exercise in the days prior to the 
experimental day may have raised basal RNA levels, which may have therefore contributed 
to dampened fold-changes seen post-exercise when relativized to pre-exercise values. The 
lack of a cold augmentation in promoter specific PGC-1α gene expression in experiment 2 
suggests this response may be extremely acute, and may not occur when cooling is 
undertaken on the third day of exercise.  
 
This thesis provides a novel insight into the influence of local, systemic and upstream 
activating mechanisms regulating the post-exercise, post-cooling and exercising in low 
glycogen states upon PGC-1α. These findings provide mechanistic application for future 
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study designs and practical application in the support for the use of CWI when the intended 
target is an upregulation of the gene PGC-1α. 
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CHAPTER 1 
 
GENERAL 
INTRODUCTION 
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1.1 BACKGROUND 
It is well established that exercise that incorporates a novel eccentric component, or is of a 
particularly high-intensity or long duration, elicits muscle structure damage and 
disturbances in cellular and metabolic homeostasis, inflammation, and discomfort for the 
athlete (Friden & Lieber, 1992; Pournot et al., 2011). These alterations to metabolic 
homeostasis, damage to the muscle structure and ensuing inflammatory response are 
paralleled by other undesirable variables such as energy substrate depletion (Tee et al., 
2007), hyperthermia (Tyler et al., 2015), and oxidative stress (Close et al., 2004). 
Collectively, this response can negatively affect an athlete through diminished quality of 
training and performance (Marcora & Bosio, 2007). This potential for decreased 
performance in training and competition, and need for ‘optimal recovery’, has ultimately 
led to significant levels of research optimising appropriate and effective recovery strategies. 
 
Of particular interest is cold-water immersion (CWI). Since inflammation is fundamental 
in the aetiology of exercise stress, whole limb cooling via cold-water immersion is 
frequently applied immediately following exercise in an attempt to alleviate some of the 
physiological and functional deficits often associated with exercise stress and/or fatigue 
(Bailey et al., 2007). Historically cold application was used in the treatment of soft tissue 
injury (Swenson et al., 2011), more recently its popularity stems from an ability to reduce 
perceptions of DOMS often associated with intense exercise (Howatson & van Someren, 
2008) and induce acute subsequent performance benefits (Leeder et al., 2012). The 
mechanisms of CWI are proposed to be related to temperature and pressure induced changes 
in blood flow and reduced muscle temperature (Gregson et al., 2011), subsequently 
reducing post-exercise inflammation (Howatson & van Someren, 2008; Leeder et al., 2012). 
Specifically, this reduction of inflammatory processes is said to be partially mediated 
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through temperature-induced reductions in micro-vascular blood flow around the injured 
tissue (Gregson et al., 2011). It is therefore proposed that whole-limb CWI is likely to be 
effective by virtue of its effect on deep muscle blood flow (Gregson et al., 2011; Mawhinney 
et al., 2013). As a proposed anti-inflammatory, CWI cannot repair the primary (structural) 
damage resulting from the exercise insult, but can act to protect against secondary damage 
caused by oedema, cytokines and oxidative stress (White & Wells, 2013). Recent data 
indicates the effects of CWI might not act by way of reducing markers of intra-muscular 
inflammation, but potentially through influencing other aspects of the inflammatory 
response; particularly analgesic perception and reduction of oedema (Peake et al., 2016; 
Allan & Mawhinney, 2017). 
 
Whilst the acute recovery period is vital for restoration of energy stores and recovery from 
exercise induced damage, it is also the window for mediating adaptation via cell signalling 
and remodelling (Close et al., 2005; White & Wells, 2013). At a molecular level, 
adaptations to training can be described as repeated, transient increases in gene expression 
that ultimately lead to increased, steady state levels of specific proteins (Coffey & Hawley, 
2007). Numerous signalling mechanisms induce changes in transcriptional activity that will 
independently, or together, activate phosphorylation networks. This will in turn activate 
transcription factors within the cell, causing them to bind to the promoter region of the gene 
of interest. In response to endurance based exercise protocols, transcription factor activation 
and messenger-RNA (mRNA) accumulation generally occurs within several hours after 
exercise (Pilegaard et al., 2005) which subsequently may induce translation of the specific 
proteins in the hours to days following (Perry et al., 2010). What is important for endurance 
performance is the training induced increase of skeletal muscle mitochondrial content, 
termed mitochondrial biogenesis. This is vital for mediating energy homeostasis and 
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resistance from fatigue (Holloszy, 1967; Coffey & Hawley, 2007) by improving the tissue’s 
capacity for oxygen consumption and ATP provision (Hood, 2009). The transcription factor 
co-activator peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) is a 
critical regulator of mitochondrial biogenesis (Wenz, 2013) and therefore the oxidative 
adaptive process. Research has shown acute skeletal muscle contraction increases PGC-1α 
mRNA abundance (Pilegaard, et al., 2003), whilst exercise training is associated with 
increased PGC-1α protein content (Burgomaster et al., 2008). 
 
In the initial discovery by Puigserver and colleagues (Puigserver, et al., 1998), PGC-1α was 
not detectable in resting muscle of mice; however, exposure to cold temperatures showed 
marked increases. Moreover, the application of a cold stimulus (e.g. CWI) may further 
enhance the expression of PGC-1α mRNA (Slivka et al., 2013; Ihsan et al., 2014a; Joo et 
al., 2016), total protein content (Ihsan et al., 2015), and therefore the adaptive process, in 
human skeletal muscle beyond that of exercise alone. Despite recent advances establishing 
that acute and regular cold application/exposure has the ability to accelerate PGC-1α mRNA 
expression and protein content above that of the exercise stimulus alone the precise 
mechanisms controlling this remain to be fully elucidated. Indeed, recent research 
surrounding isoform specific responses of PGC-1α to different modes and intensities of 
exercise offer an interesting concept to such an investigation (Popov et al., 2014; 2015a; 
2015b). With evidence showing different PGC-1α promoters important for gene expression 
at rest and exercise it remains to be seen what other external stressors can influence 
promoter-specific gene expression.  
 
Moreover, recent evidence suggests that completing exercise training under the influence 
of reduced carbohydrate (CHO) stores can enhance markers of mitochondrial biogenesis, 
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and hence oxidative adaptation, to a greater extent than when aerobic exercise is performed 
in a glycogen-replete state (Hansen et al., 2005; Psilander et al., 2013). The mechanisms 
behind a reduced-CHO augmentation of mitochondrial biogenesis appear to occur upstream 
of PGC-1α and be dependent upon AMP-activated Protein Kinase (AMPK) and p38- 
Mitogen-activated protein kinase (p38-MAPK) activation (Chan et al., 2004; Steinberg et 
al., 2006). With pre-exercise low glycogen concentration leading to gains in the post-
training oxidative adaptive process this has become an important area of research with 
plenty of avenues to explore. As both methods have been shown to augment the adaptive 
process through the PGC-1α pathway, it is suggested that a combination of CWI and 
reduced CHO availability has the potential to accelerate the activity of PGC-1α, and other 
transcriptional regulators of mitochondrial biogenesis, above levels previously seen. 
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1.2 AIMS AND OBJECTIVES OF THESIS 
The aim of this thesis is to establish the humoral and molecular mechanisms implicated in 
the cold augmentation of the transcriptional co-activator PGC-1α when CWI is applied 
following high intensity exercise. Having established potential controlling mechanisms a 
further aim is to assess whether a combination of stressful stimuli can enhance the post-
exercise PGC-1α response to an even greater extent.   As such, it is hoped that the studies 
contained within this thesis will help inform recovery prescription guidelines as well as 
scientific study designs. 
 
The aims of this thesis will be achieved by the following objectives: 
 
a) Examining whether the CWI induced increase in key regulators of mitochondrial 
biogenesis (PGC-1α) observed post-exercise is mediated through local or systemic 
mechanisms. 
 
b) Examine whether exercise commenced with low muscle glycogen further stimulates the 
post-exercise and CWI-induced expression of PGC-1α. 
 
 
c) Examining the influence of CWI and low muscle glycogen levels on the promoter specific 
regulation of the PGC-1alpha gene. 
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2.1 EXERCISE RECOVERY 
The stress of regular training and competition has the ability to impair performance, be it 
through reduced quality of training or impaired competitive performance. Inadequate 
recovery between training sessions or after competition may ultimately lead to fatigue; 
defined as the sensation of tiredness with associated decrements in muscle function and 
performance (Abbiss & Laursen, 2005). Ultimately, if fatigue is allowed to accumulate it 
may lead to overtraining/overreaching, increasing the likelihood of injury and reduced 
performance (Soligard et al., 2016). 
 
Recovery can be defined as the process of restoring the body’s physiological and 
psychological function in order to return to a pre-fatigued level of performance (Versey et 
al., 2013). Therefore, accelerated recovery should allow the athlete improved subsequent 
performance and quality of training, thus maintaining a suitable or improved stimulus for 
adaptation. Consequently, the importance of recovery to the professional athlete has led to 
a wide variety of recovery strategies being investigated, with a preliminary focus on 
providing supporting evidence to practices currently being utilised in the field. Some of the 
most popular include active recovery, stretching (Barnett, 2006), compression garments 
(Pruscino et al., 2013), sleep (Fullagar & Bartlett, 2016), nutritional strategies, massage, 
cryotherapy and hydrotherapy (Reilly & Ekblom, 2005). Hydrotherapy can be further 
devolved into hot-water immersion (HWI) and contrast-water therapy (CWT) whilst 
cryotherapy methods include ice application and/or ingestion, cooling sprays and whole-
body cryotherapy (WBC) (Meeusen & Lievens, 1986; Vaile et al., 2008a). Possibly the most 
prevalent recovery strategy spans both hydrotherapy and cryotherapy, and is termed CWI.  
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2.2 COLD WATER IMMERSION 
The use of CWI for recovery from exercise stems from its use in athletic settings, where ice 
application in the immediate treatment of acute soft-tissue injuries and rehabilitation work 
was often combined with rest, compression and elevation (Meeusen & Lievens, 1986). 
Proposed benefits of CWI were initially focussed around the analgesic effects of cold 
temperatures. Cold-induced alterations in neurological processes, such as decreased nerve 
conduction velocity (Algafly & George, 2007), allow for greater pain tolerance alongside 
decreased pain sensation (Galvan et al., 2006). Mechanisms by which CWI is purported to 
benefit recovery are hypothesised to be a combined result of temperature and pressure 
induced changes in blood flow and reduced muscle temperature (Gregson et al., 2011). Cold 
temperatures may facilitate recovery from exercise that is metabolically stressful by 
reducing intramuscular temperature and metabolism (Ihsan et al., 2013), whilst a cold-
induced reduction in muscle blood flow (Gregson et al., 2011) may limit inflammatory 
signalling, oedema and thus any subsequent secondary damage/cell stress to the muscle 
fibres (Swenson et al., 1996; Puntel et al., 2011). Despite the recent surge in CWI research, 
the mechanisms of action are still not fully understood. Physiological mechanisms and 
effects of CWI on exercise recovery are discussed in more detail in Sections 2.3-2.4.  
 
Despite its popularity in the elite setting CWI continues to lack constructive evidence based 
guidelines. Its use is largely dependent on numerous external factors that control its 
application such as mode of exercise, cost and logistics. Immersion is usually legs only or 
whole body depending on the predominant muscle mass used in the athletes chosen sport. 
Across the board CWI is adapted to suit logistical issues and independent budgets, however, 
one thing that remains consistent when applying CWI for recovery purposes is the lack of 
agreement in application guidelines, highlighted recently by McGorm and colleagues 
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(2015). Through the use of a 15-question online survey 29 respondents from 17+ sports 
showed nearly 80% use temperatures between 5-15°C, with 73% using a cold pool or 
“makeshift bath” (wheelie bin). Furthermore, 83% of respondents immersed for durations 
of 10 minutes or less, 17% used water immersion outside the range of 5-20°C and nearly a 
third failed to monitor and/or regulate the temperature of the water. The final point alone 
may reduce the effectiveness of the strategy employed due to the transfer of heat from the 
body to the water.  
 
2.2.1 Temperature.  
As the mechanisms of action of CWI are largely thought to be derived from a reduction in 
muscle tissue temperature (Section 2.4.1) it is sensible to suggest that the temperature of 
water should be adequate to reduce tissue temperature in a time frame no longer than the 
duration of immersion. Few studies have attempted to determine the ideal immersion 
temperature (Yeargin et al., 2006; Vaile et al., 2008b; Almeida et al., 2016). Yeargin et al. 
(2006) reported CWI of 14°C (12 min, legs only) preferably improved subsequent 2-mile 
running race performance vs. 5°C and a control. Vaile et al. (2008b) compared intermittent 
immersions in 10, 15 and 20 °C water for 5 min and continuous immersion in 20 °C for 15 
min following cycling. All CWI conditions supported maintenance of subsequent (1h later) 
cycling time-trial performance (10 °C: -0.6 %, 15 °C: 0.4 %, 20 °C: -1.0 %, 20 °C 
continuous: -0.6 %) compared with active recovery (-4.1 ± 1.8 %), with no signiﬁcant 
differences between CWI conditions. More recently, Almeida et al. (2016) investigated the 
effect of differing immersion protocols on the recovery of heart rate variability post-
exercise. Their findings indicated 15 min at 14°C was superior when compared to a control, 
5 min at 9°C, 5 min at 14°C and 15 min at 9°C.  
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2.2.2 Duration.  
As with temperature, a range of durations are currently applied in practice with durations as 
short as 30s utilised (McGorm et al., 2015). Ultimately such short durations will be unable 
to elicit sufficient reductions to either core or muscle temperatures and have any subsequent 
impact on physiological mechanisms such as fluid shifts as a results of hydrostatic pressure 
(Section 2.2.3); which have been shown to require at least 10 min (Hinghofer-Szalkay et 
al., 1987). Although it is likely that longer durations reduce tissue temperature to a greater 
extent, primarily through the laws of thermodynamics and heat transfer, they are often less 
likely to be applied. Longer durations may cause unnecessary discomfort to the athlete 
whilst increasing the likelihood of shivering thermogenesis, negatively impacting metabolic 
recovery through increased energy expenditure (Ihsan et al., 2015). Moreover, it has been 
shown that immersion durations of 30 min, irrelevant of temperature, may exacerbate the 
exercise-induced inflammatory response (White et al., 2014). Despite this, a recent review 
(Machado et al., 2016) suggests a dose-response relationship may occur for recovery with 
post-exercise CWI, particularly in the management of muscle soreness. Machado and 
colleagues (2016) stated that longer durations (10-15 min) are responsible for improved 
recovery, particularly immediately following exercise, and thus suggested 11-15 min as the 
optimal duration for CWI. 
 
2.2.3 Depth. 
The depth of immersion has a large impact on the hydrostatic pressure and fluid shifts that 
are proposed to benefit the athletes’ recovery (discussed in detail in Section 2.4.3). Indeed, 
Johansen et al. (1995) showed during neck deep immersion that central venous pressure 
rose by 12 mmHg and remained elevated, whilst waist deep immersion saw marginal 
increases (1.6 mmHg). However, many factors have a role to play in determining the ideal 
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CWI protocol, lending support to an individualised prescription dependent upon all of these 
factors. Only one study exists that assessed the impact of different depths of water 
immersion (seated vs. standing) upon athletic recovery (Leeder at al., 2015) with results 
indicating any slight differences in hydrostatic pressure caused by different depths lead to 
no differences between the two protocols. A paucity of data exists to support the importance 
of water immersion depth upon physiological mechanisms associated with benefits to 
recovery. Moreover, it is important to note the variable methods utilised by different groups 
and the impact this may have upon the physiological response to water immersion, with a 
particular focus on blood flow and fluid shifts.  
 
During water immersion hydrostatic pressure acts on the body, with the magnitude having 
a linear relationship with both water density and immersion depth according to the equation:  
Phyd = Patm + g x p x h 
where Phyd= water pressure (Pa), Patm = atmospheric pressure (sea level *1,013 Pa), g = 
gravity (9.81 m/s2), p = water density (1,000 kg/m3) and h = height of the water (m) 
(Wilcock et al., 2006). Therefore, hydrostatic pressure is influenced primarily by immersion 
depth, with a depth of 1m having a similar pressure to that of normal diastolic blood pressure 
(74mm Hg). Hydrostatic pressure upon the body is proposed to cause fluid shifts within the 
body, displacing gas and fluids to areas of lower pressure, thus a person standing in water 
will experience inwards and upwards compression on the body, displacing fluids from the 
lower extremities into the thoracic region (Wilcock et al., 2006). The importance of fluid 
shifts to the recovery process is highlighted by the fact that the human body is comprised 
of 50-60% fluid, located in intracellular, interstitial (between cells) or intravascular (blood 
plasma) space (Wilcock et al., 2006). CWI is said to benefit recovery through 
haemodilution: blood displacement from the interstitial to the intravascular spaces. In doing 
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so, fluids leaving the interstitial spaces are replaced by intercellular fluids, creating an 
intracellular-intravascular osmotic gradient said to allow greater metabolite removal 
implicated in the development of fatigue (Ihsan et al., 2016). One thing to note is that a 
change in temperature of the water may cause alterations in density (i.e. colder water has a 
greater density than thermoneutral water) and therefore alterations to pressure and the 
equation outlined above. Indeed, such changes in density and therefore pressure with 
temperature may impact the hydrostatic pressure upon the limb and therefore any fluid shifts 
thereafter; the extent of which is unknown. 
 
 
2.3 CWI AND EXERCISE RECOVERY  
CWI is regularly used to combat deleterious effects of exercise that is of a particularly 
intense or damaging nature, in order to reduce pain and improve subsequent training 
intensity and/or performance. A summary of this research is discussed below with interested 
readers directed to excellent reviews and meta-analyses on this topic for further information 
(Leeder et al., 2012; Versey et al., 2013).  
 
2.3.1 Metabolic Stress  
Over the last two decades, much research utilising post-exercise CWI as a method for 
promoting recovery has assessed recovery from high-intensity exercise. In this sense, high-
intensity exercise refers to exercise that involves a high metabolic cost with an eccentric 
component (i.e. repeated sprints) (Leeder et al., 2012). Indeed, a plethora of research exists 
showing positive effects of post-exercise CWI upon specific performance variables. These 
performance improvements (versus a control or in comparison to pre-exercise values) have 
been reported across a range of exercise modalities. Particularly, ones that incorporate a 
14 
 
longer duration and/or an intermittent element, including, but not limited to, running (Bailey 
et al., 2007; Brophy-Williams et al., 2011), high-intensity interval training (Broatch et al., 
2014), cycling (Lane & Wenger 2004; Vaile et al., 2008a; Vaile et al., 2011), BMX 
(Marquet et al., 2015), exhaustive anaerobic exercise (Pournot et al., 2011) and various 
match-play situations (Montgomery et al., 2008; Parouty et al., 2010; Rowsell et al., 2011). 
 
Data also shows neutral (neither positive or negative) and negative effects of CWI on 
exercise of a shorter duration and/or greater intensity; including time trial and sprint 
performance (Peiffer et al., 2010a; Higgins et al., 2011), power output, sprint cycling, 
maximal voluntary contraction and sprint swimming performance (Schniepp et al., 2002; 
Crowe et al., 2007; Peiffer et al., 2009a; Parouty et al., 2010). Inconsistencies are clear and 
shall continue to remain due to differences in exercise stimuli, immersion protocols, subject 
training status, individual differences and performance measures assessed. Despite this, 
assessment of the current literature indicates that CWI following high-intensity, short-
duration exercise is largely associated with neutral (and some negative) effects, whilst 
greater recovery tends to occur following exercise of a greater endurance component (longer 
duration, endurance and intermittent codes). 
 
One explanation for the inconsistent impact of CWI upon recovery from short-duration, 
high intensity exercise and/or maintenance of performance is the likely reduction in skeletal 
muscle tissue temperature resulting from different immersion protocols applied in these 
studies. Ultimately, a reduction in tissue temperature will reduce nerve conduction velocity 
leading to associated decrements in skeletal muscle performance (Algafly et al., 2007). 
Indeed, skeletal muscle function is greater when warmer (Faulkner et al., 1990). Shorter 
immersion durations have been investigated (Almeida et al., 2016), however CWI is 
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efficient by way of physiological impact and therefore protocols need to ensure they use the 
correct temperature, duration and depth of immersion in order to stimulate such 
physiological mechanisms purported to assist in recovery. Likewise, the greater impact of 
post-exercise CWI upon subsequent performance measures in exercise of longer durations 
may be associated with improved thermoregulatory control in the form of lower core body 
temperature observed following CWI (Peiffer et al., 2010b).  
 
2.3.2 Mechanical Stress 
Mechanical stress is often associated with exercise protocols consisting of large eccentric 
components, but relatively low metabolic cost (Leeder et al., 2012). To this extent, CWI has 
been shown to have no effect on the restoration of muscle strength, limb 
circumference/volume and isokinetic torque (Gulick et al., 1996; Paddon-Jones & Quigley, 
1997; Leeder et al., 2012; Schimpchen et al., 2016; Argus et al., 2016), whilst having more 
success in recovering estimated muscle power (Fonseca et al., 2016), 30 s continuous jump 
test (Garcia et al., 2016), jump height (Webb et al., 2013), single- and 2-leg counter 
movement jumps (Abaidia et al., 2016) and submaximal muscle function (Ascensão et al., 
2011; Roberts et al., 2014). Improvements in mechanical exercise performance also vary in 
duration, with some benefits reported to last for at least 3 days after the initial exercise 
insult. A good example of this is maximal voluntary contraction assessments, where 
improvements are regularly reported after post-exercise CWI at 24 (Skurvydas et al., 2006; 
Bailey et al., 2007; Pournot et al., 2011), 48 (Skurvydas et al., 2006; Bailey et al., 2007; 
Ingram et al., 2009) and 72 h post-immersion (Skurvydas et al., 2006; Vaile et al. 2008c).  
 
The effects of CWI on recovery from intense exercise is highlighted by a recent systematic 
meta-analysis review (Leeder et al., 2012). The authors confirm CWI is effective at reducing 
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the experienced DOMS following damaging exercise, suggesting that inconsistencies in 
research outcomes could be related to different immersion protocols, measures of 
damage/soreness and/or the type of preceding exercise. Investigations with a focus on 
DOMS cover a variety of stimuli, ranging from high-intensity interval (Brophy-Williams et 
al., 2011), team sports (Elias et al., 2013), eccentric damaging exercise (Crystal et al., 2013) 
and power based protocols (Counter-movement jumps; Jakeman et al., 2009). In a meta-
analysis, Hohenauer and colleagues (2015) and Bleakley et al. (2012) showed CWI was 
successful in significantly alleviating the symptoms of DOMS 24, 48, 72 and 96 h after 
application of the cooling stimulus.  
 
Whilst most evidence supports the use of CWI to benefit post-exercise muscle soreness 
there is some evidence that displays CWI having no effect (Eston & Peters, 1999; Howatson 
et al., 2009; Sellwood et al., 2007), highlighting the modality’s equivocal nature. The 
largely perceptual nature of muscle soreness measures could be a reasonable explanation 
for this lack of agreement, with ongoing debate existing surrounding the potential of the 
placebo effect during the use of CWI (Section 2.4.2, Broatch et al., 2014). Despite this, 
sufficient evidence exists for the benefit of CWI upon subjective measures of soreness 
(Bailey et al., 2007; Cortis et al., 2010). 
 
 
2.4 PHYSIOLOGICAL RESPONSES TO CWI FOLLOWING 
EXERCISE  
The use of CWI as a method of recovery stems from its popularity in therapeutic and 
rehabilitation settings for the treatment of acute soft-tissue injuries (Meeusen & Lievens, 
1986). Much of the attention CWI has received over the past decade has sought to 
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investigate the physiological mechanisms by which it is purported to enhance recovery. It 
is widely speculated that these mechanisms are related to changes in body temperature and 
blood flow (Leeder et al., 2012; Ihsan et al., 2016; Figure 2.1). This next section will focus 
individually on physiological mechanisms to give an overview of what effects CWI has 
upon human physiology.  
 
 
Figure 2.1: Possible mechanisms mediating the effects of CWI on EIMD (Reproduced from 
Ihsan et al., 2016, Sports Med, with permission of the publisher Springer). 
 
 
2.4.1 Thermoregulatory 
The pattern of cooling post-exercise upon various temperature measures is shown in Figure 
2.2. Generally, skin temperature decreases exponentially through cooling via heat extraction 
and conduction (Gregson et al., 2011), reaching its lowest point earliest and increasing 
exponentially through the post-cooling period. The magnitude of temperature decrease is 
dependent on the water temperature, with colder temperatures associated with greater 
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reductions in skin temperature (Gregson et al., 2011). Skin temperature is reduced during 
CWI independent of being preceded by exercise or rest. Roberts et al. (2015) showed CWI 
at 10°C for 10 min decreased thigh skin temperature from a post-exercise value of ~35°C 
to a minimum of ~24°C at the end of immersion, whilst Gregson et al. (2011) showed CWI 
per se at 8°C for 10 min reduced thigh skin temperature from a resting pre-immersion value 
of ~30°C to a minimum of ~15°C.  
 
 
Figure 2.2: Relative pattern of temperature change in different tissue layers during exercise, 
cooling and post-cooling period, from White & Wells (2013), Extreme Physiol Med. 
Permission for reproduction granted by BioMed Central. Tsk = Skin temperature, Tc-
general=core temperature following cryotherapy applied to large mass, Tc-local = core 
temperature following cryotherapy applied to small mass, Tm@1 and Tm@3 = muscle 
tissue temperature at 1 and 3cm depth. 
 
Core temperature decreases following CWI preceded by rest (Gregson et al., 2011; Joo et 
al., 2016) or exercise (Mawhinney et al., 2013), with the rate largely dependent on the 
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thermal gradient and peripheral blood flow (White & Wells, 2013). The reactivity of core 
temperature to the cooling stimulus is slower than more peripheral measures, whilst the 
magnitude of change is greater when cooling is applied following exercise (~1-2°C decrease 
from Pre-immersion values: Peiffer et al., 2009a; Joo et al., 2016) vs. rest (~ 0.2°C decrease 
from Pre-immersion values: Gregson et al., 2011; Joo et al., 2016); likely attributable to the 
large increases in core temperature that occur following exercise.  
 
Skin cooling during CWI decreases muscle temperature via conductive heat exchange and 
convective cooling of the limb (Gregson et al., 2011). Thus, changes in deeper 
intramuscular temperature occur at a slower rate than more superficial depths. In this way, 
deep muscle temperature (3cm) continues to cool through the post-cooling phase as heat is 
transferred to warmer superficial tissues, with temperatures at 2 and 1cm depths re-warming 
and returning to baseline within 3h post-immersion (Gregson et al., 2013). Indeed, the 
greater the difference in temperature between the tissue and the water of immersion (i.e. 
greater thermal gradient), the faster the temperature will change (Taylor et al., 2008; 
Gregson et al., 2011; Mawhinney et al., 2013). Additionally, the change in intramuscular 
temperature is also related to the duration of cold exposure (Meeusen & Lievens, 1986), 
with very large decreases seen (~18°C) following 3h of CWI (Abramson et al., 1966). 
Surrounding adiposity will also effect the heat transfer gradient due to insulation. A 
difference of 4°C is noted (3cm and 1cm depths) between high and low adiposity of the calf 
(>20mm vs. <8mm skinfold thickness, respectively) 30 min following ice pack application 
(Myrer et al., 2001), whilst the time taken to decrease intramuscular temperature at 1cm 
depth, by 7°C increased with greater levels of adiposity (Otte et al., 2002).  
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2.4.2 Analgesic 
The analgesic effect of reduced muscle and skin temperature represents a key mechanism 
by which CWI is purported to have positive effects on post-exercise recovery. Herrera et al. 
(2010; 2011) have shown cooling reduces the neural conductance velocity in sensory and 
motor neurons. Importantly, sensory neurons were influenced by more modest changes in 
temperature, suggesting an analgesic benefit occurs before cooling impairs contraction 
kinetics (White & Wells, 2013). Further cold-induced alterations in neurological processes, 
such as decreased nerve conduction velocity, allow for greater subjective interpretations of 
post-exercise recovery. Measures of pain tolerance and decreased pain sensation (Galvan et 
al., 2006; Algafly & George, 2007), measures often related to DOMS, have been shown to 
be improved following CWI.  
 
Separately, it has been suggested that CWI has a large psychophysiological benefit and that 
any proposed analgesic benefit in recovery might be due to individual perception of 
recovery and a possible placebo effect (Broatch et al., 2014). In this sense, CWI may be 
effective by virtue of its analgesic properties upon perception of pain acting as a placebo. 
Indeed, many CWI studies have focussed on subjective measures of muscle soreness 
(Bailey et al., 2007; Ingram et al., 2009; Rowsell et al., 2011; Stanley et al., 2012) therefore 
it is plausible that positive subjective outcomes are a result of expectation rather than altered 
physiological mechanisms. Recently the impact of the placebo has been demonstrated by 
Broatch and colleagues (2014). In a matched groups design 30 males performed an acute 
high-intensity interval training (HIIT) session consisting of 4 x 30s sprints, immediately 
followed by15min of either CWI (10°C, n=10), thermoneutral water immersion (TWI, 
34.7°C, n=10) or a thermoneutral water immersion placebo (TWP, 34.7°C, n=10). In this 
respect, the placebo condition was achieved by misleading participants to believe a pH 
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balanced skin cleanser, added to the water in sight of the subject was beneficial for recovery 
from HIIT. Main findings showed TWP was superior to TWI for recovery of quadriceps 
strength after acute HIIT, whereas no difference was seen between TWP and CWI, despite 
a reduction in intramuscular temperature seen for CWI. Results were attributed to improved 
subjective ratings of pain and readiness for exercise in the CWI and TWP conditions. 
 
2.4.3 Cardiovascular  
Purported effects of CWI may be mediated through vasoconstrictive reductions in 
microvascular blood flow to the injured muscle, which would reduce oedema and the 
induction of inflammatory events (Gregson et al., 2011). Indeed, early use of cryotherapy 
is associated with significantly less swelling (oedema) between ruptured myofibers, 
inflammation and tissue necrosis, alongside accelerated early regeneration (Schaser et al., 
2007; Järvinen et al., 2013). At rest, cold water immersion (8°C) is shown to distribute more 
blood flow to the skin, than in thermo-neutral conditions (22°C), whilst total limb blood 
flow remained unchanged between conditions (Gregson et al., 2011), indicating a possible 
reduction in skeletal muscle blood flow may be responsible for associated benefits of CWI 
upon exercise induced muscle damage. In contrast, post-exercise CWI was shown to reduce 
whole-limb blood flow (Vaile et al., 2011), however, the technique utilised in this study 
fails to distinguish between muscle and skin blood flows. Therefore, Mawhinney et al. 
(2013) examined the influence of CWI on limb (duplex ultrasound) and cutaneous blood 
flows (laser Doppler flowmetry) following exercise. Twelve participants completed a 
continuous cycle exercise protocol at 70% peak power output until a core temperature of 
38oC was attained, followed by either CWI (10-min in 8oC or 22oC water) or passive rest. 
Results showed a greater decrease in femoral artery and cutaneous blood flows throughout 
the recovery period in the cooling conditions in comparison to passive rest, however no 
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difference was found between the immersion conditions. Despite greater reductions in 
muscle temperature occurring in colder water, it was deemed to be a magnitude not large 
enough to induce a significant difference in femoral artery blood flow between the cooling 
conditions. The fact that similar reductions in muscle blood flow are shown to occur, 
independent of water temperature, offers greater insight into the mechanistic background 
by which CWI may alleviate the stress associated with intense exercise. 
 
In addition to recovery benefits arising from cold related reduction in tissue temperature, 
CWI is proposed to decrease microvascular blood flow (Lee et al., 2005). Near infrared 
spectroscopy (NIRS) has often been used to estimate changes in local muscle blood flow 
following post-exercise CWI, with muscle blood volume shown to decrease when CWI is 
applied after high intensity intermittent (Ihsan et al., 2013) and resistance (Roberts et al., 
2015) exercise protocols. However, this technique of assessment has been criticised 
(Mawhinney et al., 2013) as it only provides indirect estimates of changes in blood volume 
within the microcirculation and not changes in blood flow per se. As NIRS uses the different 
absorption of near infrared light to determine concentration changes in oxygenated 
haemoglobin, deoxygenated haemoglobin and total haemoglobin it is liable to error 
following stress such as cooling as the signal cannot differentiate the contribution of 
myoglobin from haemoglobin (Davis et al., 2006). 
 
Mechanistically, the hydrostatic pressure (see section 2.2.3) from water immersion may 
promote post-exercise recovery by way of reducing swelling, oedema and subsequent 
inflammatory events. Indeed, exercise causes blood plasma, fluid and inflammatory cell 
population movement into the muscles, the volume of which is relative to the intensity of 
exercise (Miles et al., 1983). As such, it is suggested this leads to a reduced oxygen delivery 
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via compression of localised capillaries and infiltration of inflammatory leukocytes and 
monocytes, both of which contribute to cellular damage (Pedersen & Toft, 2000). Limb 
girth is a simple way of assessing muscle oedema and swelling (Eston & Peters, 1999) 
however the effectiveness of this method is unconvincing (Goodall & Howatson, 2008).  
 
2.4.4 Inflammation 
Historically, cold, mainly in the form of icing, was originally used to treat soft tissue injury 
(Swenson et al., 2011). The term inflammation is often used loosely to encompass 
associated effects of exercise induced muscle damage, including oedema, swelling and 
DOMS. However, the inflammatory response is also characterised by physiological, cellular 
and molecular changes in the injured muscle (Peake et al., 2017a), often termed secondary 
damage. In response to stress and/or muscle damage induced by exercise the inflammatory 
response comprises the release of intracellular proteins such as cytokines, chemokines and 
myokines alongside satellite and inflammatory cell populations (such as neutrophils, 
macrophages and T cells) (Peake et al., 2017a). It is the dynamics of these cells’ interaction 
with each other within the extracellular matrix that determines the effectiveness and 
efficiency of recovery (Peake et al., 2017a).  
 
A common assessment of post-exercise inflammation is the measure of systemic 
inflammatory markers in the blood, such as immune leukocytes and monocytes (Broatch et 
al., 2014, Gonzalez et al., 2014; Jajtner et al., 2014), inflammatory cytokines (Peake et al., 
2008; Broatch et al., 2014; Stacey et al., 2010; Rowsell et al., 2014; Townsend et al., 2015), 
lymphocytes and neutrophils (Stacey et al., 2010; Broatch et al., 2014), and c-reactive 
protein (Brophy-Williams et al., 2011; Ascensão et al., 2011). The resultant impact of CWI 
is as equivocal as many other variables within the field, with results showing reductions 
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(Stacey et al., 2010; Ascensão et al., 2011; Gonzalez et al., 2014; Jajtner et al., 2014; 
Rowsell et al., 2014), no differences (Peake et al., 2008; Stacey et al., 2010; Rowsell et al., 
2014; Townsend et al., 2015) and, in situations where the immersion duration is extended 
too long (30 min), potential elevation of the systemic inflammatory response (White et al., 
2014).  
 
Original observations of the benefit of cryotherapy techniques upon secondary damage to 
skeletal tissue were seen following crush injury in rodent models. Crush injuries in rats were 
treated with continuous cryotherapy, in the form of ice application, or no treatment at all 
(Merrick et al., 1999). Greater reductions in markers of oxidative and cellular damage 
(triphenylformazan) were seen in those tissues treated with 30min continuous ice 
application, indicating that cryotherapy reduces the magnitude of secondary injury. 
 
A recent well-designed study by Peake and colleagues (2017b) incorporated several local 
(gene expression within the muscle) and systemic (blood plasma/serum concentration) 
inflammatory markers to investigate the effectiveness of CWI versus active recovery after 
a bout of resistance exercise. Results showed cytokines, neutrophils and heat shock proteins 
(HSP; help prevent aggregation of denatured proteins, Morton et al., 2009) did not differ 
significantly between CWI or active recovery. Moreover, whilst cold activated chaperone 
proteins (Cold shock proteins) can be found in humans (Lindquist et al., 2014) this remains 
an unexplored area of interest that may offer further explanation to the efficacy of CWI. 
Whilst the findings of Peake and colleagues (2017b) indicate that cold water immersion is 
no more effective than active recovery for reducing inflammation or cellular stress in 
muscle after a bout of resistance exercise, it remains to be determined if such measures are 
different when compared with no recovery protocol, or following other exercise modalities. 
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Indeed, the authors comment that the stress applied during the exercise protocol used was 
similar to that of a standard training session. Therefore, future research should focus on the 
impact of CWI on a heightened inflammatory response that occurs in eccentric, 
unaccustomed activity and/or ultra-endurance events. Despite this, the study does go some 
way in refuting the long revered hypothesis that CWI benefits recovery through reducing 
subsequent inflammatory events (Meeusen & Lievens, 1986).  
 
To date, research surrounding the physiological effects of CWI remains largely 
contradictory. Whilst a reduction in tissue temperature may provide analgesic benefits 
because of reduced neural conduction velocity (Herrera et al., 2010) and reductions in 
muscle blood flow may serve to prevent or reduce formation of oedema and swelling 
(Gregson et al., 2011; Mawhinney et al., 2013), evidence for increased metabolite removal 
via a greater osmotic gradient as a result of hydrostatic fluid shifts is weak. Moreover, 
molecular and biochemical evidence is contrasting, with systemic markers of inflammation 
in the blood being seen to reduce after CWI (Ascensão et al., 2011; Jajtner et al., 2014), 
whilst local markers within skeletal muscle show no change compared with active recovery 
(Peake et al., 2017b). Whilst a lack of agreement between studies is clear, it is apparent that 
studies highlighting a negative effect of CWI upon physiological mechanisms of recovery 
are small in number, and generally associated with short-duration, high-intensity exercise; 
with CWI having a greater impact following exercise of longer durations.  
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2.5 MOLECULAR MECHANISMS REGULATING SKELETAL 
MUSCLE MITOCHONDRIAL BIOGENESIS 
In any sport, particularly those that are endurance based, constant energy supply is 
important for proper tissue function. Mitochondria are often termed the “powerhouse of the 
cell” and serve a critical function in the maintenance of cellular energy homeostasis, 
improving the tissues capacity for oxygen consumption and adenosine triphosphate (ATP) 
provision (Hood, 2009) whilst also playing pivotal roles in thermogenesis, lipid 
metabolism, calcium signalling, metabolite synthesis and apoptosis (Kelly & Scarpulla, 
2004; Ploumi et al., 2017). 
 
Mitochondrial biogenesis is a tightly regulated process that depends on both the 
mitochondrial and nuclear genomes. Synchronised transcription and translation of nuclear 
and mitochondrial genes is needed for the generation of new organelles (Ploumi et al., 
2017). Regulation of mitochondrial biogenesis occurs with the activation of sensor enzymes 
such as transcription factors, coactivators and regulators in response to various stimuli, such 
as nutrient availability, hormones, growth factors and temperature fluctuations. Importantly, 
the transcription factors bind to specific DNA sequences of target genes, controlling the rate 
of mRNA transcription and subsequent translation of functional proteins. The nuclear 
respiratory factors (NRF1 and NRF2), estrogen-related receptors (ERR-α) and PGC-1α are 
major modulators in mitochondrial proliferation (Palikaras & Tavernarakis, 2014). In 
particular, NRF-1/-2 have been implicated in the activation of mitochondrial transcription 
factor A (TFAM), a key component in the transcription of mitochondrial DNA (mtDNA) 
(Ekstrand et al., 2004; Wenz, 2013).  
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The importance of mitochondrial biogenesis became of greater relevance to exercise 
physiologists after pioneering work showed increases in mitochondria size, number and/or 
volume occurred after a physiological stimulus (Holloszy, 1967; Gollnick & King, 1969). 
The plasticity of the response was highlighted by the fact that mitochondrial content could 
be reduced by prolonged periods of muscle disuse, such as denervation (Wicks & Hood, 
1991) or immobilization (Booth & Kelso, 1973). Since the publication of Holloszy’s (1967) 
pioneering work demonstrating that exercise training stimulates mitochondrial oxygen 
uptake and respiratory enzyme activity in animal skeletal muscle, a number of studies have 
also investigated the mitochondrial content and function in response to several weeks of 
exercise training in human muscle (Hoppeler et al., 1973, Tonkonogi et al., 2000, Nielsen 
et al., 2010). Exercise-induced mitochondrial biogenesis corresponds closely to the 
functional energy requirements necessary to improve oxidative phosphorylation, ATP 
provision and fatigue resistance (Hood, 2009). Improved substrate utilisation, increased 
glucose uptake and a greater reliance on fat metabolism are key components to this adaptive 
response (Player & Lewis, 2012). Moreover, the importance of exercise training for the 
control of mitochondrial biogenesis is highlighted by the beneficial effects of exercise on 
age-related mitochondrial dysfunction (Joseph et al., 2016) and other metabolic disorders 
such as type 2 diabetes (Mogensen et al., 2007) and obesity (Wells et al., 2008). 
 
2.5.1 Peroxisome proliferator-activated receptor γ coactivator 1-alpha (PGC-1α) 
PGC-1α has widely become known as the “master regulator” of mitochondrial biogenesis. 
Much attention has been given to this transcriptional coactivator since its discovery in 1998, 
where it was identified as a coactivator of the peroxisome proliferator-activated receptor 
gamma (PPARγ) in brown adipose tissue (Puigserver et al., 1998). Transcriptional co-
activators respond to cellular signals to enhance target transcripts by binding with 
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transcription factors or nuclear receptors, but not to DNA directly (Hood et al., 2016). In 
this way, as a transcriptional coactivator, PGC-1α is unable to directly bind to DNA and 
exerts its influence by co-activating downstream transcription factors (such as NRF-1/2, 
EERα, TFAM) important for the regulation of the nuclear and mitochondrial genomes 
(Egan & Zierath, 2013).  
 
PGC-1α is highly expressed in skeletal muscle, but is also present in other oxidative, 
mitochondria-rich tissues including the heart, kidney, liver, adipose tissue and brain (Finck 
& Kelly, 2006). Analysis of expression of PGC-1α within different tissues displayed 
significant correlation between high oxidative capacity and PGC-1α concentration (Irrcher 
et al., 2003). Moreover, PGC-1α has a key role in driving the formation of slow twitch 
muscle fibres and increasing mitochondrial enzyme expression (Lin et al., 2002; Handschin 
et al., 2007), whilst selective deletion of PGC-1α in skeletal muscle attenuates the exercise 
induced increases in mitochondrial enzymes (Geng et al., 2010). Indeed, in its role as 
“master regulator” of mitochondrial biogenesis, and adaptive responses to an oxidative 
phenotype, substantial evidence exists demonstrating exercise-induced mitochondrial 
biogenesis is modulated through PGC-1α dependant mechanisms (Calvo et al., 2008; Leick 
et al., 2010; Little et al., 2011; Safdar et al., 2011; Uguccioni & Hood, 2011; Zhang et al., 
2014). Studies have investigated the PGC-1α response to acute bouts of endurance exercise 
in animals (Baar et al., 2002) and in humans using cycling (Mathai et al., 2008; Gibala et 
al., 2009; Leick et al., 2010) and treadmill protocols (Bartlett et al., 2012; Joo et al., 2016); 
with ~3-10 fold-increases seen within the first few hours post-exercise, dependent on 
exercise intensity (Egan et al., 2010), training status and basal PGC-1α content (Gibala, 
2009). Additionally, several weeks of endurance training increases PGC-1α mRNA and 
PGC-1α protein in human skeletal muscle with greater mitochondrial enzyme activities 
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(Pilegaard et al. 2003; Burgomaster et al., 2008; Egan et al., 2013) .  In contrast, evidence 
exists to suggest that PGC-1alpha gene expression is not necessary for the endurance 
adaptive response, with other mitochondrial stimulatory pathways suggested to be 
upregulated to maintain exercise induced mitochondrial biogenesis (Leick et al. 2008; Rowe 
et al., 2012; Ballman et al., 2016).   
 
In a hallmark study by Perry et al. (2010) the time course of increases in PGC-1α mRNA 
and PGC-1α protein during exercise training was well documented. PGC-1α mRNA 
increased ~10-fold 4h after the first high-intensity training session and returned to rest levels 
by 24h. Subsequent high-intensity sessions increased expression again, but to a slightly 
lesser degree, before again returning to baseline. This ‘saw-tooth’ pattern continued (See 
Figure 2.3) with the magnitude of the 4h increase after each training session progressively 
decreasing; resulting in a ‘stair-case’ type response over seven training sessions. Increased 
PGC-1α protein expression (23%) was observed 24h after the 1st session. Unlike the reduced 
PGC-1α mRNA responses over seven training sessions, PGC-1α protein expression 
continued to increase, attaining a plateau by the 5-7th training session therefore showing 
repeated transient bursts of mRNA precede, and are required, for the transcriptional protein 
response. 
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Figure 2.3: Skeletal muscle PGC-1α mRNA (A) and protein content (C) throughout 2 
weeks of high-intensity interval training. Adapted from Perry et al. (2010), The Journal of 
Physiology. Permission for reproduction granted by the publisher John Wiley and Sons. 
Values are means ± S.E.M. for 8–9 participants. ∗Significantly different from Pre, 
§significantly different from all 24 h time points, #significantly different from 1st-4 h, b 
significantly different from all 4 h time points, †significantly different from 1st-24 h (P < 
0.05).  
 
2.5.1.1 Promoter and isoform specific regulation of PGC-1α 
For nearly twenty years, many studies have focused on PGC-1α function, the molecular 
mechanisms of its activation, and the regulation of PGC-1α gene expression. However, 
skeletal muscle expresses several PGC-1α isoforms via two different promoters offering 
additional avenues of mechanistic interest. The canonical (proximal) promoter contains two 
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major transcription initiation sites at 90 and 119 base pairs (bp) upstream of the initiation 
transcription codon ATG (Popov et al., 2015a). An alternative promoter is also located 14 
kb upstream of the canonical promoter. The canonical promoter originates at the first exon 
(1a) of the canonical PGC-1α-a mRNA isoform (Martinez-Redondo et al., 2015). Because 
of alternative splicing, the alternative promoter directs the transcription of two different first 
exons (1b and 1c) (Popov et al., 2015a). The proximal (canonical) PGC-1α gene promoter 
has higher basal expression than the alternative promoter, however the alternative promoter 
is more responsive to stimulation (Martinez-Redondo et al., 2015). Indeed, several groups 
(Norrbom et al., 2011; Ydfors et al., 2013; Popov et al., 2014) have shown that in human 
skeletal muscle, acute exercise induces PGC-1α gene expression, mainly via the alternative 
promoter (Exon 1b).  
 
Evidence in rodent skeletal muscle suggests activation of exercise-induced expression via 
the alternative promoter (Exon 1a) is regulated by the β2 adrenergic receptor- protein kinase 
A (PKA)- cyclic adenosine monophosphate (cAMP) response element-binding protein 
(CREB) signalling pathway (Chinsomboon et al., 2009; Tadaishi et al., 2011; Popov et al., 
2015b) and/or AMPK pathways (Norrbom et al., 2011; Wen et al., 2014). Moreover, 
administration of clenbuterol to mice is shown to induce not only PGC-1α4 isoform 
expression in skeletal muscle (Ruas et al., 2012) but also PGC-1α2 and PGC-1α3 (Exon 1b 
derived), while reducing the levels of canonical promoter-derived PGC-1α1 (Exon 1a 
derived) (Martinez-Redondo et al., 2015). Despite this, evidence in humans is limited. 
Recently in humans, endurance exercise with blood flow restriction was shown to attenuate 
PGC-1α isoform expression (Conceição et al., 2016). However, the promoter specific 
response of PGC-1α to physiologically derived β2 adrenergic activity, rather than external 
and/or pharmaceutical activation, in humans remains to be determined. 
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Figure 2.4: (A) The schematic structure of the 5’ region of the human PGC-1a gene (Miura 
et al. 2008). The proximal promoter drives the transcription of PGC-1a exon 1a-derived 
transcripts and the alternative promoter the transcription of PGC-1a exon 1b and 1b’-
derived transcripts. (B) Detailed descriptions of primer pairs and their possible cDNA 
targets are presented. Reproduced from Silvennoinen et al. (2015), Physiol Rep, as per 
the Creative Commons Attribution License (CC BY). 
 
Several mechanisms have been identified that lead the increased expression and activation 
of PGC-1α following an exercise stimulus. Metabolic sensors, AMPK and p38 MAPK are 
two key activators of PGC-1α (Gibala et al., 2009). Moreover, the suggested impact of β-
adrenergic activity (Puigserver et al., 1998) also remains important. These and the 
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subsequent downstream impact of greater PGC-1α expression, activation and post-
translational modification are discussed in greater detail in  the following sections. It should 
be noted that activation of PGC-1α is also possible via acetylation and methylation, however 
these methods are not within the remit of this review and are not dicussed further. 
 
2.5.2 AMP-dependent protein kinase (AMPK) 
AMPK is a serine/threonine protein kinase that responds to cellular energy status (Kemp et 
al., 1999). Any stress that results in a change of the adenosine monophosphate/adenosine 
triphosphate (AMP/ATP) ratio will result in increased activation of AMPK. Activated 
AMPK stimulates energy generating processes such as glucose uptake, glucose transporter 
type 4 (GLUT4) translocation, fatty acid oxidation and translocation into the mitochondria 
(Hayashi et al., 1998; Winder, 2001; Jäger et al., 2007; Takaguri et al., 2016) whilst 
decreasing energy-consuming processes like protein and glycogen synthesis (Carling & 
Hardie, 1989; Richter et al., 2009). AMPK has further implications on metabolic health by 
enhancement of muscle insulin sensitivity (Kjøbsted et al., 2016) and promotion of 
mitochondrial fusion and function (Kang, 2016). As such, AMPK is regularly referred to as 
the ‘energy sensor’, playing a key role in the regulation of cellular metabolism.  
 
Exercise is one of the most powerful physiological activators of AMPK. Activation of 
AMPK occurs in several manners outlined well by Jørgensen et al. (2006), however in 
skeletal muscle phosphorylation at Thr 172 of the α- subunit can enhance AMPK activity > 
100-fold (Hardie et al., 2003). Whilst phosphorylation of AMPK has been shown after 
multiple sporting modalities, one thing that is critical in controlling the response is the 
intensity of exercise; with greater intensity resulting in greater levels of activation 
(Wojtaszewski et al., 2000; Egan et al., 2010). However, this response has been disputed 
34 
 
with similar phosphorylation levels noted in matched work high-intensity vs. continuous 
exercise (Bartlett et al., 2012). Additionally, studies suggest a muscle fibre type-specific 
AMPK expression occurs (Kristensen et al., 2015), whilst trained individuals display greater 
protein content of AMPK (Nielsen et al., 2003), despite training reducing the 
phosphorylation response to a single-bout of exercise (McConnell et al., 2005).  
 
The importance of AMPK upon PGC-1α driven mitochondrial biogenesis is highlighted by 
AMPK activation increasing PGC-1α gene expression (Irrcher et al., 2008; Zhang et al., 
2014), including direct phosphorylation of PGC-1α (Jäger et al., 2007). Activity of PGC-
1α can be regulated through inhibitory acetylation by GCN5 and stimulatory deacetylation 
through SIRT1 (Cantó & Auwerx, 2009). However, the importance of deacetylation of 
PGC-1α for exercise induced mitochondrial biogenesis has been questioned (Philp et al., 
2011). Moreover, AMPK may also exert its effects in favour of mitochondrial biogenesis 
via tumour suppressor protein 53 (p53) (Bartlett et al., 2013). p53 regulates contractile-
induced increases in mitochondrial content via modulating TFAM content and/or activity, 
as p53 knock-out (KO) mice display reduced skeletal muscle mitochondrial DNA, TFAM 
mRNA and protein levels (Saleem et al., 2009; Bartlett et al., 2013). 
 
2.5.3 p38 mitogen-activated protein kinase (MAPK) 
p38 MAPK is often referred to as a stress-activated protein kinase due to its frequent 
activation by a range of environmental stresses and inflammatory cytokines. The four 
p38MAPK isoforms are all encoded by different genes and have differential tissue 
expression; p38α is ubiquitously expressed in most cell types with p38β preferentially 
expressed in the brain, p38δ the endocrine glands and p38γ skeletal muscle (Li et al., 1996; 
Cuadrado & Nebrada, 2010). p38 MAPK is inactive in the non-phosphorylated state and 
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activated by dual kinases termed MAP kinase kinases (MKK’s) phosphorylating on 
Threonine- Glycine- Tyrosine (Thr-Gly-Tyr) motifs. The contribution of MKK3 and MKK6 
to p38γ activation strongly depends on the nature and strength of the stimulus; with both 
essential for activation induced by environmental stress and mainly MKK6 in response to 
the cytokine TNFα (Risco & Cuenda, 2012). Downstream p38MAPK phosphorylates the 
Serine/Threonine (Ser/Thr) residues of its substrates including kinases, transcription factors 
and cell cycle regulators playing important roles in skeletal muscle differentiation (Cuenda 
& Cohen, 1999), development (Foster et al., 2012) and adaptation through mitochondrial 
biogenesis and angiogenesis with its impact upon PGC-1α (Pogozelski et al., 2009). 
 
Akimoto and colleagues (2005) demonstrated the importance of p38MAPK to the PGC-1α 
response, when PGC-1α promoter activity was enhanced in C2C12 cells following 
activation of p38MAPK, which could also be blocked by specific inhibitors. Moreover, 
p38MAPK stimulated activation of downstream transcription factors, that are also upstream 
regulators of PGC-1α has been shown, with activating transcription factor2 (ATF2) and 
myocyte enhancing factor2 (MEF2) of significant interest (Akimoto et al., 2005, Zarubin & 
Han, 2005).  
Since the seminal work showing the MAPK pathway is stimulated by exercise in human 
skeletal muscle (Aronson et al., 1997) a plethora of studies has shown greater rates of 
phosphorylation following different exercise modalities. Phosphorylation of p38MAPK is 
independent of exercise intensity (Egan et al., 2010; Bartlett et al., 2012) and occurs 
systemically (Widegren et al., 1998), in this sense to the same extent in an exercised vs. 
non-exercised limb. 
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2.5.4 Downstream of PGC-1α  
Activation of calcium signalling pathways during exercise may play a role in the stimulation 
of PGC-1α transcription through calcineurin and calcium-dependent protein kinases (Wu et 
al., 2002), ultimately leading to the activation of the transcription factors CREB, ATF2 and 
MEF2 (Lin et al., 2005). Importantly, activation of PGC-1α by CREB and MEF2 is 
controlled by an auto regulatory loop, whereby MEF2 binds to the PGC-1α promoter when 
co-activated by PGC-1α (Handschin et al., 2003). 
 
The wider impact of PGC-1α on phenotypic changes within skeletal muscle is highlighted 
by its post-translational modifications and downstream interactions with multiple important 
transcription factors. Two proteins implicated in the coordination of mitochondrial 
biogenesis are the Nuclear respiratory factors 1 and 2 (NRF1 and 2) (Baar, 2004). NRF’s 
are important in the control of nuclear oxidative phosphorylation genes and the expression 
of nuclear encoded factors important to mitochondrial transcription, protein import 
machinery and assembly (Wenz, 2013). NRF-1 and 2 are targets of PGC-1α (Wu et al., 
1999) and in this way, stimulate expression of TFAM; a mitochondrial matrix protein 
important in the replication and transcription of mtDNA (Virbasius & Scarpulla, 1994). 
Moreover, ERRα is also under the control of PGC-1α and plays its role in PGC-1α induced 
mitochondrial biogenesis through controlling vital mitochondrial processes such as 
oxidative metabolism, through a network of protein kinases and by regulating the 
expression of sirtuins (Ranhotra, 2014).  
 
Of the aforementioned transcription factors (NRF1, NRF2, TFAM, ERRα) important to 
PGC-1α derived mitochondrial biogenesis, data exists to show the impact exercise may have 
upon their activity and function. Following an acute bout of swimming NRF-1 and -2 DNA-
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binding activities increase at 12–18h (Baar et al., 2002), suggesting a rapid and coordinated 
activation following acute exercise. Additionally, Egan et al. (2013) showed increases in 
NRF2, TFAM and ERRα mRNA expression were present across a 14-day training period. 
Moreover, acute exercise induces translocation of p53 to the mitochondria, promoting 
interaction with TFAM, positively affecting mtDNA transcription (Saleem & Hood, 2013). 
This therefore represents an early exercise response which can promote long-term beneficial 
mitochondrial and metabolic adaptations in skeletal muscle. 
 
2.5.5 Beta adrenergic stimulation  
The importance of β-adrenergic stimulation to muscle contraction is well described (Cairns 
& Borrani, 2015). Its relative importance to PGC-1α and mitochondrial biogenesis was 
alluded to in the seminal work by Puigserver and colleagues (1998), whereby PGC-1α was 
found to be induced in brown fat and myotube cultures following exposure to cold and the 
β- adrenergic agonist, isoproterenol. Indeed, prior to the discovery of PGC-1α earlier work 
in rats (Ji et al., 1986) and humans (Svedenhag et al., 1984) had suggested that blocking the 
exercise induced increase in β-adrenergic receptor activity, via treatment with β-
antagonists/blockers propranolol and atenolol, dampened training induced mitochondrial 
biogenesis through reduced levels of mitochondrial enzymes (i.e. citrate synthase (CS), 
succinate dehydrogenase (SDH)). However, this was not without contrasting evidence, with 
a lack of change seen for CS and SDH following 6 weeks of daily adrenaline injections in 
rats (Fell et al., 1981). In a well-designed series of experiments, Miura and colleagues 
(2007) showed upregulation of PGC-1α expression in skeletal muscle by exercise is 
mediated, at least in part, by β2-adrenergic receptor activation.  In this study mice injected 
with the β2-adrenergic agonist clenbuterol increased PGC-1α expression more than 30-fold 
in skeletal muscle, which could subsequently be inhibited with pre-treatment of the β2-
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adrenergic blocker propranolol. Moreover, in ex-vivo experiments, exposure of rat muscle 
to a β2-adrenergic agonist increased levels of PGC-1alpha mRNA, whilst a similar response 
was not seen in beta-less knockout mice. In response to exercise (45 min treadmill running), 
PGC-α mRNA increased 3-5-fold, and was inhibited ~70% by propranolol or the β2-
adrenergic receptor (AR)-specific inhibitor ICI 118,551. The exercise-induced increase in 
PGC-1alpha mRNA in beta-less mice was also 36% lower than that in wild-type mice. A 
year later the same group (Miura et al., 2008) suggested that the acute adrenergic response 
to pharmacological activation, via injections of clenbuterol, in mice, was isoform specific 
with PGC-1α -b and -c increasing (Exon 1b derived), but not PGC-1α –a (Exon 1a derived), 
supported by data showing β-adrenergic receptor blocker (ICI 118551) inhibited PGC-1α -
b and –c (Exon 1b), but not -a (Exon 1a) isoform expression (Tadaishi et al., 2011). These 
studies support the findings by Puigserver et al. (1998) and implicate adrenergic 
mechanisms in the regulation of PGC-1α and mitochondrial biogenesis.  
 
Despite this, recent work tends not to agree. In rats, β-antagonist/blocker propranolol 
treatment failed to affect the training response of PGC-1α, TFAM, p-CREB and 
Cytochrome C Oxidase Subunit 4 (COXIV) (Feng et al., 2013). In humans Robinson et al. 
(2010) showed 1 hour of resting infusion with the β-AR agonist isoproterenol had no impact 
on expression of PGC-1α, TFAM, NRF-1 and 2, Cytochrome C Oxidase (COX) or 
NADHox expression. In addition, a year later Robinson et al. (2011) showed β-
antagonist/blocker propranolol did not blunt the PGC-1α mRNA response to 1 hour of 
cycling. Reasons for these discrepancies are unclear but are suggested to be a combination 
of experimental methods used (i.e. agonists vs. antagonists) and complications associated 
with adrenergic blocker treatments, such as the possibility of incomplete adrenergic 
blockade (Ihsan et al., 2014b). Moreover, it is plausible that other exercise-induced 
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pathways compensate for any blockade of PGC-1α induced of mitochondrial biogenesis 
(Ihsan et al., 2014b). Indeed, Kim et al. (2013) indicated that the reason for the lack of effect 
of β-adrenergic stimulation on PGC-1α expression in rat muscle might be that 
catecholamines do not activate p38MAPK and its subsequent increase in ATF2 
phosphorylation. 
 
One thing of importance is that much of the work conducted utilises pharmacological 
stimulation or inhibition either at rest, or prior to an exercise stimulus. To the author’s 
knowledge, only one study has investigated the impact of physiological increases of 
catecholamines and β-adrenergic activity on the PGC-1α response. Brandt et al. (2016) 
instructed participants complete four different exercise protocols where the workload of the 
legs was matched: 1) - cycling at 171 ± 6 W for 60 min (control); 2) - cycling at 171 ± 6 W 
for 60 min, with addition of intermittent arm exercise (98 ± 4 W). 3) - cycling at 171 ± 6 W 
interspersed by 30 sec sprints (513 ± 19 W) every 10 min (distributed sprints); and 4) - 
cycling at 171 ± 6 W for 40 min followed by 20 min of six 30 sec sprints (clustered sprints). 
Results showed no differences in PGC-1α mRNA expression despite elevated plasma 
adrenaline levels, and are also in contrast to those of Egan et al. (2013) showing PGC-1α 
mRNA expression is dependent on exercise intensity.  
 
Cold is sensed in the central nervous system and results in increased sympathetic output to 
peripheral tissues, including skeletal muscle (Miura et al., 2008). Indeed, the magnitude of 
the increase in sympathetic discharge to skeletal muscle is influenced by both the size of 
the tissue area exposed to cooling (Seals, 1990) and the magnitude of the cooling stimulus 
(Kregel et al., 1992). It is suggested that catecholamine production in response to cold 
triggers the activation of β-adrenergic receptors, resulting in the elevation of intracellular 
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cAMP and subsequent binding of CREB to the promoter region of PGC-1α (Miura et al., 
2008; Ihsan et al., 2014b). Indeed, the sympathetic response to cold stimulation has been 
consistently shown (Gregson et al., 2013; Joo et al., 2016; Ishida et al. 2016). However, the 
importance of cold-stimulated catecholamine release to the post-exercise PGC-1α response 
in humans remains to be determined. 
 
2.6 THE INFLUENCE OF POST-EXERCISE COOLING ON 
TRAINING ADAPTATION  
Whilst the impact of CWI on acute recovery of performance (Section 2.3) is extensive, data 
on the impact of regular CWI on training adaptations is less prevalent. Currently, a paradox 
exists on advocating the use of CWI for reducing the stress associated with intense or 
damaging exercise versus the negative impact it may have on the window of adaptation and 
necessary stress response required for molecular training adaptations (Howatson et al., 
2009). 
 
It has been suggested that the mechanisms of action of regular CWI may blunt the cell 
signalling responses to training, and thus if CWI were to be utilised on a regular basis, the 
permanent disruption of the mechanisms of fatigue and proposed reduction of inflammatory 
events may harm an athlete’s training progression (Versey et al., 2013). Much of the 
research to date shows a negative influence on performance characteristics when CWI is 
applied throughout a period of training on a regular basis. Yamane and colleagues (2006; 
2015) noted detriments of regular CWI upon strength adaptations, among other measures, 
in a series of studies. Yamane et al. (2006) demonstrated an attenuation of endurance 
performance, maximal oxygen uptake, arterial diameter and muscular endurance following 
4-6 weeks of lower leg (cycling) or arm flexor (handgrip dynamometer) training completed 
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with CWI (2 x 20 min at 5°C) or passive control. More recently, the same group (Yamane 
et al., 2015) used five sets of eight wrist-flexion exercises at a workload of 70-80% of the 
single repetition maximum, 3 times a week for 6 weeks in healthy subjects. Participants 
immersed their experimental forearms in cold water (20 min at 10°C) after wrist-flexion 
exercises, and another group served as controls (noncooled group). Wrist-flexor thicknesses 
of experimental arms increased after training in both groups, but to a lesser extent in the 
cooled group. Maximal muscle strength and brachial-artery diameter did not increase in the 
cooled group, while they increased in the noncooled group. Additionally, Frohlich and 
colleagues (2014) utilised single-leg 1 repetition max (1RM) and 12 repetition max (12RM) 
tests to assess a 5-week resistance-training programme. Directly after each training session, 
CWI was applied for one randomly assigned leg, consisting of three 4- minute intervals 
with a 30-s rest period; the contralateral leg was not cooled. Training significantly improved 
1RM and 12RM, however these improvements tended to be larger in the control limb than 
the CWI limb (1.6-2.0%). 
 
In contrast to the resistance adaptive response, Aguiar et al. (2016) recently showed CWI 
(10 °C for 15 min) after HIIT training (8–12 cycling sessions (90–110 % of peak power) 
for 60s followed by 75s of active recovery, 3x per week for 4 weeks) did not alter exercise 
performance in a 15km cycling time trial.  Time trial performance, total mean power output, 
mean power per km all improved following training, with no differences evident between 
CWI or control (recovery at room temperature) groups. Vaile et al. (2008a) showed 
improved sprint and time trial performance was noticeable in cyclists, when exercise each 
day for 5 days was followed by CWI vs. passive recovery.  Moreover, Halson and 
colleagues (2014) showed the regular use of CWI in elite cyclists showed no decrements to 
sprint performance. Competitive cyclists were randomized to CWI (15 min at 15°C) or 
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control (passive recovery) groups. The assessment period consisted of 7 d of baseline 
training, 21 d of intensified training, and an 11 d taper.  Each week cyclists completed a 
high intensity interval-cycling test and two 4-min bouts separated by 30 min. CWI was 
performed four times per week for 15 min at 15°C. Between baseline and taper, cyclists in 
the CWI group had an unclear change in overall 4-min power relative to control (2.7%, 
±5.7%), although mean power in the second 4-min effort relative to the first was likely 
higher for the CWI group relative to control (3.0%, ±3.8%). The change in 1-s maximum 
mean sprint power in the CWI group was likely beneficial compared to control (4.4%, 
±4.2%). Differences between groups for a 10-min time trial were unclear (- 0.4%, ±4.3%). 
Thus, whilst some effects of CWI on performance were unclear, data did not support the 
speculation that CWI is detrimental to performance, particularly following increased 
training load in competitive cyclists. 
 
For endurance adaptation, Ihsan and colleagues (2015) utilised a single-leg immersion 
protocol (10°C for 15 min) to assess the impact of regular CWI on an immersed vs. non-
immersed limb, when cooling was applied following each training session (3x week, for 4 
weeks). Training sessions included long (6 - 8 min), moderate (2 min) and short (30-151s) 
interval bouts performed at 80% - 110% Vmax. Whilst improvements were seen in 
participants’ peak oxygen uptake and running velocity by 5.9% and 6.2%, respectively, any 
performance benefits of training with or without CWI recovery cannot be determined due 
to the single-leg immersion technique adopted. Interpretation of single-leg immersion 
studies are difficult, as they do not take into account potential systemic effects of cooling. 
 
Considering the advances of molecular biochemistry in recent decades, it has become far 
easier to investigate the mechanisms behind such physiological developments, in particular 
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the regulation of key genes and molecular pathways of adaptation to different stimuli. A 
few key papers have taken advantage of such advancements, showing CWI has the ability 
to augment the acute and chronic PGC-1α response when used post-exercise. Importantly, 
the increase in PGC-1α occurred to a greater extent in a cooled vs. control trial, suggesting 
that CWI may help towards a greater oxidative phenotypic adaptation. Slivka et al. (2013) 
showed PGC-1α mRNA increases 8-fold after 4 hours recovery in a cold environment (7°C) 
vs. 4-fold at room temperature (20°C), however doubts remained over an increase in 
metabolic rate; a possible effect of shivering thermogenesis that suggests increases in PGC-
1α mRNA are a result of involuntary contraction rather than the cold stimulus per se. Ihsan 
Mohammed in 2014 (Ihsan et al., 2014a) used a single-leg immersion protocol to minimise 
the impact and possibility of shivering thermogenesis. Their group showed acute post-
exercise CWI (10°C for 15 min) was able to increase PGC-1α mRNA ~4-fold; however, 
limitations are again present due to a lack of exercise induced PGC-1α mRNA seen, as 
would be expected after high-intensity exercise (Egan et al., 2013).  
 
Ihsan and colleagues built on their acute data with a training study previously mentioned 
(Ihsan et al., 2015). Again, following each training session participants immersed a single 
leg into cold water (10°C for 15 min) with the non-immersed leg acting as a control. 
Repeated CWI resulted in higher total AMPK, phosphorylated AMPK (upstream effectors 
of PGC-1α), phosphorylated acetyl-CoA carboxylase and β-3-hydroxyacyl-CoA-
dehydrogenase (important in fatty acid metabolism) and the protein subunits representative 
of complex-I and III (important in aerobic respiration). Large effect sizes (Cohen’s d > 0.8) 
were noted with changes in protein content of p38MAPK, PGC-1α and PPARα in the 
immersed vs. control leg. Ultimately, these results implicate CWI as stimulating several 
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important molecular markers for oxidative adaptation, benefiting athletes in sports 
dependent on oxidative metabolism. 
 
Since this seminal work in the area more results are emerging with supportive data towards 
oxidative adaptation, showing regular CWI increases mRNA expression of heat shock 
factor 1 (HSF-1), TFAM and pyruvate dehydrogenase kinase 4 (PDK4) (all important in 
oxidative adaptation) after 4 weeks of HIIT (Aguiar et al., 2016). However, despite this the 
authors were unable to detect any cold-induced augmentation of PGC-1α mRNA to levels 
greater than the control group as shown in studies by Slivka et al. (2013, 2014) and Ihsan et 
al. (2014a). Our lab recently demonstrated post-exercise CWI augments the acute exercise-
induced expression of PGC-1α mRNA (~6-fold) in human skeletal muscle compared to 
exercise per se (~3-4-fold). Additionally, we were the first group to show CWI per se (i.e. 
without prior exercise) mediates the activation of PGC-1α (1.4-fold) and vascular 
endothelial growth factor (VEGF) mRNA (2-fold) expression in human skeletal muscle 
(Joo et al., 2016); important in mitochondrial biogenesis and angiogenesis respectively.  
 
Roberts et al. (2015) are the first to take advantage of such analytical advancements when 
looking at strength and resistance training stimuli followed by CWI.  A chronic 12-week 
lower-body training regime was undertaken to investigate the influence of regular cold-
water immersion on changes in muscle mass and strength. Participants completed two 
training sessions per week followed immediately by CWI (10°C for 10min) or active 
recovery (low-intensity cycling). Muscle mass increased for both groups but to a lesser 
extent in the CWI group (difference of 206g between groups; P<0.05) whereas cross-
sectional area and number of myonuclei increased significantly in the active recovery group, 
but not CWI. Leg press and knee extension strength were also significantly improved in the 
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active recovery group vs. CWI (differences of 34kg and 18kg respectively). This was 
followed up with an investigation into the acute response of the hypertrophy signalling 
pathways and satellite cell activity; two key markers of the adaptive response to an acute 
bout of strength exercise. This time, using a randomised crossover design, participants 
completed a bout of single-leg strength exercise followed by either CWI or active recovery 
as before. Phosphorylation and total protein content of ribosomal protein S6 Kinase beta 1 
(P70S6K), a key player in hypertrophy and anabolic signalling, was significantly greater at 
2h and 24h post-exercise in the active recovery trial vs. CWI. Total protein content of 
P70S6K did not change in the CWI trial. The number of Pax7+ and neural cell adhesion 
molecule cells (NCAM+) cells increased by 48% and 10% respectively after the active 
recovery trial, whereas no increase was seen at any time points for the CWI trial.  These 
investigations offer new insights into the impact CWI may have on acute signalling and 
chronic morphological and functional changes after resistance exercise training. Lindsay et 
al. (2016) offer support to the work of Roberts et al. (2015) by showing repetitive 
cryotherapy attenuates the in vitro and in vivo mononuclear cell activation response. 
 
Thus, a paradox exists and the question as to whether CWI should be employed as a method 
of post-exercise recovery remains. However, the answer to the question has evolved to be 
dependent upon which exercise stimulus is being employed and thus which molecular 
adaptive pathway is being stimulated. Maybe the more pertinent question is which pathway 
is more important for the athlete? However, it would be naive for scientists and coaches 
alike to confidently answer such a question at this stage. The current state of research calls 
for further investigation into the correct periodization/individualisation of CWI towards the 
goals of the athlete, particularly as the impact of regular CWI upon concurrent training 
practices is unknown. Until further research clarifies, CWI can be useful within competition 
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settings, particularly those requiring a short turn-around (such as tournament situations, 
athletic meets and cycling tours), if not for the benefits of improved subsequent performance 
then for the reduction in delayed onset muscle soreness, analgesic effects (Leeder et al., 
2012) or potential placebo effect (Broatch et al., 2014). However, there is no justification 
to use CWI during a strength/power adaptive cycle as this potentially negates the 
hypertrophy response sought.  
 
Importantly, recent research investigating the endurance adaptive mechanisms to post-
exercise cooling have utilised a single leg immersion study design (Ihsan et al., 2014a, 
2015). As previously mentioned, the interpretation of single-leg immersion studies is 
difficult, as they do not take into account potential systemic effects of cooling. Indeed, 
systemic control of important signalling kinases (p38MAPK) have previously been shown 
to respond in a systemic, rather than localised, manner (Widegren et a., 1998). Moreover, 
single-leg immersion designs that utilise a contra-lateral limb as a control (Ihsan et al., 
2014a; Frohlich et al., 2014) may be liable to error by underestimating the actual response 
occurring in the immersed limb if relativised to a non-immersed limb instead of a resting 
control. Moreover, with several mechanisms thought to have a controlling role in the cold-
induction of PGC-1α it is ever more important to determine whether the cause of such 
augmentation is systemic (β-adrenergic mechanisms) or local (as a result of reduced tissue 
temperature) in nature.  
 
2.7 THE INFLUENCE OF NUTRITIONAL MODULATIONS ON 
TRAINING ADAPTATION 
The importance of correct and sufficient nutrition for acute and chronic exercise is well 
described (Cermak & Van Loon, 2013). In addition to benefiting competition performance, 
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it is recommended that endurance athletes ensure high CHO availability before, during and 
after training sessions to support high daily training volumes and intensities and promote 
optimal recovery (Bartlett et al., 2014). Despite this, a growing body of evidence 
demonstrates potential benefits of restricted CHO availability (both endogenous and 
exogenous) in training-induced adaptations. Indeed, endurance based sessions commencing 
with low CHO availability are able to enhance the activation of cell signalling pathways 
(Bartlett et al., 2013), upregulate oxidative enzymes (Morton et al., 2009), increase lipid 
oxidation (Yeo et al., 2008) and improve exercise capacity (Hansen et al., 2005). Thus, the 
term “train low, compete high” was spawned. 
 
More specifically to the PGC-1α response, Pilegaard et al. (2005) demonstrated that 
attenuating post-exercise muscle glycogen re-synthesis in the short-term recovery phase (24 
h) further amplifies the transcription and mRNA expression of PDK4, uncoupling protein 
3 (UCP3), lipoprotein lipase (LPL), and carnitine palmitoyltransferase 1 (CPT1) (all 
important metabolic regulators), but importantly also augmented the proposed master 
regulator of mitochondrial biogenesis, PGC-1α. A similar response is seen in PGC-1α 
mRNA expression after exercise is commenced with low glycogen (Psilander et al., 2013; 
Bartlett et al., 2013).  Mechanisms controlling such a response are speculated to be a result 
of increased activity and nuclear abundance of AMPK (Steinberg et al., 2006) and 
p38MAPK (Chan et al., 2004) when exercise is commenced with low muscle glycogen. 
Despite this, and in contrast, other studies exist where low muscle glycogen was unable to 
stimulate greater post-exercise PGC-1α expression (Cluberton et al., 2005; Mathai et al., 
2008; Cochran et al., 2010; Jensen et al., 2015; Impey et al., 2016). One explanation for the 
equivocal nature of the low glycogen – PGC-1α response may be the differences in exercise 
intensity. Indeed, PGC-1α gene expression increases in an intensity dependant manner 
48 
 
(Egan et al., 2013), however it is suggested that if the duration and intensity-dependent 
activated PGC-1a increases to such an extent, subsequent dietary interventions may be 
incapable of further activating PGC-1α (Jensen et al., 2015).  
 
The impact of low muscle glycogen upon promoter specific PGC-1α expression has not 
been identified in current literature. Indeed, activation (by 5-Aminoimidazole-4-
carboxamide ribonucleotide (AICAR)) and suppression of AMPK, an important energy 
sensing kinase that is upregulated in circumstances of low muscle glycogen (Wojtaszewski 
et al., 2003), was found not to be important for an increase in any PGC-1α isoform 
expression after high intensity exercise (Tadaishi et al., 2011). However, to the best of the 
author’s knowledge, no study has directly assessed the impact of reduced muscle glycogen 
on isoform/promoter specific PGC-1α regulation.  Moreover, the combined impact of prior 
low glycogen and post-exercise CWI, two strategies reported to augment post-exercise 
PGC-1α mRNA expression, upon the total PGC-1α response remains to be determined.  
 
2.8 SUMMARY  
Post-exercise CWI remains one of the most popular recovery tools utilised in athletic 
recovery and investigated in scientific literature. Evidence supporting the use of post-
exercise CWI in return to performance and on recovery from muscle soreness is strong, 
despite being heavily dependent on the variable measured, subject characteristics, mode of 
exercise and immersion protocol utilised. It is clear that for post-exercise CWI to be 
effective it must be administered correctly in order to activate the associated physiological 
and molecular mechanisms responsible for improved recovery. Despite this, there remains 
a lack of agreement on the correct and/or most efficient technique for implementing post-
exercise CWI. Whilst equivocal data on the impact of CWI on the post-exercise 
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inflammatory response remains, alongside the paradox that CWI may stimulate and 
facilitate cell signalling related to mitochondrial biogenesis yet dampen the adaptive 
response to resistance training, further mechanistic research is required to determine how 
these mechanisms are controlled, and if they can be altered further.  
 
Evidence suggesting different mechanisms of control of the “master regulator” of 
mitochondrial biogenesis PGC-1α (local tissue cooling vs. systemic adrenergic activation) 
requires further investigation, whilst it is unknown whether the influence of prior low 
glycogen availability and post-exercise CWI can further enhance cell signalling responses 
important in oxidative adaptation, to a greater extent when combined than individually. 
With the knowledge that PGC-1α is not only augmented by post-exercise CWI, but is 
expressed via two different promoter regions that respond differently to low energy and 
heightened adrenergic environments, it is important to understand the promoter specific 
mechanisms to post-exercise CWI alone, or when combined with prior low glycogen 
availability. 
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3.1 GENERAL METHODOLOGY 
The present chapter describes the measurement techniques used within this thesis for the 
collection of thermoregulatory and metabolic measures and the biochemical and molecular 
analysis undertaken. It further provides a description of the exercise and CWI protocols 
used within the following experimental chapters.  
 
3.1.1 Location of testing and ethical approval 
All exercise testing was performed in the Exercise Physiology Research Labs of the Tom 
Reilly Building. Additional rooms were utilised for their specific purpose; such as the 
Muscle Biopsy Suite and Water Immersion Lab. Biochemical analysis of blood and muscle 
samples was undertaken in either the Tom Reilly Building or newly refurbished Life 
Sciences Building adjacent. Analysis of bloods for catecholamines was outsourced to Prof. 
William Fraser’s Lab at the University of East Anglia. Laboratory conditions were 
maintained through central university control at 21.2 ± 0.01°C. The use of an electronic fan 
was used to circulate air only, at no point was a fan pointed directly at the participant or 
located within 3m of the participant. Moreover, all measurements were taken at the same 
time of day in order to avoid circadian variation in internal body temperature (Reilly & 
Brooks, 1990). All study designs within this thesis and the corresponding protocols and 
procedures were approved by the ethical committee of Liverpool John Moores University. 
 
3.1.2 Participants 
All participants used herein were young, healthy and recreationally active volunteers 
recruited from within the School of Sport and Exercise Sciences or from various external 
contacts. All participants gave written informed consent to participate after details and 
procedures of the study had been fully explained and were fully aware of the right to 
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withdraw, without explanation, at any point (Appendix 1-4, 6). All participants were non-
smokers with no history of neurological disease or musculoskeletal abnormality and none 
were under any pharmacological treatment during the course of the study. Participants were 
instructed to refrain from exercise, caffeine and alcohol consumption at least 48 hours prior 
to any laboratory visit. Where necessary participants diet and exercise was prescribed to 
adhere to the study design. 
 
3.1.3 Anthropometry 
Subject’s height was measured whilst standing in the Frankfort plane using a stadiometer 
(Seca, Birmingham, U.K.). Semi-nude body mass was recorded using precision calibrated 
weighing scales (Seca, Birmingham, U.K.). All assessments were undertaken on their first 
visit to the laboratory and re-assessed prior to each experimental test.  
 
3.2 CARDIORESPIRATORY MEASUREMENTS 
3.2.1 Heart Rate 
Participants were fitted with a short-range radio telemetry system for the measurement of 
heart rate (HR) (Polar RS400, Kempele, Finland) during all water immersions and exercise 
experiments. The chest strap was worn directly below the pectoral muscles with the 
transmitter positioned centrally on the sternum.  This device allowed for the recording of 
HR at 5-second intervals, with the data being extracted using Polar Pro Trainer (Polar, 
Kempele, Finland) software at the end of each visit. 
 
3.2.2 Assessment of respiratory gas exchange 
During all resting and CWI measures participants were fitted with a facemask for 
measurement of respiratory gas exchange. Expired fractions of oxygen and carbon dioxide 
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were analysed via breath-by-breath measurement using an on-line gas analysis system 
(Oxycon Pro, Jaeger, Wurzburg, Germany) after calibration with known reference gases. 
Any respiratory measures performed during exercise were undertaken using a mouthpiece 
and nose clip, as opposed to a facemask. Preliminary testing indicated a facemask was too 
claustrophobic when worn for a high intensity cycling protocol lasting 47 minutes and 
prevented participants from completing. 
 
3.3 ASSESSMENT OF MAXIMAL OXYGEN UPTAKE (?̇?O2max) AND 
PEAK POWER OUTPUT (PPO) 
The maximal incremental cycling protocol used has previously been described in detail 
(Pedersen et al. 2008). Pedersen et al. (2008) commenced the test protocol at a rate of 3 
W·Kg-1Body Mass (BM) using endurance trained cyclists, however as participants in the 
present studies were not endurance trained cyclists covering >250km per week in training, 
and after preliminary testing, a starting point of 2 W·Kg-1 BM was utilised. This alteration 
is in line with research by Hawley & Noakes (1992), who reduced the workload to this 
measure for endurance-trained females. From here, the work rate was increased by 50 W 
after the first 150 seconds, and then by 25 W every 150 seconds thereafter, until exhaustion. 
Participants were encouraged to maintain a cycling cadence above 70 rev.min-1, with 
exhaustion being reached when participants could no longer maintain a cadence of 70 
rev.min-1for 15 seconds consecutively. All tests were completed using an electronically 
braked cycle ergometer (Lode Excalibur Sport, Lode, Netherlands). The V̇O2max was taken 
from an average of the highest two consecutive V̇O2 values attained in any 10 s period and 
was stated as being achieved by the following end-point criteria: 1) heart rate within 10 
b.min-1 of age-predicted maximum, 2) Respiratory Exchange Ratio (RER) > 1.1, and 3) 
plateau of oxygen consumption despite increasing workload. Expired fractions of oxygen 
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and carbon dioxide were analysed via an on-line gas analysis system (see section 3.2.2). HR 
was measured continuously using short-range radio telemetry (see section 3.2.1). PPO was 
calculated using the equation below (Pedersen et al., 2008); where CB is the wattage of the 
last complete bout, FB is the fraction of the final bout completed and 25 is the increment of 
25W between each successive bout.    
PPO = CB + (FB x 25) 
 
3.4 MEASUREMENT OF PSYCHO-PHYSIOLOGICAL VARIABLES 
3.4.1 Rating of Perceived Exertion (RPE) 
Participants’ reported ratings of perceived exertion during exercise were recorded using a 
15-point Borg Scale (Borg, 1982). Participants were familiarised to the scale during 
preliminary laboratory visits to ensure full comprehension of the subjective and descriptive 
nature of such a measure.    The category ratio scale that was used is displayed in Figure 
3.1. 
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Rating Description 
6 No Exertion At All 
7 Extremely Light 
8  
9 Very Light 
10  
11 Light 
12  
13 Somewhat Hard 
14  
15 Hard 
16  
17 Very Hard 
18  
19 Extremely Hard 
20 Maximal Exertion 
Figure 3.1: Borg scale for reporting subjective RPE during exercise (Borg, 1982). 
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3.4.2 Subjective Shivering Scale 
Participants reported ratings of perceived shivering during immersion, and in the post 
immersion resting periods, using a 4-point shivering scale (Wakabayashi et al., 2006). As 
with RPE, all participants were familiarised to the scale during preliminary laboratory visits 
to ensure full comprehension of the subjective and descriptive nature of such a measure. 
The category ratio scale that was used is displayed in Table 3.1.  
 
 
Table 3.1: Subjective shivering scale used for ratings of perceived shivering during immersion 
and resting periods. 
Rating Description 
1 No Shivering 
2 Slight Shivering 
3 Moderate Shivering 
4 Heavy Shivering 
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3.4.3 Thermal Comfort 
At the same time points for assessment of Subjective Shivering, participants also reported 
subjective Thermal Comfort (Young et al. 1987) (Figure 3.2).  
 
 
Figure 3.2: Thermal comfort scale used for subjective rating of thermal strain.  
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3.5 THERMOREGULATORY VARIABLES 
3.5.1 Rectal, Skin and Muscle temperature 
Muscle temperature was assessed using a needle thermistor (13050; Ellab, Rodovre, 
Denmark) inserted into the vastus lateralis. Thigh skinfold thickness was measured using 
Harpenden skinfold callipers (HSK BI; Baty International, West Sussex, UK) and divided 
by 2 to determine the thickness of the thigh subcutaneous fat layer over each participant’s 
vastus lateralis. Area of insertion was calculated as half the length of the femur, over the 
‘belly’ of the vastus lateralis. The needle thermistor was then placed at a depth of 3cm, plus 
one-half of the skinfold measurement, for the determination of deep muscle temperature 
(3cm). After stabilisation of temperature, the thermistor was withdrawn at increments of 
1cm for the determination of muscle temperature at 2cm and 1cm below the subcutaneous 
layer. Core temperature was assessed via a rectal thermistor (MRV-55044-A, Ellab, 
Roedovre, Denmark) self-inserted 10-15cm beyond the anal sphincter. Skin temperature 
probes were attached to the lateral upper thigh and medial calf (MHF-18050-A, Ellab) using 
adhesive surgical tape. Rectal temperature, skin temperature and muscle temperature were 
recorded at regular intervals throughout the experimental test day using an electronic 
measuring system (CTF 9004, ELLAB). Skin temperature probes and the rectal probe were 
attached and inserted, respectively, at the start of the day and at least 30 minutes prior to 
any resting measures.  
 
 
3.6 HIGH INTENSITY INTERMITTENT CYCLING PROTOCOL 
The High Intensity Intermittent cycling protocol used throughout the studies in this thesis 
has been used before, with a particular focus on the metabolic demands of such a protocol 
(Stepto et al., 2001). After a short warm up consisting of 2 min of cycling at 25%, 50% and 
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60% PPO each, at a self-selected cadence, participants rested for 2 minutes prior to 
commencing the protocol. The interval training protocol consisted of 8 x 5 minute bouts at 
82.5% PPO (which has previously been shown to closely relate to ~85% peak oxygen 
uptake (V̇O2 peak)) with 60 seconds of rest between each bout. Stepto and colleagues (2001) 
ensured that subjects continued cycling during the rest period at a rate <100W. However, 
they used highly trained athletes with a PPO >400W. After preliminary trials, it was decided 
that recreationally active participants would not pedal during the rest period. The cycle 
ergometer (Lode Excalibur Sport, Lode, Netherlands) was individually adapted to each 
participant’s specifications prior to arrival at the laboratory. It should be noted that a high-
intensity intermittent cycling protocol was utilised in order to minimise muscle damage 
associated with mechanical stress (i.e. eccentric contractions) and to allow greater 
augmentation of the PGC-1α response (Egan et al., 2010) and therefore superior analysis of 
any controlling mechanisms involved in such augmentation.  
 
3.7 COLD WATER IMMERSION 
3.7.1 Single-leg CWI 
In the first study (See Chapter 4), a single-leg CWI design was utilised to allow for 
determination of the local and systemic effect of CWI on both lower limbs. During this, 
participants immersed a single leg in 8°C water for 10 minutes to the gluteal fold. 
Participants were strapped to an electronic hoist which allowed the researchers to lower 
them a suitable way into the cold bath (ECB, Cheltenham, UK). Stools were placed to the 
outside of the bath to support the subject whilst straddling the bath, always ensuring the 
non-immersed leg remained completely dry with the use of a towel. At the end of 
immersion, participants were raised using the electronic hoist and remained seated in a 
supine position whilst post-immersion variable measures were taken. An illustration of 
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single-leg CWI is shown in Figure 3.3. Despite other immersion temperatures and durations 
being suggested as superior for recovery from stressful exercise (Machado et al., 2016) the 
immersion temperature and duration herein was chosen to remain consistent with previous 
work from our labs (Gregson et al., 2013; Joo et al., 2016; Mawhinney et al., 2013), 
particularly as this has been shown to induce a significant adrenergic response in the post-
exercise period (Gregson et al., 2013). 
 
Figure 3.3: Illustration of single-leg CWI method. 
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3.7.2 Two-legged CWI 
In the second study (Chapter 5), a two-legged immersion approach was taken as this follows 
general practice in field settings where CWI is used as a recovery method. Participants were 
lowered into the cold bath using the electronic hoist to their umbilicus for 10 minutes at 8°C 
(Figure 3.4). At the end of immersion, participants were raised from the water using the 
electronic hoist and remained seated in a semi-reclined position under the temperature-
controlled laboratory.  
 
 
Figure 3.4: Illustration of 2-legged CWI method. 
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3.8 PROCUREMENT AND STORAGE OF BLOOD SAMPLES 
Venous blood samples were drawn from a superficial vein in the anti-cubital crease of the 
forearm using standard venepuncture techniques (BD Nexiva Closed IV Catheter 22G Blue, 
Becton Dickinson, Oxford, UK). Blood samples (~10ml) were collected into vacutainer 
tubes (Becton Dickinson, Oxford, UK) containing Ethylenediaminetetraacetic acid (EDTA) 
or serum separation and stored on ice or at room temperature (serum samples, ~1h) until 
centrifugation at 1500 rev.min-1 for 15-min at 4oC. Following centrifugation, aliquots of 
plasma and serum were stored at -80oC for later analysis 
 
 
3.9 ANALYSIS OF BLOOD SAMPLES 
Samples were analysed for serum glucose, lactate, non-esterified fatty acids (NEFA) and 
glycerol concentration using commercially available kits (Randox Laboratories, Antrim, 
UK). Serum samples were also analysed for insulin using a solid phase enzyme-linked 
immunosorbent assay (ELISA, KAQ1251, Life Technologies, UK). Plasma metanephrine 
and normetanephrine concentrations were measured using liquid chromatography– tandem 
mass spectrometry (Peaston et al., 2010). Normetanephrine (NMA), metanephrine (MA) 
and their deuterated internal standards are extracted from plasma using a polymeric weak 
cation exchange solid phase extraction (SPE). The extracts eluted from the SPE plate are 
then dried under nitrogen and reconstituted prior to injection. The internal standards used 
are d3-NMA and d3-MA. Analysis is carried out by high performance liquid 
chromatography coupled to a tandem mass spectrometer in electrospray ionization positive 
mode. Identification and quantification is based on multiple reaction monitoring of each 
specific target analyte transition. 
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3.10 MUSCLE BIOPSIES  
Samples from the vastus lateralis (~30–50 mg wet wt) were obtained under local anaesthesia 
(0.5% Marcaine) using a Pro-Mag 2.2 biopsy gun (MD-TECH, Manan Medical Products, 
Northbrook, IL) (Figure 3.5). When the biopsy needle is inserted through the muscle fascia, 
the biopsy gun operates with a feed-forward mechanism of 2.5–3.5 cm, dependant on the 
angle of insertion (Morton et al., 2009). Once obtained, samples were immediately frozen 
in liquid nitrogen and stored at -80°C for later analysis.  
 
 
 
Figure 3.5: Image of the biopsy gun technique utilised. 
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3.11 ANALYSIS OF SKELETAL MUSCLE mRNA USING 
QUANTITATIVE REAL-TIME PCR 
3.11.1 Muscle sample homogenisation 
Skeletal muscle samples (~30-50 mg) were transferred to 2ml lysing tubes containing 
1.4mm ceramic beads (Lysing Matrix D, MP Biomedicals, UK) and 1ml ice-cooled TRIzol 
reagent and homogenised at 6 m/s for 3 x 40 seconds, separated by 5 minutes cooling on 
ice (MP Fastprep-24, MP Biomedicals, UK). Preliminary analyses using this method 
showed better mRNA concentrations were gained should RNA isolation continue 
immediately from this point, rather than centrifuge the homogenate. By principle, the 
ceramic beads contain much of the cell debris already and allow for removal of an aqueous 
phase immediately after homogenisation.  Thus, the aqueous phase was transferred from the 
2ml lysing tube into a labelled RNase-free Eppendorf before beginning phase separation. 
TRIZOL is a mono-phasic solution of phenol guanidine isothiocyanate that disrupts cells 
and dissolves all cell components other than RNA and DNA. All procedures below were 
carried out using RNA-free pipette tips and pipettes that were handled for RNA use only. 
A different tip was used for every sample to ensure no cross contamination. All work 
surfaces and equipment were sprayed with 75% ethanol and then RNase ZAP (Ambion- 
The RNA Company, Cheshire, UK) before commencing work with RNA.  
 
3.11.2 RNA isolation and extraction 
200µl of chloroform was added per 1ml TRIzol reagent used during homogenisation and 
shaken vigorously by hand for 15 seconds before being incubated at room temperature for 
3 minutes. Samples were then centrifuged at 12000g for 15 minutes at 4°C. After 
centrifugation, the samples were separated into their red phenol, middle interphase and 
upper aqueous phase. The upper aqueous phase was carefully removed into a clean, labelled 
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Eppendorf, ensuring the middle interphase was not disturbed, and mixed with 500µl 
isopropanol (per 1ml TRIzol). After vortex for 15s, the sample was incubated at room 
temperature for 10 minutes before further centrifugation (12000g for 10 minutes at 4°C). 
The resulting supernatant was removed and the remaining RNA pellet washed in 1ml ice-
cooled 75% ethanol (per 1ml TRIzol), vortexed briefly before centrifugation at 7500G for 
8 minutes at 4°C. The ethanol was subsequently removed and the RNA pellet allowed to air 
dry before re-suspension in 30µl RNA storage solution (RNAlater, Invitrogen, UK). 
Samples were incubated in a block heater at 50°C for 10 minutes to assist with re-suspension 
before proceeding to measurement. RNA concentration and purity were assessed by UV 
spectroscopy at optical densities of 260 and 280nm with the use of a Nanodrop 2000 
(Thermo Fisher Scientific, UK). A target of A260 / A280 ratio was set at 2.0. 70ng RNA was 
used for each polymerase chain reaction (PCR) reaction.  
 
3.11.3 Primer Design 
Primer sequences (Table 3.2) were identified using Gene 
(NCBI, http://www.ncbi.nlm.nih.gov.gene) and designed using Primer-BLAST 
(NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast). Sequence homology searches 
ensured specificity; all primers had no potential unintended targets following a blast search. 
The primers were ideally designed to yield products spanning exon-exon boundaries to 
prevent any amplification of gDNA. Three or more GC bases in the last five bases at the 3’ 
end of the primer were avoided. Secondary structure interactions (hairpins, self-dimer and 
cross dimer) within the primer were avoided. All primers were between 16 and 25 bp, and 
amplified a product of between 67 – 212bp. Primers were purchased from Sigma (Suffolk, 
UK). 
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3.11.4 Reverse transcriptase quantitative Real-Time Polymerase Chain Reaction (rt-qRT 
PCR) 
rt-qRT-PCR amplifications were performed using QuantiFastTM SYBR® Green RT-PCR 
one step kit on a Rotor-gene 3000Q (Qiagen, Crawley, UK) supported by rotor-gene 
software (Hercules, CA, USA). rt-qRT-PCR was performed as follows: hold 50°C for 10 
min (reverse transcription/cDNA synthesis), 95°C for 5 min (transcriptase inactivation and 
initial denaturation step) and PCR steps of 40 cycles; 95°C for 10s (denaturation), 60°C for 
30s (annealing and extension). Upon completion, dissociation/melting curve analysis were 
performed to reveal and exclude non-specific amplification or primer-dimer issues (all melt 
analysis in this study presented single reproducible peaks for each target gene suggesting 
amplification of a single product, Appendix 8). Following initial screening of suitable 
housekeeping genes, Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) showed the 
most stable Ct values across all RT-PCR runs, participants and regardless of experimental 
condition (23.54 ± 1.69 CT; 7% Co-efficient of variation; Chapter 4) and was selected as 
the reference gene in all RT-PCR assays. The relative gene expression levels were 
calculated using the comparative Ct (
ΔΔCt) equation (Schmittgen & Livak, 2008) where the 
relative expression was calculated as 2-ΔΔct and where Ct represents the threshold cycle. 
mRNA expression for all target genes was calculated relative to the reference gene 
(GAPDH; participants own reference, not pooled) within same subject and condition and to 
a calibrator of Pre-exercise. In Chapter 4, the calibrator of Pre-exercise for the immersed 
and non-immersed legs was the same sample. 
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Table 3.2: Primer sequences used during Real-Time PCR  
Gene Forward Primer Reverse Primer 
   
GAPDH  
NM_002046.5 
AAGACCTTGGGCTGGGACTG TGGCTCGGCTGGCGAC 
RPL13a GGCTAAACAGGTACTGCTGGG GAAAGCCAGGTACTTCAACTT 
Total PGC-1alpha 
NM_013261.3 
TGCTAAACGACTCCGAGAA TGCTAAACGACTCCGAGAA 
PGC-1alpha alternative 
promoter (Exon 1b) 
XM_011513766.1   
XM_005248132.1  
 
CTATGGATTCAATTTTGAAATGTGC CTGATTGGTCACTGCACCAC 
PGC-1alpha canonical 
promoter (Exon 1a) 
NM_013261.4 
 
ATGGAGTGACATCGAGTGTGCT GAGTCCACCCAGAAAGCTGT 
p53  
NM_000546.5 
ACCTATGGAAACTACTTCCTGAAA CTGGCATTCTGGGAGCTTCA 
SIRT1  
NM_012238.4 
CGGAAACAATACCTCCACCT CACATGAAACAGACACCCCA 
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COXIV  
NM_001861.4 
CGAGCAATTTCCACCTCTGT  GGTCACGCCGATCCATATAA 
CS  
NM_004077.2  
CCTGCCTAATGACCCCATGTT CATAATACTGGAGCAGCACCCC 
TFAM  
NM_003201.2 
TGGCAAGTTGTCCAAAGAAACCTGT 
  
GTTCCCTCCAACGCTGGGCA 
NRF2  
NM_002040.3 
AAATTGAGATTGATGGAACAG
AGAA 
  
TATGGCCTGGCTTACACATTCA 
ERRα  
NM_004451.4 
TGCCAATTCAGACTCTGTGC 
  
CCAGCTTCACCCCATAGAAA 
GLUT4  
NM_001042.2 
TCTCCAACTGGACGAGCAAC CAGCAGGAGGACCGCAAATA 
Glyceraldehyde 3-phosphate dehydrogenase –GAPDH; Ribosomal protein L13a- RPL13a; Peroxisome Proliferator-activated receptor gamma coactivator 
1-alpha – PGC-1α; Tumour suppressor protein 53- p53; Sirtuin 1 – SIRT1; Cytochrome C oxidase subunit 4 – COXIV; Citrate synthase – CS; Mitochondrial 
transcription factor A – TFAM; Nuclear respiratory factor 2 – NRF2; Estrogen-related receptor alpha – ERRα; Glucose transporter type 4 – GLUT4.
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3.12 ANALYSIS OF SKELETAL MUSCLE SAMPLES USING SDS-
PAGE AND WESTERN BLOTTING 
3.12.1 Sample preparation  
 Approximately 30 mg of frozen muscle was homogenized using 2.4 mm ceramic beaded 
tubes (6 m/s for 3 x 40 seconds, separated by 5 minutes cooling on ice; MP Fastprep-24, 
MP Biomedicals, UK), in 500 µl of ice-cold lysis buffer [25 mM Tris·HCl (pH 7.4), 50 mM 
NaF, 100 mM NaCl, 5 mM EGTA, 1 mM EDTA, 10 mM Na-pyrophosphatase, 1% Triton 
X-100] and supplemented with a protease phosphatase inhibitor cocktail (Halt Protease and 
Phosphatase Inhibitor 186 Cocktail, Thermo Scientific, # 78442). The resulting 
homogenates were centrifuged at 14,000 g for 10 min at 4°C, and the supernatant was 
collected.  
 
3.12.2 Determination of protein quantity using Bicinchoninic Acid (BCA kit) and SDS page 
The protein content of the supernatant was determined using a bicinchoninic acid assay 
(Sigma, UK). Each sample was diluted with an equal volume of 2X Laemmli buffer 
(National Diagnostics) and boiled for 10 min at 90°C. 40 µg of protein from each sample 
was loaded (65 µg for phosphorylated analytes) and then separated in Tris-glycine running 
buffer (10x Tris/glycine, Geneflow, Staffordshire, UK) using self-cast 10% separating [33% 
Protogel; (30% w/v acrylamide: 0.8% (w/v) Bis-Acrylamide stock solution (37.5:1)), 25% 
Protogel resolving buffer (1.5M Tis-HCL, 0.4% SDS, pH 8.8), 41% ddH2O, 100µl 10% 
APS, 20µl TEMED] and 4% stacking [13% Protogel, 25% Protogel Stacking buffer (0.5M 
Tris HCL, 0.4% SDS, pH 6.8), 61% ddH2O, 100µl 10% APS, 20µl TEMED] gels (National 
Diagnostics, Geneflow, UK) (Figure 3.6).  
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3.12.3 Western Blotting 
Gels were transferred semidry onto nitrocellulose membrane (Transblot Turbo, Bio-Rad) 
for 30 min at 25V and 1.0 mA in transfer buffer [10% TRIS/glycine (Sigma), 20% methanol, 
70% ddH2O). After transfer, membranes were briefly washed in TBST (0.19 M Tris pH 7.6, 
1.3 M NaCl, 0.1% Tween-20] before being blocked for 1 h at room temperature in TBST 
with 1% BSA. The membranes were then washed for 3 x 5 min in TBST before being 
incubated overnight at 4°C with antibodies for anti-phospho-AMPK Thr172 (cat no: 2532), 
p38 MAPKThr180/Tyr182 (cat no: 9211) (Cell Signalling) as well as total protein content 
of AMPK (cat no: 2531), p38 MAPK (cat no: 9212) (Cell Signalling, UK), GAPDH (25778; 
Santa Cruz), and PGC-1α (Calbiochem, Merck Chemicals, UK) all at concentrations of 
1:1000 in 1 x TBS. The following morning, membranes were washed for a further 3 x 5 min 
in TBST and subsequently incubated with goat anti-rabbit horseradish peroxidase-
conjugated secondary antibody (Bio-Rad, UK) for 1h at room temperature. After a further 
3 x 5 min washes in TBST, membranes were exposed in a chemiluminescence liquid 
(SuperSignal, Thermo Fisher Scientific, Rockford, IL) for 5 min (30s for GAPDH). 
Membranes were visualized using a Bio-Rad Chemi-doc system, and band densities were 
determined using Image Lab image-analysis software (Bio Rad, UK). Samples from each 
subject for all exercise conditions were run on the same gel and statistical analysis 
conducted on raw densitometry data. Phosphorylated AMPK Thr172 and p38 MAPK 
Thr180/Tyr182 were relativized to their total counterpart, as these did not change 
significantly across blots or samples (P > 0.05). PGC-1α was relativized to GAPDH.  
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Figure 3.6: Image of Bio-Rad Mini PROTEAN Tetra Tank system utilised for SDS page. 
 
3.13 Muscle glycogen  
For Chapter 5, to ensure all participants reported with similar levels of muscle glycogen 
they first underwent a two-legged glycogen depleting cycling protocol consisting of 2 min 
at 90% PPO, followed immediately by a 2-min recovery period at 50% PPO. They repeated 
this work to rest ratio until 2 min cycling at 90% PPO could not be maintained, determined 
as an inability to maintain a cadence of 70 rev.min-1. At this point, exercise intensity was 
lowered to 80% PPO, with the same work:rest ratio. When participants could no longer 
maintain this intensity, it was lowered to 70% and finally 60% PPO with the same work to 
rest ratio. When the participants were unable to cycle for 2 min at 60% PPO, the exercise 
protocol was terminated. This intermittent pattern of exercise has previously been shown to 
evoke glycogen depletion in both type I and type II fibres (Kuipers et al., 1987). After the 
completion of the two-legged glycogen depletion protocol, participants were provided with 
a high CHO diet for the next ~22 h (CHO 8 g·kg-1 body mass, PRO 1.4 g·kg-1 body mass 
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FAT 0.5 g·kg-1 body mass). Feeding began immediately after the cessation of exercise for 
4x hourly intervals that evening. Participants were also provided with breakfast for the 
following morning and returned to the laboratory post-breakfast to collect food for the rest 
of the day (~8g CHO·kg-1bw). The purpose of this initial glycogen depletion protocol with 
high CHO refeed was to ensure participants had a similar level of muscle glycogen prior to 
commencing the second evening depletion.  
 
The protocol used to deplete a single leg of muscle glycogen in the day prior to the 
experimental day (Chapter 5) has been utilised before (Pilegaard et al., 2002). 
Approximately 15 h prior to the experimental trial, participants attended the laboratory for 
a single-leg glycogen depletion protocol, to deplete their dominant leg only. Glycogen 
depletion of the dominant leg was undertaken as to ensure similar muscle recruitment 
patterns and therefore glycogen depletion between trials. Single-leg glycogen depletion 
involved 20 min continuous single-leg cycling at 75% PPO, followed by intermittent 
cycling at a work:rest ratio of 90s:90s. Intermittent cycling began at 90% PPO decreasing 
in 5% decrements when such a workload cannot be maintained for 5s consecutively, to 55% 
PPO. Immediately following this participants’ completed an all-out one-legged cycling bout 
at 85% PPO before going on to 30 minutes of 2-arm cycling at 50W to decrease liver 
glycogen levels (Pilegaard et al., 2002).  Participants then underwent an overnight fast 
before returning to the lab the next day.  
 
Prior to commencing trials participants underwent at least two familiarization sessions for 
both the single- and 2-leg depletion protocols. Particular care was taken to ensure 
participants were comfortable with the technique required for single-leg cycling. 
Furthermore, during single-leg cycling the spare pedal was weighted to assist with rotation, 
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this method has previously been used in other single-leg cycling protocols (MacInnis et al., 
2017). In both depletion protocols, participants were blinded to time elapsed, power output 
and number of stages completed and were only informed of whether they were completing 
a ‘high’ or ‘recovery’ interval. HR was measured continuously throughout exercise (Polar 
RS400, Kempele, Finland) and RPE (Borg, 1982) recorded with each reduction in PPO. 
Water intake was consumed ad libitum throughout exercise with the same total volume 
consumed in subsequent trials. 
 
This method of single leg depletion has previously been successful in producing 
contralateral high and low glycogen limbs (High ~600 and Low ~300 mmol·kg-1dw); 
Pilegaard et al., 2002). We further conducted pilot work on these depletion protocols to 
ensure we could match these previous results, with that pilot work showing slightly lower 
values (High ~400 and Low ~175 mmol·kg-1 dw).  
 
Muscle glycogen concentration was determined according to the method described by Van 
Loon et al. (2000). Approximately 2-3 mg of freeze-dried sample was dissected free of all 
visible non-muscle tissue and subsequently hydrolysed by incubation in 500 µl of 1 M HCl 
for 3-4 hours at 100°C. After cooling to room temperature, samples were neutralized by the 
addition of 250 µl 0.12 mol.L-1 KOH saturated with KCl. Following centrifugation, 150 µl 
of the supernatant was analysed in duplicate for glucose concentration according to the 
hexokinase method using a commercially available kit (GLUC-HLK, Randox Laboratories, 
Antrim, UK). Glycogen concentration is expressed as mmol·kg-1dw and intra assay 
coefficients of variation was <5%. 
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CHAPTER FOUR  
 
Post-exercise cold-water immersion modulates skeletal muscle PGC-1α 
mRNA expression in immersed and non-immersed limbs: evidence of 
systemic regulation 
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Communication: Oral communication at the 21st annual ECSS Congress Vienna, Austria, 
July 2016 (Appendix 7).
 
 
This study was published in Journal of Applied Physiology. In doing so, permission to 
reproduce the work in this thesis is automatically granted. 
Allan et al. 2017. Post-exercise cold-water immersion modulates skeletal muscle PGC-1α 
mRNA expression in immersed and non-immersed limbs: evidence of systemic regulation. 
J Appl Physiol, DOI: 10.1152/japplphysiol.00096.2017  
 
 
4.1 INTRODUCTION 
It is well established that the transcriptional co-activator PGC-1α, the proposed “master 
regulator” of skeletal muscle mitochondrial biogenesis, is sensitively controlled by acute 
and chronic exercise (Egan et al., 2010; Perry et al., 2010; Bartlett et al., 2012; 2013). 
Upstream control of PGC-1α includes phosphorylation by energy and stress sensing kinases 
AMPK (Jäger et al., 2007) and p38 MAPK (Akimoto et al., 2005).  Consistent with its initial 
discovery as cold-inducible (Puigserver et al., 1998; Oliveira et al., 2004), recent studies 
have examined the potential of acute post-exercise cold exposure to also modulate PGC-1α 
expression. For example, in human tissue, both cold-ambient temperatures (Slivka et al., 
2012; 2013) and post exercise cold-water immersion (Ihsan et al., 2014a; 2015) enhances 
the skeletal muscle PGC-1α gene transcription and protein translational response versus 
exercise alone. The precise mechanism(s) mediating cold-induced regulation of the PGC-
1α transcriptional pathway have yet to be fully determined, though the cooling-induced 
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alterations in muscle blood flow (Gregson et al., 2011; Mawhinney et al., 2013) are unlikely 
to mediate these effects (Norrbom et al., 2004; Taylor et al., 2016).  It is noteworthy, 
however, that chronic cold-induced changes in PGC-1α protein content arise in conjunction 
with increased activity of signalling kinases AMPK and p38 MAPK (Ihsan et al., 2015).  
These data suggest that cooling of the skeletal muscle tissue may play a role in mediating 
the post-exercise cold-induction of PGC-1α mRNA through activation of local signalling 
kinases.   
 
Alternatively, systemic control via increased β-adrenergic activity is suggested to play a 
potent role in mediating the effects of cold exposure on PGC-1α expression via AMPK 
(Manfredi et al., 2013) and β2-adrenergic receptor (Miura et al., 2007) mechanisms.  Indeed, 
plasma noradrenaline concentrations remain higher following high-intensity exercise after 
cold-water immersion versus control conditions (Gregson et al., 2013).  Studies to date have 
utilised the non-immersed limb as the control condition without the use of a true control (no 
cooling) condition (Frohlich et al., 2014; Ihsan et al., 2015; Ihsan et al. 2014a). By assuming 
the response to cold-water immersion is mediated locally, such experimental designs do not 
permit examination of the role of systemic versus localised mechanisms in mediating cold-
induced changes in PGC-1α. Indeed, Ihsan et al. (2014a) observed that PGC-1α gene 
transcription was not induced in a non-immersed control limb, despite the limb having 
previously been exercised, and exercise being a potent stimulus to induce PGC-1α 
expression. This would therefore suggest that an induction of PGC-1α expression in an 
immersed limb occurred by way of localised cold-induced mechanisms. In this regard it is 
suggested that the increased systemic β-adrenergic activity associated with post-exercise 
cooling of the immersed limb could also modulate PGC-1α expression in the non-immersed 
contralateral limb.  
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Therefore, the aim of the present study was to examine whether the cold-water induced 
increase in PGC-1α mRNA observed post exercise is mediated through local or systemic 
mechanisms.  To this end, we employed a novel experimental design (in a repeated 
measures crossover design) where ten recreationally active males completed an acute 
cycling protocol (8x5 min at ~80% peak power output) followed by a seated-rest condition 
(CON) or single-leg cold-water immersion (CWI; 10 min, 8°C). Muscle biopsies were 
obtained pre-, post- and 3 h post-exercise from a single limb in the CON condition but from 
both limbs post-exercise in the CWI trial (thereby providing tissue from a CWI and non-
immersed limb, NOT).  In this way, our design allowed us to obtain tissue from true control 
conditions but yet, also sample tissue from an immersed and non-immersed limb that was 
subject to the same hormonal milieu. 
 
 
4.2 METHODS 
4.2.1 Participants 
Ten recreationally active healthy males (age 26 ± 4 y; body mass 79.29 ± 6.73 kg; height 
180 ± 5 cm; V̇O2peak 51.46 ± 9.07 mL·kg-1·min-1 peak power output (PPO) 265.2 ± 38.33 
W; mean ± SD) participated in this study. Participants were instructed to refrain from 
exercise, alcohol and caffeine 48 hours prior to the test day. All participants gave written 
informed consent to participate after details and procedures of the study had been fully 
explained. Participants had no history of neurological disease or musculoskeletal 
abnormality and none were under any pharmacological treatment during the course of the 
study. Each subject was medically screened by a practising GP prior to participation for 
their individual risk associated with high-intensity exercise, muscle biopsy procedures and 
immersion in cold water. All procedures performed in the study were approved by the Ethics 
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Committee of Liverpool John Moores University and in accordance with the 1964 Helsinki 
declaration and its later amendments. 
 
4.2.2 Experimental Design. 
 In a repeated-measures crossover design, participants completed two high-intensity 
intermittent cycling protocols followed either by 10 min seated rest (CON) or single-leg 
CWI (10 min at 8°C). Muscle biopsies were obtained from the vastus lateralis immediately 
before, post- and 3 h post-exercise. During the CWI trial muscle biopsies in the post-
exercise period were taken from both the immersed and non-immersed leg. This design 
allowed us to assess the impact of the cold stimulus locally (immersed leg) and systemically 
(non-immersed leg) against a relevant resting control. Both experimental trials were 
conducted in a counterbalanced, randomized order with at least 10 days between conditions.  
 
4.2.3 Experimental Protocol.  
 Participants attended the laboratory on 3 separate occasions. On the first occasion, 
participants completed an incremental exercise test to fatigue for the determination of 
V̇O2max and PPO (Hawley & Noakes, 1992). Results from this test were used to determine 
the power output necessary for cycling at a proportion of PPO on subsequent test days 
(detailed below). Prior to the first test day, participants completed a 24-hour food diary to 
be replicated before the second trial. Upon arrival at the laboratory (0900h), participants 
were fitted with a heart-rate monitor (Polar RS400, Kempele, Finland), skin and rectal 
temperature probes (MHF-18050-A and MRV-55044-A, Ellab, Rodovre, Denmark). Legs 
were marked for subsequent insertion of muscle temperature needles; area of insertion was 
calculated as half the length of the femur, over the ‘belly’ of the vastus lateralis. The needle 
thermistor was then placed at a depth of 3cm, plus one-half of the skinfold measurement, 
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for the determination of deep muscle temperature (3cm). Following 10-min resting in a 
supine position, baseline measures of heart rate (HR), temperature and oxygen uptake (V̇O2; 
Oxycon Pro, Jaeger, Wuerzberg, Germany) were assessed. Resting venous blood samples 
were drawn from a superficial vein in the anti-cubital crease of the forearm using 
venepuncture cannulation (BD Nexiva Closed IV Catheter 22G Blue, Becton Dickinson, 
Oxford, UK). Resting muscle temperature was assessed using a needle thermistor (13050; 
Ellab, Rodovre, Denmark) inserted into the vastus lateralis at 3cm depth as previously 
described (Mawhinney et al., 2013).  Finally, resting muscle biopsy samples from the vastus 
lateralis (~30–50 mg wet wt) were obtained under local anaesthesia (0.5% Marcaine) using 
a Pro-Mag 2.2 biopsy gun (MD-TECH, Manan Medical Products, Northbrook, IL). At rest 
only a single leg was biopsied in the cooling trial (CWI) in attempt to reduce the stress 
experienced by participants. This leg was randomised between the immersed and non-
immersed limbs to exclude potential variation caused by leg dominance; all subsequent 
biopsies were completed in both legs, at each time point, 2cm proximal to the previous 
incision. 
 
Following the resting biopsy, participants completed a high-intensity intermittent cycling 
protocol consisting of 8 × 5min bouts at 82.5% PPO separated by 1 min rest (adapted from 
Stepto et al., 2001) followed by either single-legged CWI (CWI: 10 min at 8°C; NOT: non-
immersed leg i.e. 10 min at room temperature) or a control condition (CON; seated rest). 
CWI was conducted using a specialised seated mechanical hoist to lower the subject so that 
one leg was placed inside the cold bath, allowing the other (NOT) to remain outside, and 
dry. Participants then recovered in a semi-reclined position under normal laboratory 
temperatures (~21°C) until 3-hours post-exercise. Measures of heart rate, skin temperature 
(thigh and calf) and rectal temperature were recorded throughout the exercise and recovery 
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periods. Oxygen uptake was measured during the final minute of each high-intensity bout 
of exercise, during immersion, immediately post-immersion and again at 1, 2 and 3 h post-
exercise. Ratings of perceived exertion (RPE) were assessed during the final minute of each 
exercise bout (Borg, 1982), whilst subjective measures of perceived shivering were assessed 
throughout water immersion and the 3h recovery period using a visual analogue scale from 
1 (No shivering) to 5 (Intense Shivering) (Joo et al., 2016). Laboratory temperatures 
remained stable throughout (21.18 ± 0.76oC) and at no point were participants allowed to 
rub themselves dry or shower (changing into dry shorts after immersion was allowed). 
Participants were advised to wear the same clothes between trials. Muscle temperature was 
assessed post-exercise, immediately post-immersion and at 1, 2 and 3h post-exercise. 
Venous blood samples were also drawn at these times. Bi-lateral muscle biopsies occurred 
immediately after exercise and 3h post-exercise.  
 
Venous blood samples were drawn from a superficial vein in the anti-cubital crease of the 
forearm using standard venepuncture techniques (BD Nexiva Closed IV Catheter 22G Blue, 
Becton Dickinson, Oxford, UK). Blood samples (~10ml) were collected into vacutainer 
tubes (Becton Dickinson, Oxford, UK) containing EDTA and stored on ice until 
centrifugation at 1500 rev.min-1 for 15-min at 4oC. Following centrifugation, aliquots of 
plasma were stored at -80oC for later analysis. Plasma metanephrine and Normetanephrine 
concentrations were measured using liquid chromatography tandem mass spectrometry as 
previously described (Peaston et al., 2010). All samples were analysed in duplicate, with 
the mean value employed.  
 
 
4.2.4 rt-qRT-PCR.  
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rt-qRT-PCR amplifications were performed as specified in Section 3.11 using specific 
Primer designs outlined in Table 4.1. Following initial screening of suitable reference genes, 
GAPDH showed the most stable Ct values across all RT-PCR runs, participants and 
regardless of experimental condition (23.54 ± 1.69 Ct; 7% Co-efficient of variation) and 
was selected as the reference gene in all RT-PCR assays. The average PCR efficiency was 
90% and variation for all genes was less than 4.3%. mRNA expression for all target genes 
was calculated relative to the reference gene (GAPDH; subject’s own samples reference) 
within same subject and condition and to a calibrator of Pre-exercise. 
 
4.2.5 SDS-PAGE and Western Blotting.  
SDS-PAGE and western blotting was performed as specified in Section 3.12. Samples from 
each subject for all exercise conditions were run on the same gel and statistical analysis 
conducted on raw densitometry data. Phosphorylated AMPK Thr172 and p38 MAPK 
Thr180/Tyr182 were normalised to their total protein, as these did not change significantly across 
blots or samples (P > 0.05). PGC-1α was normalised to GAPDH.  
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Table 4.1: Primer sequences used for real-time PCR. 
Gene Forward Primer Reverse Primer Product Length (base 
pairs) 
GAPDH 
NM_002046.5 
AAGACCTTGGGCTGGGACTG TGGCTCGGCTGGCGAC 168 
PGC-1alpha 
NM_013261.3 
TGCTAAACGACTCCGAGAA TGCAAAGTTCCCTCTCTGCT 67 
p53 
NM_000546.5 
ACCTATGGAAACTACTTCCTGAAA CTGGCATTCTGGGAGCTTCA 141 
SIRT1 
NM_012238.4 
CGGAAACAATACCTCCACCT CACATGAAACAGACACCCCA 186  
COXIV 
NM_001861.4 
CGAGCAATTTCCACCTCTGT  GGTCACGCCGATCCATATAA 94 
CS 
NM_004077.2 
CCTGCCTAATGACCCCATGTT CATAATACTGGAGCAGCACCCC 137 
TFAM 
NM_003201.2 
TGGCAAGTTGTCCAAAGAAACCT
GT 
 
 
GTTCCCTCCAACGCTGGGCA 135 
NRF2 
NM_002040.3 
AAATTGAGATTGATGGAACAGAGAA 
  
TATGGCCTGGCTTACACATTCA 95 
ERRα 
NM_004451.4 
TGCCAATTCAGACTCTGTGC   CCAGCTTCACCCCATAGAAA 212 
 
Glyceraldehyde 3-phosphate dehydrogenase –GAPDH; Peroxisome Proliferator-activated receptor gamma coactivator 1-alpha – PGC-1α; Tumour suppressor protein 
53- p53; Sirtuin 1 – SIRT1; Cytochrome C oxidase subunit 4 – COXIV; Citrate synthase – CS; Mitochondrial transcription factor A – TFAM; Nuclear respiratory factor 2 – 
NRF2; Estrogen-related receptor alpha – ERRα.
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4.2.6 Statistical analysis.  
All data are presented as mean ± SD, unless otherwise stated. Baseline data, distance cycled, 
exercise HR and RPE were compared between conditions using a Paired Samples T-test. 
Blood, temperature (skin, rectal, muscle) and post-exercise HR, oxygen uptake and 
subjective ratings were analysed using a two-factor (two condition x time) within-
participants general linear model. For muscle derived variables, a two-factor (three 
condition × time) within-participants general linear model was used to evaluate the effect 
of time (baseline vs. post exercise) with shared baseline data used for NOT and CWI 
(Statistical Package for the Social Sciences version 21.0; SPSS Inc., Chicago, IL). A two-
factor (three condition × time) within-participants general linear model was subsequently 
used to evaluate the influence of the cooling intervention following exercise and the 3h post 
exercise period. The main effects for condition and time was followed up using planned 
LSD multiple contrasts.  Where a significant condition by time interaction was observed, 
the post exercise to 3h post exercise change scores were calculated and compared across the 
3-conditions using LSD multiple contrasts. The ES magnitude was classified as trivial 
(<0.2), small (>0.2-0.6), moderate (>0.6-1.2), large (>1.2-2.0) and very large (>2.0-4.0) 
(Hopkins et al., 2009). The  level for evaluation of statistical significance was set at P < 
.05.  
 
4.3 RESULTS 
4.3.1 Exercise Response.  
Distance cycled (CON 32.52 ± 4.21 km, CWI 32.33 ± 4.33 km; P = 0.629, ES 0.04 Trivial), 
heart rate (P = 0.309, ES 0.13 Trivial), V̇O2 (ml·kg-1·min-1 P = 0.855, ES 0.02 Trivial) and 
RPE (P = 0.637, ES 0.08 Trivial) were similar between CON and CWI trials (data not 
shown). Mean HR during the final minute of exercise was 182 ± 8 beats.min-1 in CON and 
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183 ± 8 beats.min-1 in CWI, equating to ~94% HR max. The RPE in the final exercise bout 
was 19 ± 1 AU and 19 ± 1 AU in the CON and CWI trials respectively.  
 
4.3.2 Recovery Response. 
Metabolic Responses. Heart rate (ES 0.90 Moderate) and V̇O2, (ES 1.20 Moderate) was 
higher in CWI vs CON during the post-exercise recovery period (Table 4.2; P < 0.001).  
The change in HR and V̇O2, over time was also different between conditions (P <0.001) 
with increases in HR and V̇O2, occurring during the initial 2 minutes of immersion.  
Following immersion, HR and V̇O2 dropped below pre-immersion values and remained 
lower throughout the 3h recovery period (HR, ES >0.92 Moderate; V̇O2, ES >1.25 Large) 
(P < 0.05). 
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Table 4.2: Heart rate and oxygen uptake during immersion and the post-immersion period (n=10, mean ± SD).  
 
 
 
  Immersion  Post-Immersion  
PreIm 2min 4min 6min 8min 10min  2min 4min 6min 8min 10min 1h 2h 3h 
HR 
(beats·
min-1)    
CON 88  
±10 
86#     
±9 
86 
±10 
86  
±9 
87  
±8 
86     
±9 
 85#   
±9 
85#   
±9 
84#   
±9 
83#   
±9 
85#  
±10 
85#  
±10 
76#  
±11 
76#  
±10 
 CWI 103 
±14 
117# 
±18 
109 
±16 
104 
±13 
102  
±14 
101 
±13 
 90# 
±13 
90# 
±12 
89# 
±12 
88# 
±11 
88# 
±11 
89# 
±11 
75# 
±13 
73# 
±14 
                 
V̇O2 
(ml·kg-
1· min-
1) 
    
CON 4.6 
±0.9 
4.2 
±0.8 
4.3 
±0.7 
4.4 
±0.8 
4.3 
±0.6 
4.3 
±0.9 
 4.4# 
±0.8 
4.5# 
±0.8 
4.3# 
±0.8 
4.2# 
±0.7 
4.3# 
±0.9 
4.5# 
±0.8 
4.3# 
±0.6 
4.0# 
±0.6 
 CWI 7.05 
±1.4 
8.1 
±1.4 
6.5 
±1.2 
6.3 
±0.7 
6.0 
±1.0 
5.9 
±0.6 
 5.2# 
±1.4 
4.8# 
±1.0 
4.7# 
±0.8 
4.4# 
±0.9 
4.1# 
±1.2 
4.3# 
±1.3 
3.8# 
±0.5 
3.8# 
±0.5 
Values are mean ± SD. A main effect for condition and time along with a significant interaction between condition and time were found for HR and V̇O2 (P < 0.05).  
# Significant difference from pre-immersion (P < 0.05).  
 
86 
 
4.3.3 Thermoregulatory Responses.  
Rectal temperature was similar between conditions throughout the post-exercise period 
(CON 37.52 ± 0.24°C, CWI 37.48 ± 0.05°C, ES 0.49 Small, P = 0.217). The change in 
rectal temperature over time was different between conditions, with a small decline in rectal 
temperature occurring after 3 minutes of immersion until 3h post-exercise (P=0.034, ES 
0.22 Small). Thigh skin temperature was generally lower throughout the post-exercise 
recovery period in CWI versus CON (ES 6.26 Very Large) and NOT (ES 6.46 Very Large) 
(Figure 4.1a, P < 0.001). The change over time was also different between conditions, with 
thigh skin temperature continually decreasing in CWI and remaining lower than pre-
immersion values until 1h post exercise (ES 3.0 Very Large, P < 0.001).  Values in CON 
and NOT limbs remained similar to pre-immersion throughout the 3h recovery period (P = 
0.10, ES 0.57 Small). 
 
Post-exercise muscle temperature (3 cm depth) was similar between CON (38.75°C), CWI 
(38.86°C) and NOT (38.54°C) (Figure 4.1b; P > 0.05). During the 3 h recovery period 
muscle temperature (3cm) was lower in CWI versus CON (ES 1.60 Large) and NOT (ES 
1.77 Large) (P < 0.001). The change in muscle temperature over time was also different 
between conditions (P < 0.001).  Muscle temperature declined to a large extent immediately 
after immersion in the CWI limb, followed by a further gradual reduction during the 
remaining 3h post-exercise period (P < 0.001).  In CON and NOT conditions, muscle 
temperature was reduced to a lesser extent immediately following immersion followed by 
a further gradual reduction during the 3h post-exercise period (P = 0.246, ES 0.34 Small) 
(See Figure 4.1b).  
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Subjective shivering ratings were greater in CWI vs CON during the post-exercise 
recovery period (ES 1.20 Large, P = 0.067). The change in shivering over time also 
tended to be different between conditions (P = 0.062), with ‘slight’ shivering observed in 
the CWI condition during the first 2 minutes following immersion (ES >0.60 Moderate).  
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Figure 4.1: Temperature response post-exercise for thigh skin (a) and deep muscle (3cm 
depth) (b) with/without CWI. Values are mean ± SD. A main effect for time, condition and 
time*condition interaction was found in both thigh and muscle temperature measures 
(P<0.05). *Significantly different from pre-immersion (Skin) or post-exercise (muscle) (P 
< 0.05). # Significantly different from CON and NOT (P < 0.05). Post Ex = Post Exercise, 
Post Im= Post Immersion, +1h= 1h post- exercise, +2h= 2h post-exercise, +3h Post= 3h 
post-exercise. 
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4.3.4 AMPK and P38 MAPK activity and total abundance 
Phosphorylation of AMPK Thr172 was not increased post-exercise (P = 0.242, ES 0.20 Small). 
At post-exercise and 3h post-exercise phosphorylation of AMPKThr172 was similar between 
conditions (P = 0.846, ES 0.03 Trivial).  However, the change in AMPKThr172 between these 
time points was different between conditions (P = 0.031; Figure 4.2). AMPKThr172 
phosphorylation increased in CWI vs. CON (P = 0.027, ES 1.22 Large) with a moderate 
increase in AMPKThr172 phosphorylation also observed in NOT vs. CON (P = 0.145, ES 
0.70 Moderate). Representative Western blots are shown in Figure 4.5. 
 
Exercise induced a small increase in phosphorylation of p38MAPKThr180/Tyr182 (P = 0.056, 
ES 0.44 Small, Figure 4.3). At post exercise and 3h post-exercise phosphorylation of 
p38MAPKThr180/Tyr182 was similar between conditions (P = 0.672; ES 0.03, Trivial). No 
differences in the change in phosphorylation between these time points was observed 
between conditions (P = 0.268, Figure 4.3). Representative Western blots are shown in 
Figure 4.5.  
 
4.3.5 PGC-1alpha mRNA and protein abundance.  
PGC-1α mRNA expression was moderately increased with exercise (P = 0.066, ES 0.92 
Moderate, Figure 4.4a). At 3h post-exercise, expression was greater in CWI (ES 1.2 
Moderate, P = 0.003) and NOT (ES 1.6 Large, P = 0.001) versus CON, but was similar 
between CWI and NOT (ES 0.6 Small, P = 0.141) (Figure 4.4a). This reflected the greater 
change in expression in CWI and NOT conditions between post exercise and 3h post 
exercise time points (P = 0.001, Figure 4.4a). PGC-1α protein content was not influenced 
by exercise (P = 0.092) or CWI (P = 0.471, Figure 4.4b). Representative Western blots are 
shown in Figure 4.5. 
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Figure 4.2: Phosphorylation of AMPKThr172 fold changes from Pre, expressed relative to 
total AMPK as total AMPK did not change significantly across blots or samples (P > 0.05). 
Values are mean ± SD. $ Significant time*condition interaction (P = 0.031). Post Ex = Post 
Exercise, 3h Post= 3h post-exercise. 
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Figure 4.3: Phosphorylation of p38MAPKThr180/Tyr182 fold change from Pre, expressed 
relative to total p38MAPK as total p38 MAPK did not change significantly across blots or 
samples (P > 0.05). Values are mean ± SD. Post Ex = Post Exercise, 3h Post= 3h post-
exercise.  
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Figure 4.4: PGC-1α mRNA (a) and protein content (b) 2-ΔΔCT fold change in expression 
with the calibrator as pre-exercise and the reference gene as GAPDH (see methods for 
details). Values are mean ± SD. A main effect for condition and time was found (P < 0.001). 
There was also a significant interaction between condition and time (P = 0.001) 
*Significantly different from baseline (P < 0.05). # Significantly different from CON (P < 
0.05).  Post Ex = Post Exercise, 3h Post= 3h post-exercise. 
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Figure 4.5: Representative Western Blots from the control (CON) non-immersed (NOT) 
and immersed (CWI) legs before (Pre), after (Post), and 3h after (3h) exercise. p-, 
phosphorylated; t-, total. Phosphorylated AMPK Thr172 and p38 MAPK Thr180/Tyr182 
were relativized to their total counterpart, as these did not change significantly across blots 
or samples (P > 0.05). PGC-1α was relativized to GAPDH. kDa= Kilodaltons. 
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4.3.6 Additional gene expression 
Exercise induced increases in SIRT1 (P = 0.057, ES 0.8 Moderate) and NRF2 (P = 0.028, 
ES 0.6 Moderate) mRNA (Figure 4.6). No changes were seen between conditions, or 
between conditions over time (P > 0.05). Gene expression analysis for p53, COXIV, CS, 
TFAM and ERRα mRNA was not influenced by exercise or CWI (P > 0.05). 
 
4.3.7 Plasma Metanephrine and Normetanephrine.   
Metanephrine concentrations were similar between conditions (P = 0.159, ES 0.15 Trivial). 
The change in metanephrine over time was also similar between conditions (P = 0.299). 
Metanephrine concentration was increased post-exercise (ES 2.46 Very Large) and post-
immersion (ES 0.77 Moderate) vs. baseline (P ≤ 0.02). Normetanephrine values were 
greater in CWI vs. CON (P = 0.034, ES 0.43 Small) with the largest difference seen post-
immersion (860 vs. 665 pmol·L-1, CWI vs. CON, respectively). The change in 
Normetanephrine over time was similar between conditions (P = 0.821). Normetanephrine 
concentrations increased with exercise (ES >4.70; P < 0.001) and remained above baseline 
post-immersion (ES 1.52 Large) and 1h post-exercise (ES 1.06 Moderate) (P <0.001). 
Concentrations returned to baseline at 2h post-exercise (See Table 4.3).  
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Figure 4.6: mRNA 2-ΔΔCT fold change in 
expression with the calibrator as pre-
exercise and the reference gene as GAPDH 
(see methods for details). Values are mean 
± SD. A main effect for time was found for 
NRF2 (P = 0.028). #Significantly different 
from baseline (P < 0.05). * Different from 
baseline (P = 0.057). 
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Table 4.3: Catecholamine concentrations (pmol·L-1) pre and post exercise, with and without CWI (n=10, mean ± SD). 
   Recovery 
Baseline Post-
Exercise 
 Post-
Immersion 
1h 2h 3h 
Normetanephrine  
 
CON 
326.7  
±165.6 
1711.9# 
±411.10 
 
665# 
±291.8 
615.7#  
±368.3 
489.3 
±407.0 
426.9 
±260.0 
  
 
CWI 
478.2* 
±189.2 
1774.1*# 
±358.4 
 
859.8*# 
±264.5 
716.8*# 
±257.3 
621.2* 
±247.5 
517.2* 
±191.0 
         
Metanephrine  
CON 
199.7 
±62.0 
489.2# 
±234.4 
 
231.4# 
±90.5 
193.4 
±75.2 
167.9# 
±62.1 
 
145.8# 
±68.4 
 
 
 
CWI 201.6 
±36.7 
509.6# 
±153.9 
 
281.8# 
±104.8 
245.6 
±78.3 
176.5#   
 ±43.9 
157.5# 
±46.4 
Values are mean ± SD. A main effect for condition was found for Normetanephrine (P = 0.034). A main effect for time was found for both Normetanephrine and Metanephrine  
(P < 0.001). 
#
 Significant difference from baseline (P < 0 .05). *Significant difference versus the CON condition (P < 0 .05).  
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4.4 DISCUSSION 
The aim of the present study was to examine whether the post-exercise cold-water induced 
increase of PGC-1α mRNA is mediated through local or systemic mechanisms. Using a novel 
experimental design, data herein shows for the first time the appearance of systemic “cross-
talk” between immersed and non-immersed limbs, as evidenced by the similar increase in PGC-
1α mRNA in these limbs after single-legged CWI.  Additionally, it is suggested that this effect 
could be mediated by β-adrenergic induced stimulation of AMPK.  In addition to providing 
novel data on the potential mechanisms mediating post-exercise cold-induced enhancement of 
PGC-1α expression, data herein also has potential implications for research designs that utilise 
non-immersed limbs as control conditions.  
 
Since its initial discovery (Puigserver et al., 1998) the importance of the post-exercise PGC-1α 
response to the oxidative adaptive process has been examined extensively, with mRNA 
increases ranging 5 to 10-fold commonly observed at 3-4 hours following exercise (Bartlett et 
al., 2012; 2013; Impey et al., 2016; Perry et al., 2010).  More recently, cold-ambient 
temperatures (Slivka et al., 2012; 2013) and post exercise cold-water immersion (Ihsan et al., 
2014a; 2015; Joo et al., 2016), have also been shown to enhance (~2- to 4- fold greater) the 
skeletal muscle PGC-1α gene transcription and protein translational response above exercise 
alone. In line with such observations, the high-intensity intermittent cycling protocol used in 
the present study elicited a ~5-fold increase in PGC-1alpha mRNA at 3 hours post-exercise. 
Furthermore, CWI enhanced this response to a greater extent than exercise alone (~9-fold 
increase vs. Pre in the CWI immersed limb).  
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There have been suggestions that reduced tissue temperature is responsible for the differences 
observed between cold-treated and control limbs. This stems from the initial discovery that 
PGC-1alpha was cold inducible in animals (Bruton et al., 2010; Eddy & Storey, 2003; 
Puigserver et al., 1998).  In humans, recent data from Ihsan and colleagues (2014a; 2015) 
implicates a reduction in tissue temperature in the cold-induced increases of PGC-1α, as 
increases in mRNA (3h post-exercise) and protein content (after 4 weeks of training) were seen 
only in a cooled limb, and not in the contralateral non-immersed limb.  Potential mechanisms 
underpinning such responses include activation of non-noxious thermoreceptors via reduced 
skin temperature (Hensel & Boman, 1960; Ishida et al., 2016). Within the present study, both 
the NOT and CWI limbs displayed similar acute PGC-1α mRNA expression (~12- and ~9-fold, 
respectively) in the 3 h recovery period, whilst skin and muscle temperature were significantly 
reduced in the CWI limb only.  Indeed, the non-immersed limb (NOT) showed a similar 
temperature profile (skin and muscle temperature) to that of CON, where the magnitude of 
PGC-1α mRNA response was almost half (~5-fold) when compared with CWI and NOT.  
When taken together, these data suggest that alterations to local muscle temperature do not play 
a significant role in cold-induced regulation of PGC-1α expression.  
 
As a result of increased local PGC-1α gene expression in the non-immersed exercised limb to 
a similar magnitude as the immersed limb, we sought to consolidate the role of the upstream 
kinases AMPK and p38-MAPK (Canto & Auwerx, 2010; Jäger et al., 2007; Wright et al., 2007) 
in their ability to regulate PGC-1α transcription. p38MAPK is a stress activated kinase that has 
been shown extensively to be phosphorylated after acute exercise, independent of intensity 
(Egan et al., 2010). Moreover, p38MAPK can exert its effect upon PGC-1α transcription via 
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upregulated ATF2 activity at the PGC-1α promoter (Akimoto et al., 2005). In the current study, 
exercise induced a small (ES 0.44, 1.5-fold) increase in phosphorylation with no further 
response to cooling.  Moreover, our data supports previous data showing acute post-exercise 
phosphorylation of p38MAPK locally in skeletal muscle tissue occurs systemically (Widegren 
et al., 1998). Exercise-induced intensity dependant AMPK phosphorylation is a well reported 
phenomenon (Gibala et al., 2009; Cochran et al., 2010; Little et al., 2011) in rodent and human 
studies (Oliveira et al., 2004; Egan et al., 2010). Moreover, AMPK is implicated in PGC-1α 
activity via direct phosphorylation, initiating many of the important gene regulatory functions 
of PGC-1α in skeletal muscle (Jäger et al., 2007). The post-exercise increase in phosphorylation 
of AMPK in the present study was similar in magnitude to previous work (Bartlett et al., 2012) 
from our laboratory, albeit failing to achieve statistical significance. Notwithstanding this, large 
and moderate effect sizes were observed at 3 h post-exercise in the CWI and NOT limbs vs. 
CON, respectively. These greater increases from post-exercise to 3 h post-exercise in the 
immersion trial (CWI and NOT limbs), compared to a slight decline observed in CON (Figure 
4.2) suggest the increases in phosphorylation of AMPK during the post-cooling period are 
controlled by a systemic mechanism, possibly adrenergic control via cold-augmented plasma 
Normetanephrine.   
 
Adrenaline and noradrenaline are both dual α- and β- adrenergic agonists. Previous in vivo and 
in vitro incubation techniques utilising α- and β- adrenergic agonists have reported increased 
AMPK activation in rodent skeletal muscle (Minokoshi et al., 2002), adipose tissue (Koh et al., 
2007) and cell cultures (Yin et al., 2003) implicating catecholamines as a potential AMPK 
activator. Despite this, support for the above hypothesis is currently conflicting, and is limited 
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by distinct differences in methodological design and species studied. In human muscle, acute 
infusion of adrenergic agonists/antagonists have previously shown to be ineffective at altering 
PGC-1α transcriptional activity (Robinson et al., 2010; 2011) and its upstream effector p38-
MAPK (Kim et al., 2013). In contrast, treatment with β-adrenergic agonists/antagonists has 
been shown to induce and inhibit PGC-1α respectively (Miura et al., 2007), whilst incubation 
of rodent skeletal muscle with the adrenergic agonist phenylephrine increased the activity of 
the upstream regulator of PGC-1α, AMPK (Minokoshi et al., 2002). When results from these 
studies are taken together, it could be suggested that adrenergic activation of AMPK is a 
potential mechanism to explain the systemic increases in PGC-1α gene expression described 
herein.  
 
In humans, one study has investigated the impact of higher catecholamine levels on AMPK 
phosphorylation in human skeletal muscle (Kristensen et al., 2007). These authors assessed 
muscle biopsies from an exercised and non-exercised limb in conditions of heightened 
catecholamine release. Results showed AMPK activity was restricted to contracting muscle 
only, with no systemic effects notable in the non-exercised limb despite the increased 
catecholamine levels. Importantly, in our study all limbs were exercised before undergoing cold 
exposure. It is therefore suggested that the cold induction of β-adrenergic pathways (via 
increased catecholamines) presented in this manuscript allows an additive response to exercise 
stimulated AMPK phosphorylation. Further studies are now required to verify this signalling 
response in related experimental conditions in human skeletal muscle. 
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Another pathway by which increased catecholamine’s may enhance PGC-1α transcription is 
via increased activation of β-adrenergic receptors. Activation of these receptors increases 
intracellular cAMP, which could ultimately activate CREB function on the PGC-1α promoter 
(Akimoto et al., 2008). However, evidence exists to show β-adrenergic stimulation does not 
activate a p38MAPK - ATF2 - CREB - PGC-1α signalling axis in skeletal muscle (Kim et al., 
2013). These findings resonate with results from the present study as no changes in 
phosphorylation of p38MAPK were observed alongside increased plasma Normetanephrine 
concentrations. Further work is required to investigate the influence of the dual stress of 
exercise and cold temperature upon this signalling axis.  
 
Downstream of PGC-1α, Slivka and colleagues (2013) noted that recovery in cold ambient 
temperatures (4h in 7°C ambient air) reduced the expression of the transcription factors NRF2 
and ERRα, whilst having no effect on TFAM. Their importance to the adaptive response is 
highlighted by their roles in oxidative metabolism. Our data suggest the immersion protocol 
used herein was not sufficient to induce such changes. Indeed, 10 minutes of single-legged 
immersion offers a much smaller cooling stimulus than the 4 hours in cool ambient 
temperatures, as used by Slivka et al. (2013). In addition, an acute increase in PGC-1α gene 
expression was not followed by changes in PGC-1α total protein content, perhaps due to the 
acute time-frame of sampling applied in the present study. With this lack of change in total 
protein content it is however, unlikely that changes in gene expression of downstream genes 
such as NRF2, TFAM, COXIV, CS, ERRα presented here, would be affected by its upstream 
protein function as a transcription factor (PGC-1α). More research is required to understand the 
effect and dose response of a cold stimulus on downstream targets of PGC-1α. 
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It is difficult to explain the differences in PGC-1alpha mRNA results between the present study 
and Ihsan et al. (2014a), particularly the difference in non-immersed limbs. Moreover, reasons 
as to why Ihsan and colleagues failed to see the expected exercise-induced response in their 
non-immersed control limb, with minor changes from baseline at 3h post-exercise (1.5-fold 
increase vs. 3-5-fold increase usually seen), remain unclear. One possible explanation might 
include the differing muscle recruitment patterns occurring between the exercise protocols 
utilised (cycling vs. running). Ultimately, results from the present study have future 
implications on scientific study designs. Those wishing to investigate cold induced post-
exercise responses in skeletal muscle must be aware of the evidence that implicates a systemic 
response of Normetanephrine, and a local response of p-AMPK in both immersed and non-
immersed limbs. Further evidence is required to support the impact of systemic transcriptional 
responses in unilateral research designs, as such designs may be liable to error; potentially 
underestimating the actual response occurring in the immersed limb if relativized to a non-
immersed limb instead of a resting control. Ultimately, the choice of scientific design lies with 
the question posed, as contralateral designs remain useful for understanding both local and 
systemic responses.  
 
In summary, the present study characterises for the first time the mechanistic control of cold 
induced PGC-1α mRNA expression. Data herein indicate a reduction in tissue temperature (2-
3°C) plays a limited role as similar levels of PGC-1α mRNA expression are observed in an 
immersed and non-immersed limb despite a reduction in tissue temperature in the CWI limb 
only. Moreover, a cold-induced systemic increase in plasma Normetanephrine may impact 
localised phosphorylation events of the signalling kinase AMPKThr172, with potential 
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downstream effects upon rates of PGC-1α mRNA expression. Future studies should investigate 
the role of β-adrenergic receptors in Normetanephrine induced AMPK phosphorylation and the 
signalling role of MEF2 and CRE/ATF2 sites to confirm a link between catecholamines and 
PGC-1α. Moreover, due to the acute nature of the present study more work is required to 
investigate whether the response seen herein is maintained over a more chronic term.  
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CHAPTER FIVE  
 
The impact of combined pre-exercise low glycogen and post-
exercise CWI on acute PGC-1α gene expression. 
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5.1 INTRODUCTION 
The importance of the transcriptional co-activator PGC-1α to exercise induced oxidative 
adaptation is well reported (Perry et al., 2010; Bartlett et al., 2012; 2013). Indeed, this master 
regulator of mitochondrial biogenesis has been found to be up regulated by an exercise stimulus 
in an intensity dependent manner (Egan et al., 2010). As a transcriptional co-activator, PGC-
1α is unable to directly bind to DNA and instead exerts its influence by co-activating a number 
of downstream transcription factors (such as NRF-1/2 EERα, TFAM) that are important for the 
regulation of the nuclear and mitochondrial genomes (Lin et al., 2005; Egan & Zierath, 2013), 
ultimately improving oxidative capacity (Bonafiglia et al., 2017).  
 
Several mechanisms have been identified that regulate the increased expression and activation 
of PGC-1α following an exercise stimulus. Metabolic sensors, AMPK and p38 MAPK are two 
key activators of PGC-1α (Gibala et al., 2009; Ihsan et al., 2015). More recently, cold-ambient 
temperatures (Slivka et al., 2012; 2013) and post exercise cold-water immersion (Ihsan et al., 
2014a; 2015; Joo et al., 2016), have also been shown to enhance the skeletal muscle PGC-1α 
gene transcription (~2- to 4-fold greater) and protein translational response versus exercise 
alone. This follows the initial discovery of PGC-1α expressed in rat skeletal muscle only after 
cold exposure (Puigserver et al., 1998). Mechanisms responsible are unknown, with β-
adrenergic activation of AMPK (Allan et al., 2017; Ihsan et al., 2015) and β-AR activation of 
a cAMP-CREB-PGC-1α signalling axis (Akimoto et al., 2008) suggested to play a role. 
Furthermore, the findings from Chapter 4 (Allan et al., 2017) indicate that cold augmentation 
of PGC-1α mRNA is systemic in nature, occurring in the presence of heightened β-adrenergic 
activator normetanephrine, following greater activation of the signalling kinase AMPK and 
independent of reductions in muscle tissue temperature. 
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The importance of correct and sufficient nutrition for acute and chronic exercise is well 
described (Cermak & Van Loon, 2013). Despite this, a growing body of evidence demonstrates 
potential benefits of restricted CHO availability in exercise-induced adaptations, albeit at the 
expense of performance capacity (Impey et al., 2016). Indeed, endurance based exercise 
sessions commencing with low CHO availability can enhance the activation of cell signalling 
pathways (Bartlett et al., 2013), upregulate oxidative enzymes (Morton et al., 2009), increase 
lipid oxidation (Yeo et al., 2008) and therefore over time enable improvements in exercise 
capacity (Hansen et al., 2005). Importantly, Pilegaard and colleagues (2005) demonstrated that 
attenuating post-exercise muscle glycogen re-synthesis in the short-term recovery phase (24 h) 
further amplifies the gene expression or activity of PGC-1α, suggesting such a response occurs 
following a second consecutive exercise day. The augmented PGC-1α mRNA expression 
response following exercise with low glycogen availability has since been replicated in 
subsequent studies (Psilander et al., 2013; Bartlett et al., 2013), whilst disputed by others 
(Jensen et al., 2015). Mechanisms controlling such a response are speculated to be a result of 
increased activity and nuclear abundance of AMPK (Wojtaszewski et al., 2003; Steinberg et 
al., 2006) and p38MAPK (Chan et al., 2004) when exercise is commenced with low muscle 
glycogen. 
 
To this end, investigations to date suggest that PGC-1α gene expression can be regulated by 
both internal (low glycogen) and external (cold stimuli) stress. Whilst available data 
demonstrates these stressors have the ability to augment post-exercise PGC-1α gene expression 
individually, no evidence exists investigating the potential further augmentation upon the PGC-
1α response when both low glycogen and cold stimuli are combined. Therefore, the aim of the 
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present study was to determine the relative influence of reduced muscle glycogen and post-
exercise cold-water immersion in mediating post-exercise increases in skeletal muscle 
signalling (AMPK and p38MAPK activity) and PGC-1α transcription. 
 
5.2 METHODS 
5.2.1 Participants 
Nine recreationally active healthy males (age 22 ± 3 yrs.; body mass 74.18 ± 7.88 kg; height 
180.50 ± 6.60 cm; peak power output (PPO) 271.8 ± 25.8 W; mean ± SD) participated in this 
study. Participants were instructed to refrain from exercise, alcohol and caffeine 48 hours prior 
to the first depletion protocol, and not to stray from the prescribed meal plan or exercise within 
the 48 hours preceding the experimental day. All procedures performed in the study were 
approved by the Ethics Committee of Liverpool John Moores University and in accordance 
with the 1964 Helsinki declaration and its later amendments. 
 
5.2.2. Preliminary testing: Prior to commencing the experimental trials the participants 
completed an incremental exercise test to fatigue for the determination of V̇O2peak and PPO 
(see Section 3). Results from this test were used determine the Watts necessary for cycling at a 
proportion of PPO on subsequent test days (See Section 3). Further preliminary visits 
encompassed familiarisation to the glycogen depletion protocols to be completed prior to the 
experimental day. 
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5.2.3 Experimental design 
In a repeated-measures, randomized crossover design, with at least 14 d between trials, 
participants reported to the laboratory a total of nine times, where the first three were 
familiarisation sessions. In order to establish a research design that allowed the investigation 
of 4 separate conditions from 2 visits participants underwent a single-leg depletion protocol 
and bi-lateral muscle biopsies with and without post-exercise CWI to give the following 
conditions: High glycogen control (HI CON), Low glycogen control (LO CON), High glycogen 
CWI (HI CWI) and Low glycogen CWI (LO CWI).  
 
Two-legged glycogen depletion, Visit 1: Participants arrived at the laboratory 40 h prior to the 
experimental trial at 1600 h and undertook a 5-min warm-up at 100 W. From here, participants 
performed an intermittent cycling protocol aimed to deplete both limbs of muscle glycogen, as 
described in Section 3.13. Participants were then fed high CHO diets to refuel both limbs to a 
similar extent (Appendix 5). 
 
Single-leg glycogen depletion, Visit 2: Approximately 15 h prior to the experimental trial, 
participants attended the laboratory for a single-leg glycogen depletion protocol to deplete their 
dominant leg only, as described in Section 3.13. An overnight fast followed. 
 
Experimental trial, Visit 3: Upon arrival at the laboratory participants were fitted with a heart-
rate belt (Polar RS400, Kempele, Finland), skin and rectal temperature probes (MHF-18050-A 
and MRV-55044-A, Ellab, Rodovre, Denmark) and legs were marked for subsequent insertion 
of muscle temperature needles (See Section 3.5.1). Following 10-minutes in a supine position 
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baseline measures of HR, temperature and oxygen uptake (V̇O2; Oxycon Pro, Jaeger, 
Wuerzberg, Germany) were assessed. Resting venous blood samples were drawn from a 
superficial vein in the anti-cubital crease of the forearm using venepuncture cannulation (BD 
Nexiva Closed IV Catheter 22G Blue, Becton Dickinson, Oxford, UK). Resting muscle 
temperature was assessed using a needle thermistor (13050; Ellab, Rodovre, Denmark) before 
resting bi-lateral muscle biopsies were sampled from the vastus lateralis (~30-50 mg wet wt). 
Immediately after the resting biopsy participants completed a high-intensity intermittent 
cycling protocol, consisting of 8 × 5 min bouts at 82.5% PPO separated by 1 min rest (See 
Section 3.6) followed by either two-legged CWI (CWI: 10 min at 7.96 ± 1.05°C) or a control 
condition (CON; seated rest). From here, participants recovered in a semi-reclined position 
under normal laboratory temperatures until 3-hours post-exercise. Measures of heart rate, skin 
temperature (thigh and calf) and rectal temperature were recorded throughout the exercise and 
recovery periods. Oxygen uptake was measured during the final minute of each high-intensity 
bout of exercise, during immersion and immediately post-immersion to assess for shivering 
thermogenesis and again at 1, 2 and 3h post-exercise. Laboratory temperatures remained stable 
throughout (~21oC) and at no point were participants allowed to rub themselves dry or shower 
(changing into dry clothes after immersion was allowed). Muscle temperature was assessed 
post-exercise, 1, 2 and 3h post-exercise, whilst venous blood samples were also drawn at these 
times. Further bi-lateral muscle biopsies occurred immediately after exercise and 3h post-
exercise. Biopsies were obtained from both limbs at all time points to allow for comparison 
between high (HI) and low (LO) glycogen legs in both CON and CWI trials. All incisions were 
individually anaesthetised, separated by 2-3cm and included four passes of muscle tissue per 
biopsy.  
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5.2.4 Blood analysis.  
All samples were analysed in duplicate. Samples were analysed for serum glucose, lactate, 
NEFA, and glycerol concentration using commercially available kits (Randox Laboratories, 
Antrim, UK). Plasma metanephrine and Normetanephrine concentrations were measured using 
liquid chromatography tandem mass spectrometry as previously described (Peaston et al., 
2010). Serum samples were also analysed for insulin using a solid phase enzyme-linked 
immunosorbent assay (ELISA, KAQ1251, Life Technologies, UK), according to 
manufacturer’s instructions (See Section 3.9).  
 
5.2.5 Muscle glycogen 
Muscle glycogen concentration was determined according to the method described in Section 
3.13.  
 
5.2.6 rt-qRT-PCR.  
rt-qRT-PCR amplifications were performed as specified in Section 3.11 using specific Primer 
designs outlined in Table 5.1. The average PCR efficiency was 91.25% and variation for all 
genes was less than 6.3%. mRNA expression for all target genes was calculated relative to the 
reference gene (GAPDH; subject’s own samples reference) within the same subject and 
condition and to a calibrator of Pre-exercise. 
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Table 5.1: Primer sequences used for real-time PCR. 
Gene Forward Primer Reverse Primer Product Length 
(base pairs) 
GAPDH 
NM_002046.5 
AAGACCTTGGGCTGGGACTG TGGCTCGGCTGGCGAC 168 
PGC-1alpha 
NM_013261.3 
TGCTAAACGACTCCGAGAA TGCAAAGTTCCCTCTCTGCT 67 
p53 
NM_000546.5 
ACCTATGGAAACTACTTCCTGAA
A 
CTGGCATTCTGGGAGCTTC
A 
141 
SIRT1 
NM_012238.4 
CGGAAACAATACCTCCACCT CACATGAAACAGACACCCC
A 
186  
COXIV 
NM_001861.4 
CGAGCAATTTCCACCTCTGT  GGTCACGCCGATCCATATA
A 
94 
CS 
NM_004077.2 
CCTGCCTAATGACCCCATGTT CATAATACTGGAGCAGCAC
CCC 
137 
TFAM 
NM_003201.2 
TGGCAAGTTGTCCAAAGAAAC
CTGT 
 
 
GTTCCCTCCAACGCTGGGC
A 
135 
NRF2 
NM_002040.3 
AAATTGAGATTGATGGAACAGAG
AA 
  
TATGGCCTGGCTTACACAT
TCA 
95 
ERRα 
NM_004451.4 
TGCCAATTCAGACTCTGTGC 
  
CCAGCTTCACCCCATAGAA
A 
212 
GLUT4 
NM_001042.2 
TCTCCAACTGGACGAGCAAC CAGCAGGAGGACCGCAAAT
A 
101 
 
Glyceraldehyde 3-phosphate dehydrogenase –GAPDH; Ribosomal protein L13a- RPL13a; Peroxisome 
Proliferator-activated receptor gamma coactivator 1-alpha – PGC-1α; Tumour suppressor protein 53- 
p53; Sirtuin 1 – SIRT1; Cytochrome C oxidase subunit 4 – COXIV; Citrate synthase – CS; Mitochondrial 
transcription factor A – TFAM; Nuclear respiratory factor 2 – NRF2; Estrogen-related receptor alpha – 
ERRα; Glucose transporter type 4 – GLUT4. 
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5.2.7 SDS-PAGE and Western Blotting 
SDS-PAGE and western blotting was performed as specified in Section 3.12. Samples from 
each subject for all exercise conditions were run on the same gel and statistical analysis 
conducted on raw densitometry data. Phosphorylated AMPK Thr172 and p38 MAPK 
Thr180/Tyr182 were relativized to their total counterpart, as these did not change significantly 
across blots or samples (P > 0.05).  
 
5.2.8 Statistical analysis 
All data are presented as mean ± SD, unless otherwise stated. Baseline data, distance cycled, 
exercise HR and RPE were compared between conditions using a Paired Samples T-test. A 
two-way (4 conditions x time) within participant’s general linear model for condition (CON 
HI, CWI HI, CON LO, CWI LO) and time was used to evaluate muscle glycogen, thigh skin 
temperature, muscle temperature, gene expression and protein activation responses. A two-way 
(2 conditions × time) within-participants general linear model was used to evaluate all blood 
measures (glucose, lactate, NEFA, glycerol, insulin, normetanephrine, metanephrine), rectal 
temperature, subjective and physiological responses (HR, RPE, shivering, V̇O2). The main 
effects for condition and time were followed up using planned LSD multiple comparisons.  The 
ES magnitude was classified as trivial (<0.2), small (>0.2-0.6), moderate (>0.6-1.2), large 
(>1.2-2.0) and very large (>2.0-4.0) (Hopkins et al., 2009). The α level for evaluation of 
statistical significance was set at P < .05.  
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5.3 RESULTS 
5.3.1 Depletion response 
In the two-legged depletion protocol no difference was present between conditions for distance 
cycled (CON 67.1 ± 18.1 km, CWI 67.3 ± 6.1 km, P = 0.394, ES 0.01 Trivial), time to depletion 
(CON 134 ± 30 min, CWI 130 ± 12 min, P = 0.669, ES 0.19 Small) or number of intervals 
completed (8 ± 2 per stage for both CON and CWI, P = 0.669, ES 0.20 Small). In the single-
leg depletion protocol no significant difference was present between conditions for distance 
cycled in the steady-state period (CON 9.5 ± 1.2 km, CWI 8.5 ± 0.9 km, P = 0.194, ES 1.09 
Large), number of high intensity bouts completed (CON 6.8 ± 2.0 per stage, CWI 6.4 ± 2.0 per 
stage, P = 0.235, 0.18 Trivial) and distance cycled during intervals (CON 47.5 ± 8.8 km, CWI 
47.9 ± 7.3 km, P = 0.587, ES 0.06 Trivial). Moreover, no differences were found between 
conditions for time (CON 40.7 ± 9.0s, CWI 37.5 ± 8.4s) and distance (CON 0.6 ± 0.2 km, CWI 
0.4 ± 0.1 km) completed in the all-out one-leg cycle (P = 0.197 ES 0.38 Small and 0.094 ES 
0.94 Large, respectively).  
 
5.3.2 Exercise response 
Distance cycled in the high-intensity intermittent cycling protocol (CON 26.8 ± 2.8 km, CWI 
26.7 ± 3.4 km; P = 0.946, ES 0.01 Trivial), heart rate (P = 0.992, ES 0.004 Trivial), V̇O2 (ml·kg-
1·min-1; P = 0.602, ES 0.24 Small) and RPE (P = 0.849, ES 0.07 Trivial) were similar between 
CON and CWI trials. Mean HR during the final minute of exercise was 179 ± 7 beats.min-1 in 
CON and 177 ± 9 beats.min-1 in CWI (P > 0.05), equating to ~80% HR max. The RPE in the 
final exercise bout was 19.6 ± 0.7 AU and 19.3 ± 0.5 AU in the CON and CWI trials 
respectively.  
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5.3.3 Metabolic Response 
Heart rate was similar between conditions (P = 0.584, ES 0.18 Trivial) during the immersion 
and recovery period. The change in HR over time was also similar between conditions (P = 
0.137), declining during the post-immersion period in both conditions. During the same period 
oxygen uptake was greater in CWI vs. CON (P = 0.014, ES 1.83 Large). The change in V̇O2 
over time was also different between conditions (P = 0.045) with increases in V̇O2 occurring 
during the initial 2 minutes of immersion. Following immersion, V̇O2 dropped below pre-
immersion values and remained lower throughout the 3h recovery period (ES >0.58 Small) (P 
< 0.05). Subjective ratings of shivering were greater in CWI (P = 0.052, ES 0.94 Large). The 
change in subjective ratings of shivering over time also tended to be greater in CWI with values 
increasing during immersion and the 10-minute period immediately post-immersion (P = 
0.089) (Table 5.2). 
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Table 5.2: Heart rate (n=9) and oxygen uptake (n=8) during immersion and the post-immersion period (mean ± SD). 
  Immersion  Post-Immersion  
Pre 
Im 
2min 4min 6min 8min 10min  2min 4min 6min 8min 10
min 
1h 2h 3h 
HR (beats.min-
1)    
CON 84  
±5 
81     
±4 
82    
±2 
80  
±3 
78  
±5 
82     
±7 
 84   
±5 
83   
±5 
80   
±6 
82  
±5 
80   
±4 
79  
±5 
76  
±8 
74  
±7 
 CWI 95 
±19 
110 
±20 
94  
±6 
85 
±12 
81  
±4 
89   
±18 
 79 
±10 
76  
±9 
74  
±8 
76 
±11 
80 
±11 
78 
±9 
69 
±9 
73 
±12 
                 
V̇O2 (ml·kg-
1·min-1) 
    
CON 5.4 
±0.8 
5.0 
±0.7 
4.7 
±0.6 
4.6 
±0.7 
4.4 
±0.6 
4.6 
±0.6 
 4.7 
±0.6 
4.5# 
±0.7 
4.3# 
±0.5 
4.9# 
±0.8 
4.7# 
±0.
7 
4.6# 
±0.6 
4.6# 
±0.
8 
4.2# 
±0.
7 
 CWI 8.5 
±2.0 
9.7 
±2.1 
9.0 
±1.6 
8.8 
±2.1 
8.4 
±2.1 
8.8 
±2.6 
 6.8 
±1.8 
6.9# 
±1.9 
6.2# 
±1.3 
6.4# 
±1.7 
6.3# 
±1.
6 
6.0# 
±1.5 
5.4# 
±1.
9 
5.6# 
±1.
5 
                 
  PreI
m 
  5min  10min  2min 4min 6min 8min 10
min 
1h 2hr 3hr 
Subjective 
Shivering 
CON 1  
±0 
  1  
±0 
 1  
±0 
 1  
±0 
1  
±0 
1  
±0 
1  
±0 
1  
±0 
1  
±0 
1  
±0 
1  
±0 
(AU) CWI 1  
±0 
  2 
±1 
 2 
±1 
 2 
±1 
2 
±1 
2 
±1 
2 
±1 
2 
±1 
1 
±0 
1 
±0 
1 
±0 
Values are mean ± SD. A main effect for condition and time along with a significant interaction between condition and time was found for V̇O2 (P < 0.05).  
#
 Significant difference from pre-immersion (P < 0.05). PreIm = Pre Immersion, AU = arbitrary units.
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5.3.4 Blood plasma and muscle metabolites 
Plasma glucose, lactate, NEFA, insulin and glycerol concentrations were similar between 
conditions (P < 0.05) (Figure 5.2). The change in these measures over time was also similar 
between conditions (P < 0.05). Significant differences were seen over time for glucose, lactate, 
glycerol and NEFA. Glucose increased immediately post-exercise (P = 0.012 vs. Pre), before 
decreasing to values below pre-exercise at 1h (P = 0.011), were it remained. Lactate increased 
post-exercise (P = 0.001 vs. Pre) and had returned to pre-exercise values by 1h post-exercise 
(P = 0.055). Glycerol increased post-exercise, remaining greater than pre-exercise values at 3h 
post-exercise (P < 0.001). NEFA increased from Pre at 1h post-exercise (P < 0.001), remaining 
at these levels by 3h post-exercise (P < 0.001).  
 
Muscle glycogen concentrations were greater in the HI limbs compared to contralateral LO 
limbs throughout the experimental design (CON HI vs. CON LO: P = 0.017, ES 1.04 Moderate; 
CWI HI vs. CWI LO: P = 0.001, ES 1.18 Moderate; Figure 5.1). The concentration of muscle 
glycogen was similar between respective HI (CON HI vs. CWI HI: P = 0.819, ES 0.07 Trivial) 
and LO conditions (CON LO vs. CWI LO: P = 0.751, ES 0.14 Trivial; Figure 5.1). The change 
in muscle glycogen concentrations over time was similar between conditions (P = 0.116). 
Muscle glycogen was decreased immediately following exercise (P = 0.001, ES 1.11 Moderate) 
and 3h post-exercise (P = 0.003, ES 1.10 Moderate) compared to pre-exercise values.  
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Figure 5.1: Skeletal muscle glycogen content immediately pre- and post-exercise and after 3h 
of recovery. Biopsies were obtained from both limbs in each condition (CON or CWI) with 
limbs starting the day being high (HI) or low (LO) in glycogen stores. A main effect for time 
(P = 0.001) and condition (P = 0.003) was observed. No interaction effects were present (P > 
0.05). * Significantly different from PRE. # Significantly different from contralateral LO limb 
(n = 9, mean ± SD). PRE= Pre exercise, POST= Post-exercise, +3hr= 3h post-exercise. 
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Figure 5.2: Plasma derived metabolic 
markers measured pre-exercise, post-exercise, 
1h, 2h and 3h following the cessation of 
exercise (n=9, mean ± SD). * Significantly 
different from pre-exercise. 
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5.3.5 Thermoregulatory Response 
Rectal temperature (Trec) was similar between conditions during exercise and post-exercise 
recovery (P = 0.887, ES 0.02 Trivial). The change in Trec over time was also similar between 
conditions (P = 0.252, Figure 5.3b). During the immersion and recovery period, Trec decreased 
from the fifth minute of immersion until 3h post-exercise (P < 0.001). Thigh skin temperature 
(Tthigh) was lower during immersion and the post-immersion period in CWI vs. CON 
conditions (P < 0.001, ES 2.48 Very Large). The change in Tthigh over time was also different 
between conditions, with Tthigh continually decreasing during cooling in CWI conditions, 
remaining lower than pre-immersion values at 3h post exercise (P = 0.001, Figure 5.3a). Muscle 
temperature (Tmus) was lower following immersion (P <0.001) in the CWI limbs (P < 0.001, 
ES 0.90 Moderate). The change in Tmus over time was also different between conditions 
Muscle temperature declined to a large extent immediately after immersion in the CWI limb, 
followed by a further gradual reduction during the remaining 3h post-exercise period (P = 
<0.001, ES 1.0 Moderate, Figure 5.4). 
 
 
120 
 
         
 
 Figure 5.3: Thigh skin temperature (°C) (a) and rectal temperature (°C) (b) during immersion 
and the 3h post-exercise period. *Significantly different from pre-imm. #Significantly different 
from CON (n = 9 skin, n= 8 rectal; mean ± SD). Pre-Im= Pre Immersion. 
*# 
*# 
*# 
*# 
*# 
*# 
*# 
*# 
a 
b 
* * * 
* 
* * 
Immersion 
Immersion 
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Figure 5.4: Deep muscle temperature (3cm; °C). *Significantly different from PRE. 
#Significantly different from CON (n = 8, mean ± SD). 
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5.3.6 Plasma Metanephrine and Normetanephrine 
Metanephrine concentrations were similar between conditions (P = 0.955, ES 0.02 Trivial, 
Figure 5.5). The change in metanephrine over time was also similar between conditions (P = 
0.438). Metanephrine concentration was increased post-exercise (P < 0.001, ES 2.10 Very 
Large) and remained above baseline at 1h post-exercise (P = 0.02, ES 0.59 Small). 
Normetanephrine concentrations were similar between conditions (P = 0.130, ES 0.14 Trivial, 
Figure 5.5). The change in normetanephrine over time was different between conditions, with 
normetanephrine concentrations decreasing to a greater extent in CON during the 3h post-
exercise period (P = 0.026, ES 1.60 Large). Normetanephrine concentration increased post-
exercise (P = 0.002, ES 1.50 Large) and remained above baseline in CWI conditions until 2h 
post-exercise (P < 0.05; P = 0.058).  
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Figure 5.5: Plasma adrenergic catecholamines measured pre-exercise, post-exercise, 1h, 2h 
and 3h following the cessation of exercise (n=9, mean ± SD). A main interaction effect was 
resent for normetanephrine (P = 0.026). *Significantly different from Pre-Exercise. Pre-Ex = 
Pre Exercise, Post-Ex= Post Exercise, +1h= 1h post- exercise, +2h= 2h post-exercise, +3h 
Post= 3h post-exercise. 
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5.3.7 AMPK and P38MAPK activity and total abundance 
Phosphorylation of AMPK Thr172 was similar between conditions (P = 0.443), with no change 
over time (P = 0.684; Figure 5.6). Representative Western blots are shown in Figure 5.7. 
Phosphorylation of p38MAPKThr180/Tyr182 was similar between conditions (P = 0.202), with no 
change over time (P = 0.283; Figure 5.6). Representative Western blots are shown in Figure 
5.7.  
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Figure 5.6: Phosphorylation of AMPKThr172 (a) and p38MAPKThr180/Tyr182 (b) fold changes from 
Pre, expressed relative to total AMPK (P > 0.05). Values are mean ± SD.   
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Figure 5.7: Representative Western Blots from CON HI, CON LO, CWI HI, CWI LO limbs 
before (Pre), after (Post), and 3h after (3h) exercise. Phosphorylated AMPK Thr172 and p38 
MAPK Thr180/Tyr182 were relativized to their total counterpart (P > 0.05). kDa= Kilodaltons; 
P-= phosphorylated; T- = total. 
 
5.3.8 Gene expression  
PGC-1α mRNA was increased from baseline at 3h post-exercise (P < 0.001; ES 1.99 Large). 
At 3h post exercise, PGC-1α mRNA expression was greater in the HI vs. LO glycogen limbs 
(CON HI vs. CON LO: P = 0.023, ES 1.22 Large; CWI HI vs. CWI LO: P = 0.019, ES 1.43 
Large; P = 0.039). Expression was also higher in CWI HI vs. CON HI limb (P = 0.281, ES 0.67 
Large) (Figure 5.8). These differences reflected greater changes in expression between post 
exercise and 3h post exercise time points (P < 0.001).  
 
Gene expression analysis for COXIV, CS, TFAM, SIRT1, NRF2 and GLUT4 mRNA (Figure 
5.9) was not influenced by CWI or exercise (P > 0.05). 
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Figure 5.8: PGC-1α mRNA 2-ΔΔCT fold change in expression with the calibrator as pre-exercise 
and the reference gene as GAPDH (see methods for details). Values are mean ± SD. 
*Significantly greater than Pre and Post-Exercise (P < 0.001), # Significantly greater than LO 
counterpart (P = 0.023), + Greater than CON HI (P = 0.281, ES 0.67 Large). 
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Figure 5.9: mRNA 2-ΔΔCT fold change in expression with the calibrator as pre-exercise and 
the reference gene as GAPDH (see methods for details). Values are mean ± SD.  
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5.4 DISCUSSION 
The aim of the present study was to investigate the potential further augmentation of post-
exercise PGC-1α in response to combined low glycogen (internal) and cold (external) stimuli. 
A further aim was to investigate potential mechanisms in control of such a response. A key 
finding of the present study is that post-exercise CWI is able to augment the PGC-1α mRNA 
response to exercise vs. a non-immersed control condition, as has previously been shown 
(Chapter 4); however, this response was not evident in limbs where muscle glycogen is depleted 
to ~85 mmol·kg-1dw prior to exercise. 
 
The impact of training with reduced glycogen levels are well documented, with low muscle 
glycogen availability resulting in greater activation of mitochondrial signalling enzymes 
compared to when the same exercise is commenced with normal glycogen values (Hawley & 
Morton, 2014). Indeed, Hansen et al. (2005) observed limbs that trained twice every second 
day (low glycogen; vs. limbs that trained once every day, high glycogen) showed improved 
time to exhaustion, greater resting muscle glycogen levels and greater activity of the 
mitochondrial enzymes 3-hydroxyacyl- CoA dehydrogenase and citrate synthase; all important 
markers of endurance adaptation and/or mitochondrial biogenesis. More recently, commencing 
exercise with muscles in a low glycogen state has been shown to augment the exercise induced 
expression of the transcriptional coactivator, and so-called ‘master regulator’ of mitochondrial 
biogenesis, PGC-1α (Psilander et al., 2013; Bartlett et al., 2013). Meanwhile, data from our lab 
and others has confirmed the role of post-exercise CWI in further augmenting the PGC-1α 
response to exercise (Ihsan et al., 2014a; Joo et al., 2016; Allan et al., 2017). The idea that both 
mechanisms could influence the acute post-exercise PGC-1α response to a greater extent than 
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individually has not previously been investigated. Presently, glycogen depletion of a single 
limb was successful in reducing muscle glycogen content versus the contralateral limb 
(~85mmol·kg-1dw vs. ~200mmol·kg-1dw, P < 0.05, ES 1.11 Moderate). Muscle glycogen 
concentration was also similar between HI limbs and between LO limbs throughout the 
experimental design irrespective of condition (CON or CWI). This is in line with previous 
research that shows CWI does not negatively impact the acute (up to 4h) phase of post-exercise 
muscle glycogen resynthesis (Gregson et al., 2013). Moreover, HI limbs herein (~200mmol·kg-
1dw) failed to replete to the desired level and are better described as Low glycogen, whilst LO 
limbs herein (~85mmol·kg-1dw) are better described as Very low glycogen. A lack of clarity 
on what constitutes high and low levels of muscle glycogen exists, however, low glycogen is 
often referred to as anything below 200-300 mmol·kg-1dw (Psilander et al., 2013; Camera et 
al., 2015; Knuiman et al., 2015) with high glycogen being above ~550 mmol·kg-1dw (Impey et 
al., 2016; Knuiman et al., 2015).  
 
Limbs that commenced the high-intensity intermittent cycling protocol with ‘high’ glycogen 
concentrations (CON HI, CWI HI; ~200 mmol·kg-1dw) showed large increases in PGC-1α 
expression at 3h post-exercise, with post-exercise CWI augmenting the exercise-induced 
increase further (CWI HI ~8-fold vs. CON HI ~6-fold), as previously observed (Ihsan et al., 
2013; Joo et al., 2016; Allan et al., 2017). However, when exercise was commenced with low 
glycogen concentrations (CON LO, CWI LO; ~85mmol·kg-1dw) the expected augmentation of 
PGC-1α versus a HI equivalent was not evident, with CWI having no additional benefit and 
showing the lowest fold change at 3h post-exercise versus all other conditions (CWI LO ~2.5 
-fold change from Pre). This is in agreement with other studies that show low muscle glycogen 
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is unable to stimulate greater post-exercise PGC-1α mRNA expression (Cluberton et al., 2005; 
Mathai et al., 2008; Cochran et al., 2010; Jensen et al., 2015; Impey et al., 2016) with 
differences in exercise intensity thought to be responsible (Egan et al., 2013).  
 
It should be noted, previous literature using glycogen depletion protocols have failed to reach 
pre-exercise values as low as presently attained (~85mmol·kg-1dw vs. ~184 mmol·kg-1dw 
Camera et al., 2015; ~166mmol·kg-1dw Psilander et al., 2013; ~135mmol·kg-1dw Taylor et al., 
2013), ~103mmol·kg-1dw Bartlett et al., 2013). Importantly, glycogen concentration in the 
present HI limbs are comparable to those of the low condition from previous research (Camera 
et al., 2015, Psilander et al., 2013) stimulating similar levels of PGC-1α gene expression 3h 
post-exercise (6-8 -fold increase in CON HI and CWI HI PGC-1α mRNA, Psilander et al., 
2013, Taylor et al., 2013) irrespective of the mode of exercise completed. Taken together, it 
could be suggested a critical level of glycogen depletion exists for the benefits of low glycogen 
concentration upon the post-exercise PGC-1α mRNA response. Indeed, results in the present 
LO limbs surpassed such a critical threshold thus offering an explanation for the lack of cold 
and/or low glycogen induction in PGC-1α gene expression. Pilegaard et al. (2002) suggested 
such a threshold of glycogen might be evident for the expression of other genes (PDK4, UCP3). 
Further work is required to investigate whether a critical level of pre-exercise glycogen 
concentration exists before negating the post-exercise PGC-1α mRNA response. 
 
Previous suggested mechanisms controlling the cold-induced (Ihsan et al., 2015) and low 
glycogen stimulated (Hawley & Morton, 2013) augmentation of PGC-1α are the upstream 
kinases AMPK and p38-MAPK. p38MAPK is a stress activated kinase that has been shown 
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extensively to be phosphorylated after acute exercise, independent of intensity (Egan et al., 
2010). p38MAPK phosphorylates and activates PGC-1α (Puigserver et al., 2001; Knutti et al., 
2001). Furthermore, Chan and colleagues (2004) demonstrated that reduced muscle glycogen 
availability increased the phosphorylation of nuclear p38MAPK versus the same exercise with 
normal glycogen stores. In the current study small (~1.5 fold, P > 0.05) increases in the 
phosphorylation of p38MAPK were present in the 3h post-exercise period, however no 
differences were evident in response to glycogen or immersion status. These results were to be 
expected given that the present study utilised contralateral HI and LO glycogen limbs and that 
p38MAPK has previously been shown to be activated systemically (Widegren et al., 1998; 
Allan et al., 2017). Exercise-induced intensity dependant AMPK phosphorylation is a well 
reported phenomenon (Gibala et al., 2009; Cochran et al., 2010; Little et al., 2011) in rodent 
and human studies (Oliveira et al., 2004, Egan et al., 2010). Moreover, AMPK is implicated in 
PGC-1α activity via direct phosphorylation, initiating many of the important gene regulatory 
functions of PGC-1α in skeletal muscle (Jäger et al., 2007). The phosphorylation of AMPK in 
the present study was incongruent to previous work from our laboratory (Bartlett et al., 2012, 
Allan et al., 2017), with control limbs (CON HI, CON LO) showing a reduction in 
phosphorylation at 3h post-exercise. Meanwhile, data from CWI limbs (CWI HI and CWI LO) 
showed post-exercise phosphorylation of AMPKThr172 was maintained at 3h irrespective of 
glycogen concentration.  
 
Similar p-AMPKThr172 in contralateral limbs during the same experimental condition (similar 
CON HI and CON LO, similar CWI HI and CWI LO) provides stimulus to the suggestion that 
AMPK is systemically regulated (i.e. via catecholamines; Chapter 4), and induced by a cold 
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stimulus (Ihsan et al., 2015; Chapter 4). The hypothesis that catecholamines are implicated as 
a potential AMPK activator is conflicting (discussed in detail in Chapter 4). Briefly, only one 
study in humans has assessed the impact of higher catecholamine levels on AMPK 
phosphorylation in human skeletal muscle (Kristensen et al., 2007), with results showing 
AMPK activity restricted to contracting muscle only, with no systemic effects notable in the 
non-exercised limb despite the increased catecholamine levels. In the present study, two-legged 
CWI (8°C for 10 min) slowed the decrease in post-exercise normetanephrine concentration up 
to 2h post-exercise. It is suggested that this greater adrenergic response seen for CWI HI and 
CWI LO limbs may provide the difference between the maintenance of p-AMPK at 3h post-
exercise, and the decrease noted in CON HI and CON LO limbs. Such an adrenergic response 
following CWI has been seen previously using a two-legged (Gregson et al., 2013) and single-
legged (Chapter 4 – Allan et al., 2017) immersion design. The impact of β-adrenergic 
stimulation of p-AMPKThr172 requires further investigation, with a particular emphasis on β-AR 
function within this response. 
 
It is difficult to explain the reasons for the lack of expected increases seen in post-exercise 
phosphorylation of AMPKThr172 and PGC-1α gene expression, particularly in LO glycogen 
limbs, however this could be related to cycling technique. It is well established that power 
output is depressed in glycogen-depleted limbs (Gejl et al., 2014). Indeed, Ørtenblad et al. 
(2011) demonstrated glycogen depletion at levels above (167 mmol·kg-1dw) those seen in the 
present LO limbs (~85mmol·kg-1dw) are associated with impaired sarcoplasmic reticulum 
function by diminished vesical Ca2+ release, and thus reductions in peak power. Taken together 
it could be suggested participants herein preferentially turned the pedals with the HI glycogen 
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limb, unconsciously supporting the depleted LO limb and thus offering a greater exercise 
stimulus to the HI limb vs. LO limb; resulting in the lack of expected PGC-1α and p-AMPK 
response in the LO limbs. Indeed, previous research using the high-intensity intermittent 
cycling protocol employed here demonstrated a greater distance (~6km greater) covered by 
comparable participants (Chapter 4). The difference between that study and the present study 
is that the present study included 2 days of glycogen depletion protocols prior to the 
experimental protocol. Taken together with the fact that one limb was glycogen depleted during 
the experimental protocol, a critical level of glycogen being surpassed may have been a key 
factor in being unable to produce an intensity necessary to obtain expected levels of 
phosphorylation of AMPK and gene expression of PGC-1α in the LO limbs. Future 
investigations should look to assess any imbalance in power output between depleted and non-
depleted limbs upon subsequent p-AMPK and PGC-1α gene expression. 
 
In summary, the present study failed to see a benefit of combined low glycogen exercise with 
post-exercise CWI. Despite this, data herein characterises for the first time the potential 
existence of a critical threshold for the expected augmentation in post-exercise PGC-1α gene 
expression seen when exercise commences with low glycogen concentrations. Data herein 
suggest that whilst the cold induced increase in PGC-1α mRNA remains in limbs that begin 
exercise with glycogen concentrations >180mmol·kg-1dw, the cold induced and low glycogen 
induced augmentation of post-exercise PGC-1α mRNA is abolished in limbs with glycogen 
concentrations ~85mmol·kg-1dw, potentially due to reduced contraction kinetics. Moreover, 
this study offers support of previous work (Chapter 4 – Allan et al., 2017) that suggest cold-
induced systemic control of AMPK phosphorylation potentially occurs via adrenergic 
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mechanisms. Further investigation is required to assess the role of β-adrenergic receptors in 
Normetanephrine induced AMPK phosphorylation and the signalling role of MEF2 and 
CRE/ATF2 sites to confirm a link between catecholamines and PGC-1α. Moreover, more work 
is required to confirm the existence of a critical glycogen threshold for controlling post-exercise 
PGC-1α gene expression.  
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CHAPTER SIX  
 
Local and systemic impact of the cold and low glycogen on 
PGC-1α promoter specific gene expression. 
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6.1 INTRODUCTION 
Since the discovery of the transcriptional co-activator peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (PGC-1α) by Puigserver and colleagues (1998), it has been 
shown to be highly expressed in multiple human tissues, including the largest metabolically 
active tissue, skeletal muscle (Fick & Kelly, 2006). Here, it has been previously shown to play 
a key role in driving the formation of slow twitch muscle fibres (Lin et al., 2002) and is 
inextricably linked to improving oxidative capacity (Irrcher et al., 2003) via increasing 
mitochondrial biogenesis after exercise (Uguccioni & Hood, 2011). Indeed, ~3-10 fold-
increases in PGC-1α transcription are often seen within the first few hours post-exercise 
(Bartlett et al.. 2012; Joo et al., 2016; Allan et al., 2017), a reponse that is exercise intensity 
dependant (Egan et al., 2010), yet somewhat variable based on prior training status and/or basal 
PGC-1α content (Gibala, 2009). 
 
More recently it has been shown that skeletal muscle expresses several different transcript 
variants that produce different protein isoforms of PGC-1α (reviewed in Popov et al. 2015a), 
highlighting a potential broad spectrum of alternative functions for this protein. To date, more 
than eight alternative protein isoforms have been described in human skeletal muscle, where 
the gene expression of these isoforms is thought occur via two alternate promoter regions on 
the same gene (Popov et al., 2015a; Martinez-Redondo et al., 2016). The proximal (canonical) 
PGC-1α gene promoter (Exon 1a) is constitutively expressed at rest compared to the alternative 
promoter (Exon 1b). The alternative promoter is more responsive post exercise stimulation 
(Martinez-Redondo et al., 2015; Popov et al., 2015b), where several transcript variants are 
expressed from the alternative gene promoter (Exon 1b & 1c) leading to the protein isoforms 
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of PGC-1α2, PGC-1α3 and PGC-1α4 (Martinez-Redondo et al., 2016). Although originating 
from the same promoter and upon identical stimuli, the different PGC-1α isoforms regulate 
altered transcriptional programs. Several groups have shown that in rodent and human skeletal 
muscle, acute exercise induces PGC-1α gene expression, mainly via the alternative promoter 
(Exon 1b) (Norrbom et al., 2011; Ydfors et al., 2013; Popov et al., 2014; Wen et al., 2014; 
Popov et al., 2015b). However, in humans, gene expression of exon 1c is not highly expressed 
post exercise with levels reported to be very low to negligible (Popov et al., 2015b). 
 
Whilst evidence exists that supports exercise regulation of PGC-1α via a program of expression 
of distinct transcript variants, the contribution of post-exercise cold water (Chapter 4) or prior 
low muscle glycogen (Chapter 5) in the activation of PGC-1α via either the canonical (Exon 
1a) or alternative (Exon 1b) promoter, and therefore the gene expression of Exon 1a vs. Exon 
1b, has not been determined. Moreover, PGC-1α expression driven by exercise, cold and low 
glycogen stimuli is thought to be regulated by AMPK (Norrbom et al., 2011; Wen et al., 2014) 
or β-adrenergic receptor, protein kinase A (PKA), cAMP response element binding protein 
(CREB) signalling (Chinsomboon et al., 2009; Tadaishi et al., 2011). Therefore, of particular 
interest is whether the individual impact of exercise, cold stress and low glycogen would 
preferentially activate either the Exon 1a or Exon 1b PGC-1a promoter and whether the 
combined impact of these stimuli would further enhance PGC-1a gene expression. Indeed it 
has been suggested that Exon 1a may largely be AMPK activated, whilst Exon1b is more 
susceptible to β-adrenergic stimulation (Popov et al., 2015a). Thus, the aim of this study was 
to: 1) assess the impact of local and systemic cooling (using the samples collected from Chapter 
4) on PGC-1α promoter specific mRNA expression, and 2) assess the impact of combined post-
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exercise cooling and prior low glycogen content (using the samples collected from Chapter 5) 
within skeletal muscle on the post-exercise PGC-1α transcript variant response. It is 
hypothesised that cold-water immersion and prior low glycogen combined would increase the 
exercise induced PGC-1α alternative (Exon 1b) promoter to a greater extent than cold water or 
low glycogen alone.  
 
6.2 METHODS 
For full methodological details of experiment 1 (chapter 4) and experiment 2 (chapter 5) see 
section 4.2 and 5.2 respectively. Briefly, Chapter 5 investigated the local versus systemic 
response of post-exercise CWI by comparing an immersed limb, with a non-immersed limb 
and a complete (rested, no immersion) control. Results showed the cold-induction of PGC-1α 
transcription can be evoked systemically, with a similar augmentation in the non-immersed as 
well as the immersed limb versus the control. Chapter 6 built on this and investigated whether 
this cold induced augmentation can be further increased by commencing exercise with low 
glycogen. Results showed the potential existence for a critical threshold in low glycogen 
stimulated PGC-1α augmentation, however further research is required to fully clarify such a 
response. This chapter took muscle biopsies from Chapter 4 and Chapter 5 and used them to 
isolate mRNA (See Section 3.11.2) and assess promoter specific PGC-1a gene expression (exon 
1a and 1b). 
 
Primer sequences (Table 6.1) were identified using Gene 
(NCBI, http://www.ncbi.nlm.nih.gov.gene) and designed using Primer-BLAST 
(NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast). Sequence homology searches ensured 
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specificity and that all primers had no potential unintended targets. The primers were ideally 
designed to yield products spanning exon-exon boundaries to prevent any amplification of 
gDNA. Three or more GC bases in the last five bases at the 3’ end of the primer were avoided. 
Secondary structure interactions (hairpins, self-dimer and cross dimer) within the primer were 
avoided. All primers were between 20 and 25 bp, and amplified a product of between 127-153 
bp. Primers were purchased from Sigma (Suffolk, UK).  
 
rt-qRT-PCR amplifications were performed as specified in Section 3.11 using specific Primer 
designs outlined in Table 6.1. Following initial screening of suitable reference genes, GAPDH 
showed the most stable Ct values across all RT-PCR runs, participants and regardless of 
experimental condition (23.54 ± 1.69 Ct; 7% Co-efficient of variation) and was selected as the 
reference gene in all RT-PCR assays. The average PCR efficiency was 90% and variation of 
efficiencies across all genes was low at 2.8%. mRNA expression for all target genes was 
calculated relative to the reference gene (GAPDH; subject’s own samples reference) within 
same subject and condition and to a calibrator of Pre-exercise. 
 
6.2.1 Statistical analysis 
Experiment 1- A two-way (3 condition × time) within-participants general linear model was 
subsequently used to evaluate the influence of the cooling intervention following exercise and 
the 3h post exercise period. The main effects for condition and time was followed up via the 
use of planned LSD multiple contrasts.  Where a significant condition by time interaction was 
observed, the post exercise to 3h post exercise change scores were calculated and compared 
across the 3-conditions using LSD multiple contrasts. The ES magnitude was classified as 
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trivial (<0.2), small (>0.2-0.6), moderate (>0.6-1.2), large (>1.2-2.0) and very large (>2.0-4.0) 
(Hopkins et al., 2009). The  level for evaluation of statistical significance was set at P < .05.  
 
Experiment 2- A two-way (4 condition x time) within participant’s general linear model for 
condition (High glycogen control (HI CON), Low glycogen control (LO CON), High glycogen 
CWI (HI CWI)) and time (Pre, Post, 3h) was used to evaluate the influence of low glycogen 
and CWI following exercise and the 3h post exercise period. The main effects for condition 
and time were followed up using planned LSD multiple comparisons.  The ES magnitude was 
classified as trivial (<0.2), small (>0.2-0.6), moderate (>0.6-1.2), large (>1.2-2.0) and very 
large (>2.0-4.0) (Hopkins et al., 2009). The α level for evaluation of statistical significance was 
set at P < .05. 
 
Independent t-tests were used to assess the difference in mean baseline and 3h post-exercise 
gene expression (CT scores) between Exon 1a and Exon 1b promoter regions. Moreover, 
further independent t-test were used to assess the difference in Pre-exercise and 3h post-
exercise Exon 1b expression between HI and LO glycogen limbs.
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Table 6.1: Primer sequences used for real-time PCR. 
Gene Forward Primer Reverse Primer Product 
Length (base 
pairs) 
Location 
     
Exon 1a 
NM_013261.
4 
 
ATGGAGTGACATCGAGTGTGCT 
 
 
GAGTCCACCCAGAAAGCTGT 
 
127 159-285 
Exon 1b 
XM_011513
766.1  
XM_005248
132.1  
CTATGGATTCAATTTTGAAATGTGC CTGATTGGTCACTGCACCAC 153 77-229 
Exon 1a = PGC-1α Exon 1a; Exon 1b = PGC-1α Exon 1a.
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6.3 RESULTS 
Experiment 1- Promoter-specific PGC-1α gene expression in immersed vs. non-immersed 
limbs 
Exon 1a- Exercise significantly increased the expression of Exon1a mRNA ~2-4 fold from 
Pre (Pre – Post Exercise: P < 0.001, ES 2.50 Very Large, Figure 6.1). In the 3h post-exercise 
recovery period no change in level of expression was seen (P = 0.202, ES 0.27 Small) 
between conditions (P = 0.146, ES 0.74 Moderate). The change over time was significant 
(P = 0.05). 
Exon1b- Exercise significantly increased the expression of Exon 1b mRNA (Pre – Post 
Exercise: P = 0.016, ES 1.14 Large, Figure 6.1). In the 3h post-exercise recovery period 
Exon 1b expression increased significantly (P = 0.007, ES 1.15 Large) between conditions 
(P = 0.011). Post-hoc analysis showed NOT (2344- fold change from Pre, ES 1.12 Large) 
significantly increased Exon 1b gene expression compared to CON (579-fold change from 
Pre, P = 0.010) and CWI (1860-fold change from Pre, ES 0.61 Moderate) on average 
increased Exon 1b gene expression versus CON, an observation that approached statistical 
significance (P = 0.07). No significant change in Exon 1b gene expression between NOT 
and CWI (P = 0.185, ES 0.29 Small) was evident. No significant interaction effect was 
present (P = 0.092). 
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Figure 6.1: PGC-1α mRNA specific to Exon1a (a) and Exon1b (b) 2-ΔΔCT fold change in 
expression with the calibrator as pre-exercise and the reference gene as GAPDH (see 
methods for details). Values are mean ± SD. *Significantly different from baseline (P < 0.05). # 
Significantly different from CON (P < 0.05). $ Different from CON (P=0.070). Post= Post-exercise, 
+3h= 3h post-exercise. 
 
 
* 
* 
#      $ 
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Experiment 2- Promoter-specific PGC-1α gene expression in cold water and low glycogen 
conditions 
Baseline/Pre-exercise expression was basally/constitutively higher in Exon1a than Exon1b, 
as would be expected based on previous literature (Martinez-Redondo et al., 2015; Popov 
et al., 2015b), demonstrated by later cycle threshold (Ct) values (lower basal expression) 
for Exon1b vs. Exon 1a (Ct 23.69 ± 2.52 vs. 21.99 ± 2.64 respectively, t = 0.006) at baseline. 
Therefore, when gene expression 3h post exercise increased for Exon 1b (low Ct 
value/higher expression of 20.41 ± 4.01 vs. a higher Ct/lower expression of 22.82 ± 4.13 (t 
= 0.014) for Exon 1a) this resulted in changes in the magnitude of 100-1000 fold for Exon 
1b vs. fold changes in the 10’s for Exon 1a. Moreover, pre-exercise expression of Exon 1b 
gene expression was higher in LO glycogen limbs than HI (Ct 22.58 ± 2.70 vs. 24.81 ± 1.76, 
LO vs. HI limbs, t = 0.006), with gene expression increasing to a similar level in both HI 
and LO glycogen limbs (Ct 21.36 ± 3.96 vs. 19.46 ± 3.94, LO vs. HI limbs, t = 0.159).  
 
Exon 1a- Exercise evoked an increase in the expression of Exon1a mRNA, peaking 
immediately post exercise (~1.5-2-fold change from Pre, ES 1.07 Moderate) before 
decreasing towards baseline at 3h post-exercise (~1-1.5-fold change from Pre, P = 0.065, 
ES 0.33 Small, Figure 6.2). No statistical significance was present between conditions or 
for the change over time (P = 0.086 and 0.492, respectively). 
 
Exon 1b-  Exercise evoked an increase in the expression of Exon1b mRNA, with the greatest 
increases seen at 3h post-exercise (CON HI and CWI HI ~159-fold change from Pre, CON 
LO ~ 58-fold change from Pre, CWI LO ~56-fold change from Pre, P = 0.057, ES 1.20 
Moderate/Large). Significant differences were observed between conditions (P = 0.035, 
Figure 6.2) with both HI limbs having greater expression than their corresponding LO limb 
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at 3h post-exercise (CON P = 0.025, ES 0.67 Moderate; CWI P = 0.062, ES 1.14 Large). 
No difference was present in both LO or both HI limbs when the CWI intervention was 
applied (LO P = 0.398, ES 0.26 Small; HI P = 0.966, ES 0.007 Trivial) suggesting a cold-
induced response in exon 1b gene expression was not present. No significant interaction 
was seen (P = 0.111). 
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Figure 6.2: PGC-1α mRNA specific to Exon1a (a) and Exon1b (b) 2-ΔΔCT fold change in 
expression with the calibrator as pre-exercise and the reference gene as GAPDH (see 
methods for details). Values are mean ± SD. $ Trend towards increase from Pre ((a) P=0.065) (b) 
P=0.057. A main effect for condition and time was found (P < 0.001). *Different from 
corresponding LO limb (P = 0.025), +Different from corresponding LO limb (P=0.062). Post= Post-
exercise, +3h= 3h post-exercise. 
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6.4 DISCUSSION 
This is the first study to investigate the relative influence of localised and systemic cooling 
as well as the impact of prior reduced glycogen with and without post-exercise cooling on 
the promoter specific mRNA expression of the transcriptional coactivator PGC-1α. Data 
herein provides novel results to show PGC-1α mRNA expression from the alternative 
promoter (Exon 1b) mirrors the pattern of expression for total PGC-1α previously described 
in Chapter 5, thus the contribution to total PGC-1α mRNA expression post-exercise is likely 
a result of changes occurring from the alternative promoter (Exon 1b) (Figure 5.8). 
Moreover, a systemic response to CWI is seen from the alternative promoter (Exon 1b) with 
large (~2000) fold-changes from Pre-exercise in the immersed and contralateral non-
immersed limbs, versus a non-immersed control (<1000 fold change from Pre). When levels 
of muscle glycogen are reduced below 85 mmol·kg-1dw this response is abolished, with LO 
glycogen limbs showing reduced mRNA expression via the alternative promoter (Exon 1b) 
versus the contralateral HI glycogen limb. Moreover, a cold stimulus had no influence upon 
promoter specific expression when glycogen concentration was low. Finally, data herein go 
some way to confirm previous reports that PGC-1α alternative promoter (Exon 1b) gene 
expression is responsible for the regularly observed exercise induced increase in total PGC-
1α mRNA, in an intensity dependent manner. 
 
The transcriptional coactivator PGC-1α has become a key target in many scientific studies 
focussing on skeletal muscle adaptation to different training stimuli because of its critical 
role in mediating mitochondrial biogenesis (Hood, 2009). The expression of this gene 
occurs via two different promoter regions, offering additional avenues of mechanistic 
interest. The proximal (canonical) PGC-1α gene promoter (Exon 1a) has higher basal 
expression; however, an alternative promoter (Exon 1b and 1c) is more responsive to 
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exercise stimulation (Martinez-Redondo et al. 2015). Indeed, several groups (Norrbom et 
al., 2011; Ydfors et al., 2013; Popov et al., 2014) have shown in human skeletal muscle that 
acute exercise induces PGC-1α gene expression mainly via the alternative promoter (Exon 
1b).  This occurs particularly via Exon 1b as gene expression of Exon 1c post-exercise in 
humans is very low to negligible (Popov et al. 2015b) and thus exon 1c was not measured 
in the present study. 
 
In Experiment 1 of the present study, we sought to investigate the local vs. systemic effect 
of post-exercise cooling upon the promoter specific expression of PGC-1α mRNA. 
Expression from the canonical promoter (Exon1a) showed a significant increase post 
exercise in all limbs (2-4 fold change from Pre, P < 0.05). Large fold changes were present 
in expression from the alternative promoter (Exon1b), with values ranging ~1000-2000 fold 
increases from Pre-exercise values (P < 0.05). The sizeable difference in change of 
expression between the different promoter regions is likely to be due to the differential 
expression at baseline and response to an exercise stimulus. Indeed, Exon 1a is 
constitutively expressed at higher levels basally (at rest) to a greater extent than Exon 1b, 
whilst Exon 1b is constitutively expressed at lower basal levels, however, is more 
responsive to an exercise stimuli (Martinez-Redondo et al., 2015; Popov et al., 2015b). Data 
herein (Experiment 2) support previous data with lower Ct values (thus more gene 
expression) of Exon 1a at baseline vs. Exon 1b. Moreover, as the pattern of response to 
exercise from the alternative (Exon 1b) promoter closely mirrors that of total PGC-1α gene 
expression seen previously (Chapter 4) this data offers further support to previous evidence 
showing the response of total PGC-1α mRNA to acute exercise is largely driven by the 
alternative promoter (Exon 1b) (Norrbom et al., 2011; Ydorfs et al., 2013; Silvennoinen et 
al., 2015; Popov et al., 2015b). Additionally, data from our second experiment, to 
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investigate the impact of commencing exercise with low glycogen combined with post-
exercise cooling on the promoter specific response, shows PGC-1α alternative promoter 
(Exon 1b) expression continued to rise at 3h post-exercise in all conditions, whilst 
expression from the canonical promoter (Exon 1a) decreases between the same time points 
(post-exercise – 3h post-exercise). This emphasises the role of the alternative promoter to 
the exercise induced augmentation in total PGC-1α gene expression.  
 
Importantly, in Experiment 1, the local vs. systemic investigation, PGC-1α gene expression 
from the alternative promoter (Exon 1b) showed large increases in response to high-
intensity intermittent cycling (CON, <1000 fold change from Pre), which was augmented 
even further in limbs exposed to systemic cold stress (NOT and CWI, ~2000 fold change 
from Pre, P = 0.07 and <0.05 vs. CON, respectively). Indeed, the fact that a similar pattern 
of response is seen in total PGC-1α mRNA (Chapter 4) suggests the contribution to cold 
induced total-PGC-1α gene expression is also driven by the alternative (Exon1b), and not 
the canonical (Exon1a) promoter region. This data is the first to show such a response to 
cold in either animal or human studies.   
 
Previous evidence in rodent skeletal muscle has suggested that activation of exercise-
induced expression via the alternative promoter (Exon 1b) is regulated by the β2 adrenergic 
receptor- protein kinase A (PKA)-cAMP response element-binding protein (CREB) 
signalling pathway (Chinsomboon et al., 2009; Tadaishi et al., 2011; Popov et al. 2015b). 
Ruas and colleagues (2012) showed administration of the β-adrenergic agonist clenbuterol 
in mice, induced expression of PGC-1a2 and 3 (Exon 1b derived) whilst levels of the 
canonical promoter derived PGC-1α1 (Exon 1a) were reduced. Moreover, Norrbom et al. 
(2011) showed AMPK activator AICAR stimulates transcription from both Exon 1a and 1b 
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promoter regions, whilst AICAR injected simultaneously with noradrenaline stimulated 
Exon 1b to a greater extent, thus suggesting noradrenaline had an additive effect on 
alternative (Exon 1b) promoter gene expression. We show a similar response occurs in 
humans whilst investigating Experiment 1; whereby higher levels of normetanephrine in 
the cooled condition occurs alongside continued increases in alternative promoter 
expression (Exon 1b) at 3h post-exercise. We have previously shown (Chapter 4 and 
Chapter 5) that the cooling conditions used in both experiments herein successfully 
increased and maintained plasma normetanephrine concentration, a β- adrenergic agonist. 
Thereby it would seem logical that the increased β-adrenergic activity that follows post-
exercise CWI may play a sufficient role in the alternative promoter (Exon1b) driven cold-
augmentation of total PGC-1α gene expression. Further work is required to confirm this 
response in humans. 
 
The benefit of training with low glycogen levels upon the post-exercise PGC-1α mRNA 
response is well established (Psilander et al., 2013; Bartlett et al., 2013). We have shown 
previously (Chapter 5) that a potential critical limit of glycogen depletion may exist for such 
a benefit to occur, as limbs depleted below 85 mmol·kg-1dw glycogen concentration failed 
to show an expected augmentation of total PGC-1α gene expression following high intensity 
intermittent cycling. It is suggested the very low levels of glycogen herein (Chapter 5) may 
have also prevented a cold induction of PGC-1α gene expression, with similar levels of 
expression in both LO glycogen limbs (CON LO and CWI LO), despite larger expression 
in the high glycogen cooled limb (CWI HI) versus its contralateral low glycogen cooled 
limb (CWI LO). Additionally, PGC-1α canonical (Exon 1a) promoter gene expression 
closely matched the pattern of response of total PGC-1α gene expression.  
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Mechanisms responsible for the lack of low glycogen stimulated augmentation of PGC-1α 
gene expression above the exercise induced response are unknown. However, it must be 
noted that exercise intensity may have confounding implications. More specifically, had 
participants struggled to produce a similar pedal force in glycogen depleted limbs, in 
comparison with the high glycogen contralateral limb, during the high-intensity intermittent 
cycling protocol, as would be expected due to impaired calcium release (Ørtenblad et al. 
2011), it may be that cycling technique was altered to preserve total power output. With this 
said, participants could have subconsciously turned the pedals with the higher glycogen 
limb, sparing the already depleted (LO) limb. As a result, the higher glycogen limb will 
have been exposed to sufficiently greater exercise intensity and total work load, thus 
resulting in the discrepancy seen in total PGC-1α (Chapter 5) and Exon 1b (present 
Experiment 2) gene expression at 3h post-exercise from what would be expected.  
 
As Exon 1a gene expression has previously been shown not to be dependent on exercise 
intensity (Popov et al., 2015b) it would suggest the lower expression from this promoter 
region in LO glycogen limbs (CON LO and CWI LO) at 3h post exercise is a result of the 
lower glycogen concentration. However, it should be noted that this suggestion is 
confounded by the reality that LO glycogen limbs underwent depleting exercise the night 
before the experimental day, whilst the HI limbs did not. This may therefore have led to 
higher absolute pre-exercise mRNA values in the LO vs. HI glycogen limbs, ultimately 
lowering the potential fold changes seen at 3h post exercise when compared with pre-values. 
Moreover, the smaller fold changes noted in the second experiment herein from the 
alternative promoter (Exon 1b) (~200 fold change from Pre), in comparison with 
Experiment 1 (~2000 fold change from Pre), despite both sets of participants undergoing 
the same relative exercise protocol, is perhaps a product of the same limitation. The prior 
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exercise completed in the second experiment (2 nights of depletion prior to the experimental 
day) may have altered the absolute basal levels of PGC-1α Exon 1a and 1b, limiting the fold 
changes seen at 3h post exercise; particularly as the 48 hours prior to experiment 1 included 
restricted levels of exercise and lower mean Ct values (therefore higher gene expression) 
were seen for LO glycogen limbs vs. HI glycogen limbs Pre-exercise. Indeed, maximum 
fold changes for total PGC-1α expression were lower in experiment 2 (Chapter 5, Figure 
5.8) (max. ~8 fold change from Pre) vs. experiment 1 (Chapter 4, Figure 4.4) (max. ~12-
fold change from Pre). This hypothesis is supported by Chris Perry and colleagues (2010) 
who showed the PGC-1α mRNA response to high intensity interval training was diminished 
almost 2-fold on the third day of exercise, compared to the first. Despite this, significant 
main effects over time suggest the greater fold changes seen at 3h post-exercise in HI 
glycogen limbs are also somewhat a result of exercise stimulation. Future studies should 
look to match the work and intensity done prior to the experimental day whilst altering the 
glycogen content of the muscles. 
 
Despite the fact that differing exercise intensity may have played a role in blunting the 
response of exercising with low glycogen upon PGC-1α (Chapter 5), it is interesting that an 
expected cold-induction of PGC-1α mRNA was not seen in CWI limbs of the second 
experiment of this chapter, from either promoter region (Exon 1a and 1b). Indeed, we have 
previously shown that cold water immersion without prior exercise is able to evoke an 
increase in total PGC-1α gene expression (Joo et al., 2016). Thus, it is particularly confusing 
as to how a cold augmentation in total PGC-1α mRNA was seen in Chapter 5 between CON 
HI and CWI HI limbs, yet not for promoter specific expression (particularly Exon 1b) in 
the present chapter. Taken together, data from Experiment 1 established a close relationship 
between total and alternative promoter (Exon1b) derived PGC-1α mRNA in cooled 
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conditions that is not supported by the present data in this chapter from Experiment 2. 
Indeed, the fact that no cold-induction of promoter specific derived PGC-1α mRNA 
occurred in Experiment 2 could suggest alternative promoter (Exon 1b) expression is not as 
important in the overall cold induction of total PGC-1α gene expression as initially thought; 
with other, unidentified mechanisms yet to be discovered. Despite this, there are also other 
potential causes for such a response. Indeed, as previously mentioned, data herein are 
measured as fold-changes from pre exercise values. Prior exercise in the days leading up to 
Experiment 2 may have subsequently resulted in higher baseline absolute values and thus 
smaller fold changes at 3h post exercise, shown by the higher levels of pre-exercise 
expression in Exon 1a vs. Exon 1b, and LO vs. HI glycogen limbs for Exon 1b. If this 
hypothesis were true it begs the question that the cold-induced augmentation of PGC-1α is 
an acute response that occurs after a single exercise + cooling session, and is less likely to 
occur to a similar extent following several exercise + cooling sessions. Future work should 
look to follow a similar design as Perry and colleagues (2010) whereby the impact of CWI 
upon PGC-1α mRNA (total and promoter specific) is measured at regular acute intervals 
following exercise 4 times over the course of 7 days. This would allow determination of the 
time course changes in the PGC-1α response to several acute periods of cooling, and may 
explain why no cooling induced alterations in PGC-1α are noted in Experiment 2 herein, 
particularly as this experiment followed 2 days of prior depleting exercise. 
 
In conclusion, this is the first study to show the systemic cold-induced augmentation of total 
PGC-1α as seen previously (Chapter 4) is largely a result of increased expression from the 
alternative promoter (Exon 1b), rather than canonical promoter (Exon 1a). Moreover, 
further research is required to confirm the suggestion that a critical level of glycogen is 
necessary to allow the expected low glycogen stimulated post-exercise augmentation in 
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PGC-1α mRNA. Evidence herein further supports the notion that PGC-1α gene expression 
from the alternative promoter (Exon 1b) is more reactive to an exercise and cold stimulus. 
Moreover, reduced gene expression fold changes in LO vs. HI glycogen limbs at 3h post-
exercise (Exon 1b) likely occurs as a combined result of higher absolute basal expression 
pre-exercise and greater intensity/workload in the HI glycogen limb during exercise. 
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CHAPTER 7 
 
SYNTHESIS OF 
FINDINGS 
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The aim of this chapter is to integrate and interpret the findings within this thesis. The initial 
section provides an overview of the findings in relation to the original aims and objectives 
of the thesis, set out in Chapter 1. A general discussion is then presented where specific 
attention is given to how the data herein has advanced the understanding of the 
transcriptional co-activator PGC-1α, its expression in the acute post-exercise period and 
the influence of the stress of low muscle glycogen and post-exercise CWI.  
 
7.1 Realisation of aims and objectives 
The aim of this thesis was to establish whether the cold induction of critical regulators in 
mitochondrial biogenesis are controlled systemically, or more locally through temperature 
induced changes in cell signalling pathways of the cooled muscle. Once established, 
subsequent aims served to investigate whether such a response could be enhanced when 
exercise was commenced with low glycogen stores. Additionally, this thesis sought to 
establish the impact of these stressors on the promoter specific response of the gene PGC-
1α. 
 
It was established in Study 1 (Chapter 4) that transcriptional regulation of the “key 
regulator” in mitochondrial biogenesis, PGC-1α responds in a systemic manner to local 
cooling. Similar increases in gene expression in a cooled and non-cooled contralateral limb, 
occurred to a greater extent than a control, uncooled limb post-exercise. Muscle temperature 
decreased in the cooled limb (CWI), not the uncooled limbs (NOT and CON), suggesting 
the gene expression response was not a result of local cooling of skeletal muscle tissue. 
Systemic increases in the β-adrenergic agonist normetanephrine during the post-exercise 
period of the cooling trial (CWI and NOT limbs) plays a role in this cold augmentation of 
PGC-1α gene expression via phosphorylation of the upstream signalling kinase AMPK. 
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Study 2 progressed upon the results from Study 1to assess the impact of further stress upon 
the post-exercise and cooling response of PGC-1α, notably prior reduced glycogen 
concentration. In the higher glycogen limbs results were as expected, with CWI enhancing 
the post-exercise response compared with CON. No response of PGC-1α was noted in either 
low glycogen limb, with or without cooling. CWI produced expected local and systemic 
results by decreasing muscle temperature and increasing plasma normetanephrine. Data 
from Study 2 (Chapter 5) implicates a critical level of glycogen depletion exists for the 
augmentation of PGC-1α gene expression after exercise, and after exercise followed by 
cooling. In Study 3 (Chapter 6) the aim was to further assess the controlling mechanisms 
responsible for the regularly seen cold augmentation of post-exercise PGC-1α gene 
expression. In measuring the promoter specific response of PGC-1α data show for the first 
time the systemic cold-augmentation of PGC-1α largely occurs in a similar fashion to that 
of exercise induced PGC-1α, via the alternative promoter region (Exon 1b). Data show little 
impact of reduced glycogen on the promoter specific response, however, further data is 
required to confirm this response. 
 
7.2 General discussion of findings 
Whilst it has been apparent for some time that the transcriptional co-activator PGC-1α plays 
a critical role in mediating cell signalling pathways associated with mitochondrial 
biogenesis (Wenz, 2013), more recent work shows post-exercise CWI augments the 
exercise-induced PGC-1α response (Ihsan et al., 2014a; 2015; Joo et al., 2016). Despite 
these recent advances in the literature, the precise controlling mechanisms of the cold-
induced augmentation in post-exercise PGC-1α gene expression remained to be determined. 
Upstream control of PGC-1α includes phosphorylation by energy and stress sensing kinases 
AMPK (Jäger et al., 2007) and p38 MAPK (Akimoto et al., 2005).  Importantly, long-term 
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cold-induced changes in PGC-1α protein content arise in conjunction with increased activity 
of AMPK and p38 MAPK (Ihsan et al., 2015). Alternatively, β-adrenergic activity is 
suggested to play a potent role in mediating the effects of cold exposure on PGC-1α 
expression via AMPK (Manfredi et al., 2013). To date, studies investigating the impact of 
CWI upon post-exercise gene expression have utilised the non-immersed limb as the control 
condition without the use of a true control (no cooling) condition (Frohlich et al., 2014; 
Ihsan et al., 2014a; 2015). By assuming the response to cold-water immersion is mediated 
locally, such experimental designs do not permit examination of the role of systemic versus 
localised mechanisms in mediating cold-induced changes in PGC-1α.  
 
Study 1 (Chapter 4) utilised a bi-lateral muscle biopsy design with single-leg CWI in order 
to establish the localised (cooled limb) and systemic (non-cooled limb) response to post-
exercise CWI, versus a complete control. Similar acute PGC-1α gene expression in the 
immersed and non-immersed limbs, both greater than the control limb, led to the conclusion 
that the cold-augmentation of the post-exercise PGC-1α response is influenced 
systemically. Greater plasma normetanephrine concentration during the post-exercise 
period for the cooled conditions (immersed and non-immersed limbs) alongside an 
interaction effect noted for the phosphorylation of AMPK, provides support for the 
hypothesis that β-adrenergic activity plays a potent role in mediating the effects of cold 
exposure on PGC-1α expression via AMPK (Manfredi et al., 2013). Moreover, that muscle 
temperature was significantly lower in the immersed vs. non-immersed limb, despite similar 
augmentation of PGC-1α gene expression, indicates that the cold-induced regulation of this 
gene is not locally controlled by mechanisms of reduced tissue temperature, but influenced 
by systemic mechanisms, likely β-adrenergic activation. Importantly, recent work utilising 
a contralateral control limb design and local cooling of one limb (via ice application) has 
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concluded this method of cooling does not impact the expression of mitochondrial-related 
genes (including PGC-1α) (Shute et al., 2017) and the metabolome and transcriptome of 
human skeletal muscle (Sarver et al., 2017).  This lack of difference noted between a cooled 
and non-cooled limb could well be a factor of the systemic regulation noted in our results 
herein (Chapter 4), highlighting our earlier point that such study designs do not allow for 
examination of both the localised and systemic responses with the comparative results being 
underrepresented where a true control condition is missing. 
 
As a result of establishing that the cold-induced augmentation of the post-exercise PGC-1α 
gene expression response was systemic in nature investigations progressed to assess 
whether such a response could be increased to an even greater extent. In this sense, we 
sought to take advantage of the fact that previous research has shown exercise commencing 
with low glycogen concentrations enhances the post-exercise PGC-1α response (Psilander 
et al., 2013; Bartlett et al., 2013). Theoretically, with exercise alone enhancing post-exercise 
PGC-1α mRNA 3-4 fold as is regularly shown (Slivka et al., 2013; Ihsan et al., 2014a), and 
post-exercise CWI enhancing this response up to 6-10 fold (Ihsan et al., 2014a; Joo et al., 
2016; Allan et al., 2017) we assessed whether post-exercise CWI of limbs that commence 
exercise with low glycogen concentrations would see a response greater than this.  
 
In utilising a bilateral muscle biopsy design four conditions were established from two 
experimental visits. Depleting a single limb in the day prior to the experimental test day 
allowed measurement of high and low glycogen conditions, with and without post-exercise 
CWI.  Whilst high glycogen limbs produced results as expected, with the high glycogen 
cooled limb producing greater expression of PGC-1α mRNA than the high glycogen control 
limb (~8 vs. ~6- fold increase from Pre exercise, respectively) the results were not matched 
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in the low glycogen limbs. Indeed, low glycogen prior to commencing exercise had no 
beneficial impact on the rate of PGC-1α gene expression, with or without CWI. Thus, data 
shows a critical level of glycogen depletion exists for the benefits of low glycogen 
concentration upon the post-exercise PGC-1α mRNA response 
 
Indeed, that results in the low glycogen limbs of Chapter 5 surpassed such a critical 
threshold might explain the lack of cold and/or low glycogen induction in PGC-1α gene 
expression. However, this Chapter failed in its aim to have a high vs. low glycogen limb as 
rates of repletion in the intended high glycogen limb did not occur as had done in pilot 
testing. Thus, the data from Chapter 5 are better described as low vs. very low glycogen, 
rather than low vs. high glycogen limbs. The identification of a critical threshold of 
glycogen depletion to maintain the associated augmentation of post-exercise PGC-1α after 
exercise is commenced with very low glycogen concentrations requires further 
investigation. Whilst it is not bold to suggest such an occurrence, considering this is not the 
first time such a threshold has been suggested to occur (Pilegaard et al., 2002), it is important 
to establish the mechanisms by which such a threshold would prevent the expected 
augmentation of PGC-1α. Alternatively, it is suggested that such low levels of muscle 
glycogen may influence the efficiency of muscle recruitment and therefore not provide a 
sufficient stimulus in which to augment PGC-1α gene expression.  
 
One emerging area of research is that PGC-1α gene expression occurs by way of two 
separate promoter regions; a proximal (canonical, Exon 1a) and an alternative (Exon 1b/c) 
promoter, with this alternative promoter responsible for the exercise-induced increases of 
PGC-1α mRNA (Martinez-Redondo et al., 2015; Popov et al., 2015b). In Chapter 4, design 
of RT-PCR primers for PGC-1α demonstrated that these promoter regions differentially 
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express PGC-1α mRNA dependent upon the stress applied (i.e. baseline vs. post-exercise). 
Further analysis of the samples collected from Chapters 4 & 5 would allow determination 
of the influence of post-exercise CWI and prior low glycogen upon the differential 
expression from the two promoter regions; and may go some way to explaining the 
mechanisms involved in such responses. Data from Chapter 6 were able to show PGC-1α 
mRNA expression from the alternative promoter (Exon 1b) closely follows the pattern of 
expression for total-PGC-1α gene expression, with similar systemic increases in immersed 
and non-immersed limbs; suggesting a role for Exon 1b derived PGC-1α in the cold-
augmented post-exercise response. Moreover, data confirmed previous reports that show 
the exercise-induced response is promoter specific, with PGC-1α gene expression occurring 
via the alternative (Exon 1b) promoter following high-intensity exercise (Martinez-
Redondo et al., 2015; Popov et al., 2015b).  
 
Mechanistic studies like those in this thesis often offer great implication for future research 
design. Researchers wanting to investigate the cold-induced post-exercise responses in 
skeletal muscle must be aware of the evidence of systemic regulation. In the case of the 
present thesis, this means the implication that a systemic response of normetanephrine may 
have upon the local response of p-AMPK and PGC-1α. Future work should look to establish 
further evidence to support the impact of systemic transcriptional responses in unilateral 
research designs, as these might be liable to error. As such, utilising a contralateral limb as 
a control limb may underestimate the actual response occurring in the intervention 
(immersed/cooled) limb. The choice of scientific design lies with the question posed, as 
contralateral designs remain useful for understanding both local and systemic responses. 
Ultimately, it is hoped that the results from Chapter 5 and Chapter 6 stimulate more 
questions than answers, and allow for further investigation into the mechanisms controlling 
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this cold-induced augmentation of PGC-1α. Results from Chapter 6 are the first to identify 
the promoter specific PGC-1α transcriptional response to CWI in either animals or humans. 
As this is a new and emerging area that can be easily investigated with the careful and 
correct design of suitable qRT-PCR primers it is suggested that all future work where PGC-
1α plays a key role in determining answers to the research question should look to analyse 
the promoter specific response to different stimuli, in different populations in order to 
expand knowledge in the area. 
 
7.3 Practical applications 
In an applied sense, results from Chapters 4 and 5 offer further support to literature that 
shows PGC-1α gene expression is augmented to a greater extent than exercise alone, when 
the exercise is followed by CWI (Ihsan et al., 2013; Joo et al., 2016). Moreover, with much 
debate around the efficacy of CWI upon the adaptive response, stemming from the work of 
Roberts et al. (2014) showing post-exercise CWI dampens strength gains and adaptive 
processes (satellite cell activation) following a programme of resistance training, data from 
this thesis offers further support to the other side of the current paradox; that the oxidative 
adaptive response is augmented by post-exercise CWI.  
 
The fact that a greater augmentation of the transcriptional co-activator PGC-1α and 
phosphorylation of AMPK were seen with exercise followed by CWI, in an immersed and 
contralateral non-immersed limb, suggests that single legged CWI is an appropriate 
technique to use for systemic cellular and molecular signal generation important in 
mitochondrial biogenesis and oxidative adaptation. However, coaches and sports scientists 
alike should be aware that in doing so they are preventing the athlete from gaining other 
benefits associated with CWI, such as hydrostatic pressure fluid shifts, reduced 
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swelling/oedema and reduced sensory neural conductance velocity associated with reduced 
perception of pain and fatigue.  
 
With the apparent suggestion that a critical level of glycogen availability exists in order to 
produce an exercise intensity required to promote cellular and molecular activation of the 
pathways important for oxidative adaptation (AMPK, PGC-1α) coaches, athletes and sports 
scientists should be clear on the positive and negative implications associated with “train 
low” strategies. Indeed, if glycogen availability is allowed to reach levels seen in Chapter 5 
(~85 mmol·kg-1dw) there is the potential for impaired contraction kinetics (Ørtenblad et al., 
2011) to disrupt the quality of subsequent training sessions and/or performance. Following 
this it is difficult to suggest any benefits of an athlete combining low glycogen strategies 
with post-exercise CWI for the purpose of improving recovery and acute adaptive 
responses. Further work is required to determine critical levels of glycogen depletion that 
will allow continued exercise intensity and support a post-exercise adaptive signalling 
response. 
 
Whilst data herein support the use of post-exercise CWI to promote oxidative cellular and 
molecular adaptive responses in the exercised muscle it is ever more important that applied 
practitioners understand the surrounding literature in order to successfully apply that 
knowledge to practice. The use of academic consultants to professional clubs is one way of 
addressing such issues. Whilst recent evidence shows there are no positive (or negative) 
implications of post-exercise CWI upon the inflammatory and cellular stress response, CWI 
may be useful in other ways. If not for the important signalling mechanisms involved in 
oxidative adaptation noted in this thesis, or to combat post-exercise inflammatory events 
(Peake et al. 2017b), CWI can still be important for greater functional recovery, improved 
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subsequent performance, reductions of DOMS and improved perception of recovery; be it 
via sensory or placebo mechanisms. The focus for any applied practitioner should now be 
how to suitably periodise and individualise recovery programmes to each athlete with 
particular attention being paid to their training and competition schedule, environmental 
conditions and personal preferences. 
 
7.4 Limitations 
Subject characteristics. The current thesis recruited participants who were physiologically 
active and free from current injury or illness. However, one thing that was not accounted 
for was the training status of individual participants that may undoubtedly differ due to the 
specific nature of their training history (i.e. running, cycling, team sports) and that provides 
altered adaptive stimuli (i.e. frequency and intensity). As this thesis contained large amount 
of cell-signalling analysis, with training history potentially impacting upon this (Coffey et 
al., 2006), future studies should pay particular attention to the inclusion criteria for subject 
recruitment so as to minimise the effect of training status upon cell signalling responses. 
 
Translation progression.  Whilst measuring mRNA content is an extremely useful tool in 
the acute response to exercise and/or external stimuli, increased mRNA content for a given 
protein may not necessarily translate into increased protein abundance (Baar et al., 2002; 
Hornberger et al., 2016). Thus, the need for further training studies highlighting the impact 
of regular use of CWI upon the cellular and molecular responses is required. This would 
allow for a better assessment of the impact of interventions on the PGC-1α protein, but 
analysis of other important factors (i.e. mitochondrial enzyme activity, mitochondrial 
quality and quantity, performance characteristics) would allow assessment upon the impact 
of adaptation towards a more oxidative phenotype.  
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Intensity dependency of PGC-1α. As was highlighted in Chapter 5, the lack of expected 
increases seen for post-exercise phosphorylation of AMPKThr172 and PGC-1α gene 
expression, particularly in low glycogen limbs may have been a result of poor cycling 
technique. One explanation may be that the depleted limbs in the low glycogen conditions 
were unable to produce the same power output as their contralateral high glycogen 
counterparts, particularly as low glycogen concentrations are linked to diminished 
sarcoplasmic reticulum function and therefore decreased power output (Ørtenblad et al., 
2011). Therefore, to maintain total power output during the cycling protocol utilised herein 
participants could have preferentially chosen to pedal more with the high-glycogen limb, 
thereby exposing that limb to a greater exercise intensity and total workload and creating 
an imbalance in the resulting expression of PGC-1α mRNA. Whilst no visible signs of 
preferential choice in limb used to turn the pedals were evident during testing procedures, 
future research should look to study designs that do not allow for this potential imbalance. 
Running protocols or cycle ergometers with individual power meters on each pedal are 
simple solutions to prevent such a problem. 
 
Depletion protocols raising absolute baseline levels of mRNA. As discussed in Chapter 6, 
mRNA data herein are measured as fold-changes to Pre-exercise values. Prior exercise in 
the form of glycogen depleting protocols (Chapter 5) in the days leading up to the 
experimental day may have subsequently resulted in higher baseline absolute values and 
thus smaller fold changes at 3h post exercise. Indeed, this hypothesis is supported by Perry 
and colleagues (2010) who showed the PGC-1α mRNA response to high-intensity interval 
training was diminished almost 2-fold on the third day of exercise compared to the first. 
Ideally, bilateral muscle biopsy studies like the one utilised herein (Chapter 5) should look 
to match the work done in each limb in the days prior to experimental days. This however, 
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due to the nature of bilateral study designs, is difficult to ensure particularly where glycogen 
depletion of a single limb is involved. Future work of a similar design should look to 
complete four separate condition visits, rather than utilise a bilateral design, ensuring the 
days prior to the experimental day are matched for work and intensity and with the only 
difference occurring being that required to alter muscle glycogen concentration (i.e. diet 
alteration to promote/negate muscle glycogen resynthesis). 
 
7.5 Recommendations for future research 
The following points are recommendations for potential future work so as to gain a more 
complete insight into the controlling mechanisms of the cold-induced augmentation of 
PGC-1α, particularly with lessons learnt and ideas gained from the investigations in this 
thesis: 
 
Recommendation 1: The role of β-adrenergic receptors in Normetanephrine induced AMPK 
phosphorylation. 
Results from Chapter 4 suggest control of the post-exercise cooling response in PGC-1α are 
systemic in nature, potentially via an increase in the β-adrenergic agonist normetanephrine 
upon AMPK phosphorylation. Future work should look to confirm such a mechanism by 
assessing the role of β-adrenergic receptors and the downstream cell signalling that 
potentially leads to the augmentation of PGC-1α. 
 
Recommendation 2: The signalling role of MEF2 and CRE/ATF2 sites to confirm a link 
between catecholamines and PGC-1α. 
Considering that MEF2 and CRE/ATF2 sites are required for PGC-1α transcription 
(Akimoto et al., 2008) measurement of CREB/ATF2 phosphorylation would allow links to 
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be made between catecholamine response and PGC-1α transcription, especially considering 
β-adrenergic stimulation is mediated by activation of p38 MAPK-CREB- ATF2, signalling 
axis, mediating the increase in PGC-1α transcription (Kim et al., 2013). 
 
Recommendation 3: Establish the impact of very low glycogen concentrations prior to 
commencing exercise upon the post-exercise and post-exercise plus cooling response.  
Chapter 5 in this thesis shows data to suggest a critical limit of glycogen depletion may exist 
for the augmentation benefits associated with commencing exercise with low glycogen to 
be seen. Future work should look to address this hypothesis particularly as this is not the 
first time a critical threshold of glycogen for gene expression has been suggested (Pilegaard 
et al., 2002).  
 
Recommendation 4: The impact of regular acute CWI upon PGC-1α mRNA (total and 
promoter specific). 
Future work should look to follow a design similar to that of Perry and colleagues (2010) 
where gene expression and protein content are measured at regular acute intervals following 
exercise 4 times over the course of 7 days. This would allow determination of the time 
course changes in the PGC-1α response to several acute periods of cooling. Gene array 
analysis would also be useful here, followed up with rt-qRT-PCR, to establish important 
cell-signalling pathways involved in the longer-term adaptive processes controlled by the 
so-called master regulator, PGC-1α. 
 
Recommendation 5: The impact of regular CWI on concurrent training adaptations. 
As previously mentioned, due to the sheer numbers of athletes that partake in training 
programmes that contain both endurance and resistance type exercises the influence of post-
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exercise cooling upon concurrent training will be of great applied interest. Indeed, with the 
current hypothesis that concurrent training may lead to cell-signalling interference of the 
resistance side of the coin (Coffey & Hawley, 2017) it would be interesting to see the 
influence cold water immersion may have upon these cell signalling processes. 
 
7.6 Conclusion 
The investigation in Chapter 4 has major implications for future research designs. As 
discussed in Section 7.2, recent work highlighting a lack of impact of localised cooling on 
a non-cooled contralateral limb utilised as the control condition (Shute et al., 2017; Sarver 
et al., 2017) may be a result of systemic regulation producing similar responses in both 
limbs. Without the comparison with a true control it remains impossible to assess the impact 
of systemic regulators in the measured variables. These recent studies highlight the 
importance of findings from Chapter 4. Chapters 4 and 5 offer further support to the already 
established notion that the post-exercise PGC-1α response is augmented to a greater extent 
when exercise is followed by CWI. Moreover, Chapter 5 indicates a critical limit exists for 
glycogen concentration to influence PGC-1α gene expression. The mechanisms controlling 
this response are suggested to be molecular in nature or as a result of decreased efficiency 
in muscle fibre recruitment, and remain to be determined. Chapter 6 is the first investigation, 
in animals and humans, to show the post-exercise cooling response of promoter specific 
PGC-1α gene expression. Importantly data herein show the cold induced augmentation seen 
in recent literature (Ihsan et al., 2013; Joo et al., 2017; Allan et al., 2017) is largely a result 
of alternative (Exon 1b) promoter specific gene expression. Importantly it is suggested that 
any future investigations assessing the acute PGC-1α response also measures the promoter 
specific response due to the ease of measurement and impact such data would have on the 
understanding and controlling mechanisms behind the “master regulator” of mitochondrial 
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biogenesis, PGC-1α. The results from this thesis not only offer mechanistical insight for 
future research design, but go some way in supporting previous work that provides evidence 
of post-exercise CWI positively influencing the signalling pathways associated with 
mitochondrial biogenesis. Ultimately, this offers confidence for practitioners that CWI is 
an effective recovery strategy, not only by way of analgesic and pain relieving properties, 
but via molecular mechanisms linked to an improved oxidative phenotype. The emphasis 
now should be on the correct periodisation of CWI, and how it is aligned to the individual 
athlete. 
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Figure 7.1: Synthesis of findings in relation to physiological mechanisms by which post-
exercise CWI is purported to promote recovery. Black text = physiological mechanisms of 
post-exercise CWI, Red text = molecular and signalling mechanisms influencing PGC-1α 
gene transcription (addition to knowledge provided by this thesis). Dark boxes = outcome, 
dashed boxes = key physiological response to cooling. CBV= Central Blood Volume, 
NCV= Neural Conductance Velocity, Tmus= Muscle temperature, Tskin= Skin 
temperature, O2= oxygen, AMPK= AMP-activated protein kinase, p38MAPK= p38 
mitogen activated protein kinase, PGC-1α= Peroxisome proliferator activated-receptor 
gamma coactivator -1 alpha. 
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APPENDIX 1 
PARTICIPANT INFORMATION SHEET 
  
 
Title of Project: The impact of glycogen 
manipulation on the mechanisms responsible for the benefits of post-
exercise cold water immersion (CWI).  
  
Research team: Mr Robert Allan, Dr James Morton, Dr Adam Sharples & Prof. Warren Gregson. 
School of Sport and Exercise Sciences, Faculty of Science.   
  
You are being invited to take part in a research study. Before you decide to take part, it is important 
that you understand why the research is being done and what it involves. Please take time to read 
the following information. If you are unsure of anything then do not hesitate to ask for more 
information. Take the time to decide if you want to take part or not.   
  
1. What is the purpose of the study?   
Short and long-term training results in muscle damage, causing inflammation, athlete discomfort 
and reduced performance. Cold water immersion (CWI) promotes the recovery of soft tissue (i.e. 
muscle) injury by reducing the inflammatory response, swelling and pain in injured tissue. It has 
additionally been shown able to maintain, and even improve, performance short-term. Post-
exercise CWI can also increase the endurance adaptive response to exercise to a greater extent 
than exercise alone. We are now interested in seeing whether this amplification of the adaptive 
response by CWI can be extended further by altering carbohydrate status.   
   
2. Do I have to take part?   
No, it is voluntary and entirely your own choice. If you do decide to take part you will be given 
this information sheet and asked to sign a consent form. You are still free to withdraw at any 
time and without giving a reason. A decision to withdraw at any stage throughout the testing 
period, for any reason, will not affect your rights/any future treatment/service you receive.   
  
3. Am I eligible to take part?   
 To be eligible to take part in this study you must meet the following criteria:   
 Male, aged 18-40.   
• Physically active and free from injury or illness (engaging in some form of physical training).   
• Not suffering from / no history of Raynaud’s syndrome (excessively reduced blood flow in response 
to cold or emotional stress).  
• No serious food allergies e.g. to nuts   
  
4. What will happen to me if I take part?  
You shall be required to attend the Tom Reilly Physiology laboratories 9 times in total. The first 3 
visits shall be to complete a two-legged test to assess your maximum oxygen consumption and 
peak power output. The test shall commence at a power output of 2Watts per 1kg of your body 
mass, increasing by 50Watts after the first 150s and 25Watts every 150s thereafter. One of these 
3 initial visits shall include familiarisation to the water immersion protocol by immersing you into 
8°C water via an electronic hoist for 10 minutes. Additionally, these visits will provide you with a 
 
 
200 
 
chance to witness any unfamiliar invasive procedures (such as bloodletting, muscle temperature 
and rectal temperature measurement) and allow time for open discussions around anything to do 
with the project. The third visit includes a medical screen by a Doctor. 
  
The next 6 visits shall take place on 3 consecutive days of two separate weeks (Control and Cold-
Water Immersion conditions separated by a minimum of 10 days).   
  
Day 1 and 4: You will arrive on Monday evening (for example purposes; days may change due to 
availability) and complete a two-legged cycling protocol with the aim of depleting glycogen stores 
in the legs. After a 5-min warm-up at 100 Watts, you shall cycle for 2 min at 90% of your 
predetermined peak power, followed by a 2-min recovery period at 50%. This work to rest ratio is 
maintained until you can no longer complete 2 min cycling at 90%. At this point the high-intensity 
bout will be lowered to 80% before being lowered further 70% and finally 60% as and when the 
target of 60 rev.min-1 cannot be met. When you are unable to cycle for 2 min at 60% the exercise 
protocol shall be terminated. That evening you shall receive a meal plan for a high CHO meal before 
returning to the lab the next morning after an overnight fast.  
       
Day 2 and 5: The next morning you shall receive a high CHO meal plan (~8g·kg-1 body mass of CHO) 
for the day, before undergoing a single-leg depletion protocol that evening. Single-leg glycogen 
depletion involves 20 minutes continuous single-leg cycling at 75% of your predetermined ‘one-
leg maximal oxygen consumption’, followed by intermittent cycling (90s at 90% : 90s rest) 
decreasing in 5% decrements to 55%. Immediately after this you shall complete an all-out one 
legged cycling bout at 85% one-leg maximal oxygen consumption before going on to 30 minutes 
of 2-arm cycling. You shall then undergo an overnight fast before returning to the lab the next day.  
  
Day 3 and 6; Test day: you will complete a high-intensity endurance cycling protocol (8 x 5 minutes 
at 85% of your maximal endurance capacity, separated by 60s rest). During exercise your heart 
rate will be measured via a loose fitting band strapped around your chest, expired air shall be 
assessed via a small facemask at regular intervals. Following completion of the exercise protocol 
you will undergo two-legged cold water immersion (8°C) for 10 minutes (CWI condition) or sit on 
a chair at room temperature for 10min (Control condition). On both occasions you will then remain 
seated at room temperature until 3h post-exercise.  
  
Muscle temperature will be monitored immediately after exercise and CWI as well as at 1 and 3 
hours post-exercise by inserting a needle to a depth of 3-4cm into the upper thigh. Rectal and skin 
temperature will also be monitored at various points throughout the day. Skin temperature will be 
assessed by taping small metal thermistors to different regions of the body (thigh and calf) prior 
to exercise. Blood samples will be drawn from the forearm pre-exercise, immediately post-
exercise, post-CWI and at 1, 2, and 3 hours after completing the cycling protocol. Blood samples 
will be taken by a fully certified and experienced phlebotomist. A muscle biopsy will be obtained 
from both the thighs pre-, post-exercise and at 3 hours post-exercise. The total number of biopsies 
over the course of the study will be 12.   
  
Please note that on completion of the research we may wish to keep both blood and muscle tissue 
for future research in the area of sport and exercise. This tissue will be treated in the strictest 
confidence with no association made between your identity and the data observed.  
  
Blood plasma shall be frozen and stored for later analysis of markers of muscle metabolism and 
catecholamines. Muscle samples are immediately frozen in liquid nitrogen for later analysis of 
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markers of mitochondrial adaptation. For more information please feel free to contact Robert 
Allan on the details at the bottom of this form.  
 
5. Are there any benefits / risks involved?  
There are some invasive procedures involved that may cause slight discomfort, a brief outline of 
which is highlighted below:  
CWI; upon immersion (to waist height) you may experience what is known as a “cold-shock” 
response. This involves short, sharp fast breathing whilst you experience numbness and a “pins 
and needles” sensation during acclimation to the temperature, normally lasting 2-3 minutes.  
Muscle Temperature; you will experience a small amount of sharp pain that will disappear 
quickly, similar to that of a needle injection. Upon removal of the needle there may be a small 
amount of bleeding; this is normal and usually minimal.  
Rectal Temperature; measured by inserting a rectal probe 15 cm beyond the external anal 
sphincter prior to the exercise insult to provide an indication of your internal body 
temperature throughout the day.  This may initially result in you feeling some discomfort 
which will disappear as you progress with the test.  
Bloodletting; Cannulation, a small plastic tube inserted into the vein of the arm to allow for 
multiple blood sampling and thereby reducing the need for repeated needle insertions, shall 
be performed at the start of the day and removed at the end. This is a routine procedure and 
should result in no more than a small amount of discomfort on insertion of the needle.   
Muscle Biopsies; will be fully explained prior to participating in the study and will be conducted 
by a fully qualified member of staff. A clinical assessment by a medic shall be completed prior 
to commencing any biopsies. Further information on the procedure is included in the 
accompanying biopsy information sheet. Should you have any concerns after your biopsy we 
can arrange for assessment by a medic. 
  
Benefits  
The study offers no direct benefits for your participation. However, taking part in this trial 
means that you are contributing to important research. Without such volunteers, research 
such as this and many other important studies would not be possible. The researcher team is 
comprised of experienced exercise physiologists and sports nutritionists, who will be on hand 
to answer any questions and/or offer information regarding training and diet habits and an 
insight into the research setting if this is of interest to you.  
 
  
6. Will my taking part in the study be kept confidential?  
In the study, any data collected from you is fully anonymised. Data and tissue samples may be 
used in further investigations to develop current or future research with your consent. Any 
data and samples not needed following completion of the study will be destroyed. Your 
confidentiality is of utmost importance and thus will not be compromised at any point.  
  
This study has received ethical approval from LJMU’s Research Ethics Committee   REC Reference 
Number  15/SPS/030  
 Date: 31-07-2015 
  
Contact Details of Researcher-Principal Investigator  
Robert Allan  
Football Exchange / Muscle Metabolism Research Group  
Liverpool John Moores University  
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Tom Reilly Building, Byrom Street, L33 AF   r.j.allan@2013.ljmu.ac.uk  
  
Contact Details of Research-Supervisor   
Prof. Warren Gregson  
Football Exchange / Muscle Metabolism Research Group  
Liverpool John Moores University  
 Tom Reilly Building, Byrom Street, L33 AF    
W.Gregson@ljmu.ac.uk  
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APPENDIX 2 
Participant Consent Form and PAR-Q 
Title of project  
The impact of carbohydrate (CHO) manipulation on the systemic response of post-exercise cold-water 
immersion (CWI) on markers of mitochondrial biogenesis.  
Name of Researchers and School/Faculty  
  
Mr. Robert Allan, Dr James Morton, Dr Adam Sharples, Dr Warren Gregson  
  
The Research Institute for Sport and Exercise Sciences  
  
  
1. I confirm that I have read and understand the information provided for the above study. I 
have had the opportunity to consider the information, ask questions and have had these 
answered satisfactorily  
  
  
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving a reason and that this will not affect my legal rights.  
  
  
3. I understand that any personal information collected during the study will be anonymised 
and remain confidential  
  
  
4. I agree to take part in the above study  
  
  
  
5. I consent to the removal and storage of tissue samples which will be collected  during the 
study  
  
  
6. I agree to the storage of my tissue samples for future research purposes  
  
  
  
  
  
 Name of Participant               Date                       Signature  
  
  
  
 Name of Researcher                    Date      Signature  
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 Name of Person taking consent    Date      Signature  
(if different from researcher)  
  
  
  
 
Non-Validated Questionnaires (PARQ, Muscle Biopsy, Cryotherapy)  
Physical Activity Readiness Questionnaire (PAR-Q)  
 For most people, physical activity should not pose any problem or hazard. The PAR-Q is designed to 
identify the small number of adults for whom physical activity might be inappropriate or those who should 
seek medical advice concerning the type of activity most suitable for them.  
1. Do you have a bone or joint 
problem such as arthritis, which 
has been aggravated by exercise or 
might be made worse with 
exercise?   
YES   NO  
2. To your knowledge, do you have 
high blood pressure?   
YES   NO  
3. To your knowledge, do you have 
low blood pressure?   
YES   NO  
4 Do you have Diabetes mellitus or 
any other metabolic disorder?   
YES   NO  
5. Has your doctor ever said that 
you have raised cholesterol (serum 
level above 6.2mmol/L)?   
YES   NO  
6. Do you have or ever suffered a 
heart condition?   
YES   NO  
7 Have you ever felt pain in your 
chest when you do physical 
exercise?   
YES   NO  
8. Is your doctor currently 
prescribing you drugs or 
medication?   
YES   NO  
9. Have you ever suffered from 
shortness of breath at rest or with 
mild exercise?   
YES   NO  
10. Is there any history of 
Coronary Heart Disease within 
your family?   
YES   NO  
11. Do you ever feel feint, have 
spells of dizziness or have ever lost 
conciousness?   
YES   NO  
12. Do you currently drink more 
than the average amount of alcohol 
per week (21units for men and 14 
units for women (1 unit = ½ pint of 
beer/cider/larger or 1small glass of 
wine))   
YES   NO  
13. Do you currently smoke?   YES   NO  
14. Do you NOT currently 
exercise regularly (at least 3 times 
per week) and/or work in a job that 
is physically demanding.   
YES   NO  
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15. Are you, or is there any 
possibility that you might be 
pregnant?   
YES   NO  
16. Do you know of any other 
reason why you should not 
participate in a programme of 
physical activity?   
YES   NO  
  
  
  
  
 If you have answered YES to any of the above please give  
details:……………………......................................…………………………………………………
… 
……………………………………………………….….……………………………………………
… 
………………………………………………………………..............................................................
....  If you answered YES to one or more questions:   
If you have not already done so, consult with your doctor by telephone or in person before increasing your physical activity 
and/ or taking a fitness appraisal. Inform your doctor of the questions that you answered ‘yes’ to on the PAR-Q or present 
your PAR-Q copy. After medical evaluation, seek advice from your doctor as to your suitability for:   
1. Unrestricted physical activity starting off easily and progressing gradually, and …  2. Restricted or supervised activity 
to meet your specific needs, at least on an initial basis.   
  
If you answered NO to all questions:   
If you answered the PAR-Q honestly and accurately, you have reasonable assurance of your present suitability for:   
1. A graduated exercise programme  2. A fitness appraisal.   
  
Assumption of Risk   
I hereby state that I have read, understood and answered honestly the questions above. I also state 
that I wish to participate in activities, which may include aerobic exercise, resistance exercise and 
stretching. I realise that my participation in these activities involve the risk of injury and even the 
possibility of death. I hereby confirm that I am voluntarily engaging in an acceptable level of 
exercise, which has been recommended to me.  
  
Name (Print):   Investigator’s Name:   
Subject’s Signature:   Signature:   
Date:   Date:   
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APPENDIX 3 
Liverpool John Moores University Muscle Biopsy 
Information Sheet   
   
  
The muscle biopsy technique is a commonly employed technique within the exercise 
sciences.  It is usually employed in studies that are examining the structure, metabolic and 
cellular state of a muscle in response to acute and chronic bouts of exercise.  The following 
information is designed to inform all individuals interested in participating in a muscle 
biopsy study of the specific procedures and their associated risks and discomfort. Muscle 
biopsies are always carried out by fully qualified and experienced medical doctors.  
   
The procedure of a muscle biopsy and possible associated discomfort  
  
The muscle biopsy involves the removal of a small piece of muscle tissue from one of the muscles in your leg 
using a sterile hollow needle.  The area over the outside of your lower thigh muscle (vastus lateralis muscle) 
and/or (calf) gastrconemius muscle will be carefully cleaned.  A small amount of local freezing (anesthetic) 
will be injected into and under the skin.  You will likely experience a burning sensation while the freezing is 
injected, but this will only last momentarily.  Then a small, 4 – 5 mm incision will be made in your skin in 
order to create an opening for the biopsy needle.  There is often a small amount of bleeding from the incision, 
but this is usually minimal. The biopsy needle will then be inserted through the incision into the thigh/calf 
muscle and a small piece of muscle (20 – 50 mg) will be quickly removed and the needle taken out.  During 
the time that the sample is being taken (about 5 seconds), you may feel the sensation of deep pressure in the 
muscle, and on some occasions this is moderately painful.  However, the discomfort very quickly passes and 
you are quite capable of performing exercise and daily activities.  There may be some minimal bleeding when 
the needle is removed which may require application of pressure for a few minutes. Following the biopsy, the 
incision will be closed with sterile tape (steri-strips), and wrapped with a tensor bandage.  Once the freezing 
wears off, your leg may feel tight and often there is the sensation of a deep bruise.    
  
What to do following a muscle biopsy  
 After the procedure, you may feel some mild discomfort and possibly see some bruising. This often feels 
like the sensation of a ‘dead leg’ and your leg may feel discomfort when walking down the stairs etc. This is 
perfectly normal and should not cause you any undue concern.  The tightness in the muscle usually 
disappears within 2 days.  Seven to ten days after the biopsy you will be asked to visit the doctor who 
performed the biopsy at the Research Institute for Sport and Exercise Sciences for a formal assessment of 
how the biopsy site is healing.  
  
Potential risks associated with muscle biopsies  
 The local freezing will likely result in a burning feeling in the muscle at the time of the injection.  This will 
last only 5 – 10 seconds.  There is an extremely low risk of allergic reaction to the local injection (1 in 1 
million). The chance of a local skin infection in less than 1 in 1000.  Carefully cleaning the skin and keeping 
the area clean until the skin heals will minimize this. Most subjects experience local soreness and stiffness in 
the leg for two or three days after the biopsy similar to a deep bruise.  There is a very low risk of internal 
bleeding at the biopsy site which can result in more prolonged pain and stiffness in the leg. On occasions, a 
small lump of scar tissue may form under the site of the incision, but this normally disappears within 2-3 
months, or within a few weeks if massaged.  A small visible scar often remains from the biopsy incision. 
There is the possibility of a small area of numbness (about the size of a two pence piece) around the biopsy 
site.  This usually resolves over 5 – 6 months.  There is a very low risk (estimated at less than 1/5000) of 
damage to a small nerve branch to the muscle.  This would result in partial weakness of the muscle and 
would likely have no impact on day-to-day activities.  Nerve injuries like this usually resolve in 8 – 12 
months, but there is a theoretical risk of mild leg weakness.  
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Problems or concerns  
Infection can be serious and if you therefore experience a lot of bleeding from the biopsy site, swelling or 
infection around the biopsy site, faintness, light headedness, heart pain, chest pain or increasing pain in your 
leg which is not relieved by Paracetamol, you must contact the doctor who did the biopsy right away.  
However, if for some reason, you are not able to contact this physician then you should contact your family 
doctor or go to the Accident and Emergency Department.  
  
 
 
MUSCLE BIOPSY SUBJECT SCREENING FORM  
Research Institute for Sport and Exercise Science Liverpool John Moores University.  
Tom Reilly Building  
Byrom Street Campus  
L3 3AF  
To help us ensure your safety and well-being please answer the following questions.   
1. Have you ever had a negative or allergic reaction to local freezing (e.g. during dental 
procedures)?  
 No    Yes   
  
2. Do you have any tendency toward easy bleeding or bruising (e.g with       minor cuts or 
shaving)?  
   No    Yes   
  
3. Are you currently taking any medication  
   No    Yes   
  
4. Have you ever fainted or do you have a tendency to faint when undergoing        or watching 
medical procedures?  
  No    Yes  5.  Will you contact the physician who did the biopsy directly if you 
have any  concerns about the  biopsy site including:  excessive redness, swelling,  
infection, pain or stiffness of the leg? 
   No    Yes   
6. Are you willing to visit the physician who did the biopsy 7 – 10 days following the 
biopsy for an assessment of the biopsy site? No    Yes   
7. Are you willing to allow samples collected from you to be used for analysis of mRNA 
abundance and protein content for the purpose of the research study outlined in the Subject  
 Information sheet and future research of the same interest? No    Yes  
 Subject Name (print) :_____________________________________   
Subject Signature :_______________________________________  
  
Date :_________________   
        
Signature of Person Conducting Assessment: ________________________  
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CRYOTHERAPY SCREENING FORM  
Tom Reilly Building  
Liverpool John Moores University  
To help us ensure your safety and well-being, please answer the following questions.  
1. Have you ever suffered from any of the following cold related conditions?  
  
• Raynaud’s disease    
• Vasospastic diseases (blood vessels don’t dilate properly)   
• Cold  hypersensitivity  
• Compromised local circulation  
  
No                         Yes   
  
2. Have you ever had a negative or allergic reaction to cryotherapy (cold) exposure?   
 No  Yes     
  
3. Has your doctor ever said you have a heart condition?   
 No  Yes    
  
4. Do you currently have or ever been diagnosed with high blood pressure?  
 No  Yes      
  
5. Have you been diagnosed with a rheumatoid condition?  
   No  Yes    
  
  
Subject name (print):_______________________________  
Subject signature:__________________________________  
Date:____________  
Signature of person conducting assessment:_______________________  
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APPENDIX 4 
 
Post biopsy treatment guidelines 
 
After the procedure, you may feel some mild discomfort and possibly see some bruising. The 
biopsy site will often feel like the sensation of a ‘dead leg’ and your leg may feel discomfort when 
walking down the stairs etc. This is perfectly normal and should not cause you any undue 
concern.  The tightness in the muscle will usually disappear within 2 days.   
 
Please refer to the following advice in order to limit the possibility of infecting the wound and 
speeding up the repair process.  
 
Key points: 
- Try to keep the wound clean at all times. The most serious risk to you is infection.  
- Do not take the sterile plaster off for 2 days (48h). 
- If the plaster falls off in the first 48h please replace it with one of the spares we provided. 
- After 48h do not re-apply a plaster to the site. 
- Replace the steri-strips if they fall off until the wound has healed. If you are unsure about this 
please contact the research team and we can do this for you.  
- DO NOT SWIM OR HAVE A BATH FOR AT LEAST 4 DAYS AFTER THE BIOPSY. 
- You may shower but try to keep the plaster or steri-strip dry. 
- Do not use soap or abrasive materials over the wounds.  
- Do not exercise for 48h following the biopsy (unless the study protocol requires this) 
- Regularly apply ice for short periods (20 minutes) for the first 48 hours after the biopsy.  
- Bandaging of the leg is at your discretion. It will help reduce soreness but can be uncomfortable 
to wear.  
- You can take paracetamol or another pain killer  
 
Infection can be serious; therefore, if you experience a lot of bleeding from the biopsy site, 
swelling or infection around the biopsy site, faintness, light headedness, heart pain, chest pain or 
increasing pain in your leg which is not relieved by Paracetamol, you must contact the study 
team who will put you in touch with the study medic.  However, if for some reason, you are not 
able to the study team then you should contact your GP. 
 
Study team Contact Details: _____________ 
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APPENDIX 5 
DEPLETION/REPLETION MEAL PLAN 
      CHO PRO FAT 
6pm PM MEAL 380 ml Lucozade original    
    4 x jaffa cakes 34.4 2.4 4 
        
7pm   coco pops 100g 85 5 2.5 
    200ml whole milk 9.4 6.5 7.2 
         
8pm   hartleys strawberry jam (15g) x2 18.2 0.8 0 
    4 white bread 83.2 18.8 3.6 
         
9pm   GO Energy drink (500ml) 47 0 0 
    One banana 23 1 0 
         
      364.8 34.5 17.3 
      
7am meal1 coco pops 100g 85 5 2.5 
  200ml whole milk 9.4 6.5 7.2 
      
  
4 x white toast (warbutons white toastie) 
 ~ 95g) 83.2 18.8 3.6 
  hartleys strwberry jam (15g) x2 18.2 0.8 0 
      
8am  380ml lucozade original 64.6   
10am Snack 1 Yeo valy yoghurt (150g) 10 7 6.3 
  Tin peaches drained (250g) 27.5 0 0 
  GO Energy drink (500ml) 47 0 0 
      
1pm meal2 Tesco chicken breast 100g 0 23.5 1.7 
  Tilda white basmati (250g pack) 70.4 7.2 4.8 
  tesco broccoli 50g 0.9 2.2 0.45 
  GO Energy drink (500ml) 47 0 0 
      
2pm snack2 GO Energy drink (500ml) 47 0 0 
      
      
3pm meal3 Tesco chicken breast 100g 0 23.5 1.7 
  Tilda white basmati (250g pack) 70.4 7.2 4.8 
  tesco broccoli 50g 0.9 2.2 0.45 
  GO Energy drink (500ml) 47 0 0 
      
5/6pm depletion     
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APPENDIX 6 
 
PARTICIPANTS WANTED! 
Are you a keen cyclist? 
Are you interested in optimising your 
post-exercise recovery? 
The Research Institute of Sport and Exercise Sciences 
are looking to investigate the mechanisms responsible 
for the benefit of Cold Water Immersion / Ice baths! 
To be eligible for this study, you must meet the following criteria;  
 Male, aged 18-40 
 Physically fit and free from injury or illness 
 Undertake regular exercise in the form of cycling 
 
The research involves 3 visits to the Tom Reilly Building 
Laboratories, Liverpool, two of which will contain Cold Water 
Immersion (8°C) and muscle biopsies. 
 
For more information on the study aims and procedures please do 
not hesitate to contact us on: 
 R.J.Allan@2013.ljmu.ac.uk  Robert Allan, PhD Student  
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APPENDIX 7 
Presented as an Oral at ECSS 2016, Vienna, YIA category. 
 
The acute cold-induced increase in PGC-1α is mediated systemically through increased β-
adrenergic stimulation.  
Allan R, Sharples AP, Close G, Drust B, Shepherd S, Fraser W, Mawhinney C, Hammond, K, Morton 
JP, Gregson W 
INTRODUCTION 
Post-exercise cold water immersion (CWI) increases the PGC-1α mRNA response to exercise (Ihsan 
et al. 2014). The molecular mechanisms mediating this response are yet to be fully elucidated but 
may involve upregulation of the local signalling kinases AMPK and p38 MAPK (Ihsan et al. 2015) 
and/or increased systemic β-adrenergic stimulation (Puigserver et al. 1998; Ihsan et al. 2014).  
Using a single leg immersion protocol our aim therefore was to examine whether the cold-induced 
post exercise increase in skeletal muscle PGC-1α mRNA is locally and/or systematically mediated.  
METHODS 
In a repeated measures cross-over design 10 active subjects completed high-intensity intermittent 
cycling (8 x 5 minute bouts separated by 60 sec rest, ~80% peak power output) followed by seated 
rest (CON) or single-leg cold water immersion (CWI; 10 min, 8°C). Muscle biopsies of the immersed 
(CWI) and CON legs were taken pre, post- and 3h post-exercise. In the non-immersed leg (NOT) 
biopsies were taken post- and 3h post-exercise. qRT-PCR and Western Blots were performed to 
assess gene expression (mRNA) and signalling kinase activity respectively. Plasma 
normetanephrine concentration was used as a measure of the systemic β-adrenergic response. 
Two factor (condition × time) within-subjects GLM with repeated measures determined treatment 
differences. LSD pairwise comparisons was used to locate the difference. 
RESULTS 
Exercise per se induced increases in PGC-1α mRNA 3h post-exercise (~5-fold; P < 0.001). These 
changes were further elevated following CWI (~9-fold; P < 0.001) and were similar in both CWI and 
NOT (~12-fold; P < 0.05). Plasma normetanephrine concentration was higher in CWI vs. CON (P = 
0.034) (860 vs. 665 pmol·L-1 post-immersion). 
DISCUSSION 
We report for the first time that local cooling of the immersed limb evokes transcriptional control 
of PGC1-α in the non-immersed limb. This suggests that increased systemic β-adrenergic 
stimulation, and not the effects of localised cooling on skeletal muscle signalling kinases, mediates 
the post-exercise increases the PGC-1α mRNA. Results from the present study have important 
implications for research designs which adopt contralateral non-immersed limbs as a control 
condition, whilst presenting new directions for mechanistic research into cold-induced PGC-1α 
responses. 
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APPENDIX 8 
Melt curve analysis presented single reproducible peaks for each target gene 
suggesting amplification of a single product. 
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